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Summary
Many different strategies have been developed for the analysis of microarray data and 
these have a significant influence on the level and quality of knowledge that may be 
achieved from a microarray-based experiment. Two such strategies are explored in this 
thesis.
Part A of this thesis describes explorations of a resource-efficient strategy that could 
allow for large-scale integration of microarray data in an unsupervised fashion. For this 
purpose, comparisons were carried out between a series of genelists manually extracted 
from the literature, representing a disparate set of microarray experiments. Initial results 
were highly unexpected, and are likely to have been caused by violations of the 
assumptions of the hypergeometric test used for assessing comparisons. Statistical 
modelling was found to successfully simulate these results; however the estimated net 
effect of these violations was found to be considerable. These findings strongly caution 
against the comparison of microarray experiments using their genelists.
Part B then describes the development of Gene Set Discovery (GSD), a novel 
methodology to perform threshold-free gene set analysis of microarray datasets without 
requiring sample class information. This was achieved by deriving a novel metric that 
allows for the selection of those gene sets that exhibit significant discrimination between 
samples. GSD was implemented on four microarray datasets and the results were found 
to be biologically plausible and/or in agreement with prior analyses of these datasets. 
These findings suggested that GSD could be a potentially useful tool for biological 
theme discovery in microarray datasets, particularly in studies of cancer where sample 
classification is problematic. Also described is a related methodology for extraction of 
informative genes from within selected gene sets, and a scheme for visualization of 
results in an integrated format.
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Chapter 1: Introduction
Chapter 1: Introduction
The work described in this thesis primarily concerns the implementation and 
development of methods with which to analyze and interpret data from microarray-based 
experiments. This chapter introduces some of the basic underlying concepts of 
microarray technology. It also aims to provide a broad overview of the analytical 
workflows, technical methodologies and strategies used for microarray data analysis. 
Because this is a constantly developing sphere of research with a varied range of 
available options, this chapter places emphasis on describing those concepts, methods 
and strategies that are relevant to work described in this thesis.
Section 1.1 examines the importance of high-throughput gene expression profiling, and 
the evolution of microarrays for this purpose. Section 1.2 then introduces Affymetrix 
GeneChip technology and the generation of gene expression data. Section 1.3 describes 
several different strategies for microarray experimental design and analysis, the choice 
of which to use depends on the aims of an experiment. Section 1.4 describes the 
underlying concepts of methodologies that have been popularly used to aid the 
biological interpretation of microarray data. In particular, this section describes methods 
used to link microarray data to prior biological knowledge. Section 1.5 examines the 
concepts and strategies used for integration of data from different microarray-based 
experiments. Finally Section 1.6 describes the scope and structure of work described in 
this thesis, as well as guidance regarding the terminology used.
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Chapter 1: Introduction
1.1 Gene expression profiling using microarrays
1.1.1 The paradigm shift in molecular biology
A grand aim of molecular biology studies has been to elucidate how information coded 
in the genome is used for the development and maintenance of a functional living 
organism. Prior to the development of some of the technologies described below, most 
research was carried out by studying the functions of one gene at a time. However, the 
biochemical processes of life involve complex networks and interactions between genes 
and gene products, and the scope for such a ‘reductionist’ approach to capture these 
complexities is limited (Vukmirovic and Tilghman 2000).
Over the past 10-15 years, there have been several technological advancements that have 
allowed for molecular biology studies to be carried out using a ‘holistic’ approach. One 
of the first such developments was that of high-throughput whole-genome sequencing 
technologies, which has led to the sequencing of complete genomes of hundreds of 
organisms, including humans (Lander et al. 2001; Venter et al. 2001). While genome 
sequences (along with the information derived from sequence analyses) can be thought 
o f as ‘gene catalogues’ representing lists of all the components of a functional genome, 
other high-throughput ‘post-genome’ technologies have been developed that allow 
global studies of the interactions and relationships between these components. One of 
the most widely used of these technologies is DNA microarrays (Pease et al. 1994; 
Schenaetal. 1995).
Microarrays allow for global gene-expression profiling, by monitoring the levels of 
mRNA expressed by thousands of genes simultaneously. The mRNA complement of a 
cell (i.e. its transcriptome) is a major determinant of phenotype and function. Unlike the 
genome, it is highly dynamic, changing rapidly and dramatically both during normal 
cellular events (such as cell division), or in response to external stimuli (such as 
treatment with a drug) (Lockhart and Winzeler 2000). The rationale for the use of
14
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microarrays is that observation of the levels of gene expression (i.e. mRNA abundance), 
and the conditions for expression, can provide clues about the functions of genes. 
Patterns of expression shared by many genes can inform about broader biochemical 
themes and processes (such as pathways and regulatory mechanisms), as well as 
interactions between genes and gene products. Simultaneous observation of large 
numbers of genes (such as all genes of an organism) allows for identification of 
potentially all genes relevant to particular experimental conditions.
Microarrays have been used for a wide variety of applications, such as biomarker 
identification, pharmacogenomics, toxicogenomics, disease class discovery, etc. While 
microarrays have been developed for other purposes, such a detection of mutations 
(‘genotyping arrays’), this thesis only concerns use of microarrays for gene expression 
profiling.
1.1.2 The development of microarray technology
The key principle underlying microarray technology is that complementary nucleic acid 
(DNA or RNA) strands hybridize to each other. This principle has formed the basis for 
several established molecular biology techniques, such as Southern and Northern 
blotting. In Southern blotting, short nucleic acid sequences are radio-labelled and used 
as ‘probes’ to hybridize to DNA sequences that have been separated on the basis of size 
by gel electrophoresis. The occurrence of binding is then visualized using radiation- 
sensitive photographic film. In Northern blotting, the probes are hybridized to mRNA 
instead. In both cases, the intensity of the radio-labelled probe on the film is then used as 
a semi-quantitative measure of the amount of DNA/RNA present, as compared to a 
known standard.
The use of arrays for gene expression profiling has developed from the idea of a mass 
parallel version of these blotting techniques (Lander 1999), with a key distinction being
15
Chapter 1: Introduction
the immobilization of probes to a solid substrate. The first such arrays (‘macroarrays’) 
involved spotting of cDNA libraries (usually of unknown sequence) as probes onto 
porous nylon membranes, onto which radio-labelled mRNA was hybridized. The 
microarrays that are used today have evolved from these, and involve great 
improvements in terms of experimental efficiency and information content. Several 
factors have aided the development of microarrays, such as the use of non-porous solid 
substrate (glass slides), the use of fluorescence for detection (as opposed to radio- 
labelling) and the development of technologies for synthesis or deposition of probes on 
substrates at very high densities (Lockhart and Winzeler 2000).
1.1.3 Overview of microarray technologies
There are several different techniques that can be used to create microarrays, which in 
turn require different experimental workflows and data analysis pipelines. However, all 
these aspects share some fundamental principles. Firstly, in all cases, the nucleic acid 
sequences representing the probes are bound to solid surfaces (usually glass slides) at 
known positions, using a variety of techniques. Next, expressed mRNA is extracted from 
an experimental sample and converted into cDNA by reverse transcription. This is then 
labelled using fluorescent dyes, eluted onto the arrays and allowed to hybridize. 
Hybridization is detected by fluorescence following laser excitation, and the intensity of 
the fluorescence is used to compute an estimate of expression levels. Details of two of 
the most popularly used microarray technologies are described below.
1.1.3.1 cDNA (‘spotted’) microarrays
cDNA microarrays (Brown and Botstein 1999) are created by robotic spotting of entire 
cDNA/EST sequences onto glass slides at precise pre-defined points, to be used as 
probes. Normally, these are used to assess differential expression between two samples: 
cDNA reverse-transcribed from mRNA extracted from one sample is labelled with a 
green fluorescent dye (Cy3), and that from the other with a red fluorescent dye (Cy5).
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The labelled cDNA is mixed and allowed to co-hybridize on the slide. The slide is then 
scanned using two different wavelengths of a laser to obtain the intensities for each dye 
used (two-channel detection).
1.1.3.2 High-density oligonucleotide microarrays
Oligonucleotide arrays (Lipshutz et al. 1999) are created using photolithographic 
techniques that allow for extremely high feature density with complete control of 
sequences used as probes. Typically, a set of probes comprising of unique sequences are 
used to represent a single gene or expressed sequence tag (EST). cDNA reverse- 
transcribed from the mRNA from each sample is labelled and hybridized onto separate 
arrays, each of which is laser-scanned separately (single channel detection).
1.1.3.3 Choice of microarrays
The choice of which microarray technology to use is decided by the needs of the 
researcher, and both technologies described above have advantages and disadvantages 
relative to each other. cDNA microarrays are typically designed and produced by the 
researchers themselves, and this system allows a great deal of flexibility with regards to 
array design and features. This also does not require prior knowledge of the sequence of 
the probes, which is useful for experiments on organisms for which availability of 
sequence data is limited. Oligonucleotide microarrays are usually designed and produced 
by commercial manufacturers, and require sequence information for probes. However, 
this removes the resource-intensive and potentially error-prone requirement for 
researchers to maintain and use cDNA libraries for probes.
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1.2 Affymetrix GeneChip technology
Asymetrix is one of the largest commercial manufacturers of high-density 
oligonucleotide microarrays. All data presented in this thesis are derived from 
experiments carried out on this platform.
1.2.1 Experimental workflow and data generation
1.2,L l Array design
The Affymetrix GeneChip microarrays consist o f oligonucleotide probes (25 nucleotides 
long) synthesised by a photolithographic process. Each gene is represented by one or 
more probe-sets, each comprising of 11-20 perfect-match (PM) oligonucleotide probes 
and 11-20 corresponding mismatch (MM) probes. The PM probes have sequences that 
are complementary to sequence fragments of a particular gene. The MM probes are 
identical to the PM probes except with a single base substitution at position 13 (out of 
25). Figure 1.1 displays the Affymetrix probe-set design strategy for eukaryotic 
organisms. Affymetrix claims that MM probes allow for quantification of (and 
subsequent control for) background noise and cross-hybridization by transcripts from 
different genes. The sequences used to design the probes are derived from several public 
sequence databases, such as UniGene, RefSeq, GenBank and dbEST (Affymetrix 2001).
1.2.1.2 Sample processing
The typical experimental workflow for samples from eukaryotic organisms is described 
as follows: first mRNA is isolated from cells (which may be from a tissue sample or a 
cell line), and then reverse-transcribed into double-stranded cDNA.
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5'
mRNA reference sequence
3'
„  _ Spaced DNA probe pairs
Reference sequence
TGTGATGGTGGGAATGGGTCAGAAGGACTCCTATGTGGGTGACGAGGCC
AATGGGTCAGAAHGACTCCTATGTGGGTG Perfect Match Oligo 
AATGGGTCAGa J J s ACTCCTATGTGGGTG Mismatch Oligo
Perfect match probe cells
Fluorescence Intensity Image
Mismatch probe cels
Figure 1.1 A ffym etrix probe-set design strategy. This figure is reproduced from 
Figure 2b in Lipshutz et al (1999)
The next stage involves amplification of this cDNA into biotin-labelled cRNA which is 
then fragmented. This cRNA is then eluted over an array to allowr for hybridization to 
occur over an extended period of time (16 hours) at optimal hybridization temperatures. 
It is assumed that the amounts of cRNA that hybridize to their respective probes is 
proportional to their relative levels within the original sample. Following this, 
unhybridized material is washed away and a fluorochrome (streptavidin-phycoerythrin) 
is added to bind to the biotin-label on the hybridized cRNA. The array is then placed in a 
scanner where a laser is applied to excite the fluorochrome. An image of the array is 
stored as a DAT file, recording the intensity of fluorescence for each probe in many 
pixels. Using software included with the scanner, a single intensity value is calculated 
for each probe using all pixel intensities for that probe. These probe intensity values are 
stored in a CEL file.
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1.2.2 Data pre-processing
The probe intensity values contained in CEL files represent the ‘raw data’ from 
microarray-based analyses. However, a series of data manipulation and statistical 
modelling steps are usually carried out to make this data comparable within and across 
arrays. Such pre-processing is carried out to produce biologically meaningful data that 
can then be used for expression analysis. Many pre-processing methods are now 
available; the Affycomp (Cope et al. 2004) initiative to benchmark these methods has 
been used to assess nearly 90 such methods (as of July 2009). However it is still unclear 
as to which is the method is the ‘best’ (Allison et al. 2006).
Most of these methodologies have in common a three-stage approach (Bolstad et al. 
2005; Gentleman and Huber 2008): one stage involves ‘background correction’ to 
control for any non-specific signal (as may be caused by cross-hybridization of non- 
target transcripts with similar sequences), and to identify a detection threshold. Carrying 
out of this stage helps make the data across an array comparable, and increases array 
sensitivity.
The second stage is the process of ‘between-array normalization’ which is performed to 
minimize undesirable technical variability between data across the arrays, as may be 
caused by differences in handling, labelling, hybridization and scanning of different 
arrays. This stage is necessary to make the data comparable across chips, and to ensure 
much of the variability between arrays is due to biological reasons (which are of interest 
to a researcher).
The final stage is ‘summarization’; this is particularly relevant to data from Affymetrix 
arrays because a probe-set representing a single gene transcript on an array comprises of 
11-20 different probes. This process then involves combining the multiple probe 
intensity values for each probe-set to produce a single gene expression value for that 
probe-set.
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Two of most widely used pre-processing methodologies are described below.
1.2.2.1 Microarray Suite 5.0 (MASS)
MAS5 (Affymetrix 2002) is the software developed by Affymetrix for pre-processing of 
microarray data, and utilizes probe intensity data for both PM and MM probes. 
Background correction is carried out by using the lowest 2% probe intensities for 
various regions of the array to calculate background values for those regions. Probe 
intensities are then adjusted using a weighted average of each of the background values. 
Between-array normalization is carried out using a scaling technique: a baseline array is 
selected and all other arrays are scaled to have the same mean intensity as this array. 
Summarization is carried out by calculating a ‘Signal’ value representing the expression 
level for each probe-set, using intensity values for all PM probes and adjusting these for 
intensity values of all MM probes. MAS5 also provides for each probe-set, a ‘Detection 
Call’ to indicate if the transcript represented by a probe-set is ‘Present’, ‘Marginal’ or 
‘Absent’.
1.2.2.2 Robust Multichip Average (RMA)
The RMA algorithm, which was developed by independent researchers (Irizarry et al. 
2003), utilizes intensity values for only the PM probes. Background correction is carried 
out by modelling probe intensity values as the sum of a Gaussian noise component and 
an exponential signal component. Between-array normalization is performed by using 
quantile-quantile normalization to impose the same empirical distribution of intensities 
to each array. Summarization is based on a multi-array model using the ‘median polish’ 
algorithm to robustly estimate central tendency.
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1.3 Microarray data analysis strategies and workflows
Pre-processing of Affymetrix microarray data is usually followed by one or more steps 
of data transformation, such as log transformation, and gene-wise mean/median centring. 
This yields a ‘gene expression matrix’ which is the starting point for all subsequent data 
analysis. It comprises of a matrix where the rows represent genes (probesets) and the 
columns represent experimental conditions (samples). The cells are filled with numbers 
representing the expression level of a gene within a sample.
The following sections describe categories of statistical methodologies and data mining 
techniques that are commonly used to analyze microarray data. These can be divided 
into two broad categories on the basis of whether or not they utilize information 
regarding the samples (Allison et al. 2006; Butte 2002; Causton et al. 2003; Dudiot and 
Fridyland 2003; Tarca et al. 2006). The choice of the data analysis workflow depends on 
the nature and design of the experiment, as well as the information desired by the 
researcher.
1.3.1 Supervised Analysis -  Class comparison and prediction
Methodologies used to analyze microarray data can be considered to be ‘supervised’ if 
they require knowledge regarding the classes of samples. These classes usually represent 
two or more different experimental conditions. Sample class information may be known 
a priori during the experimental design phase (for example, normal versus diseased 
samples, cells treated with a chemical versus untreated cells, or different times points of 
a developmental process) or may be derived through unsupervised class discovery 
studies (see Section 1.3.1.2).
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1.3.1.1 Class comparison: assessing differential gene expression
The primary objective of class comparison studies is to assess whether the expression 
profiles of samples representing two or more classes are different, and to identify which 
genes exhibit differential expression levels across these sample classes. Typically, these 
involve performing a statistical test to assess the significance of differences in gene 
expression levels across sample classes for each gene separately. A wide range of tests 
have been used for this purpose (Jeffery et al. 2006; Pan 2002), such as variants of the 
Student’s t-test for two-group analyses and variants of the analysis of variance 
(ANOVA) test for when more than two groups are being analyzed. Genes can then be 
ranked on the basis of some metric derived from these tests and then selected using a 
pre-defined cut-off value to indicate significance (typically, a p-value of <0.05).
An issue that arises because of the performance of separate statistical tests on each of 
several thousand genes is that of the potentially large number of ‘false positives’ that 
would be expected. For example, when selecting genes exhibiting p-values of less than 
0.05 after carrying out a statistical test for differential expression on 20,000 genes, it is 
expected to select as many as 1,000 genes simply by chance alone (and not for any 
biological reasons). For this reason, it is considered necessary to carry out some form of 
‘multiple testing correction’, such as the Benjamini-Hochberg FDR method (Benjamini 
and Hochberg 1995) to increase p-values in proportion to the number of tests being 
performed (i.e. the number of genes being tested). Because the stringency of these tests 
increases with the number of genes analyzed, it has also become standard practice to 
carry out ‘non-specific filtering’ of genes to reduce this ‘gene universe’ size (Huber et 
al. 2008; Scholtens and Heydebreck 2005). These include removing genes that fail to 
exceed threshold levels of expression (such as those used by the MAS5 algorithm to 
assign Detection Calls of ‘Present’), or variability (because genes exhibiting stable 
expression levels across sample classes are unlikely to be of interest).
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1.3.1.2 Class prediction: developing sample classifiers
The objective of class prediction (also known as ‘classification’) techniques is to build a 
set of genes (a ‘classifier’) using samples with known classes that can classify other 
samples for which class information may not be available. Given a dataset with known 
sample classes, class prediction is typically carried out by first using a subset of this data 
(the ‘training set’) to derive a classifier. The accuracy of class prediction achieved by the 
classifier is then tested on another subset of the data (‘validation’). Having assessed the 
quality of the predictions, the classifier can then be used on new datasets. Several 
different supervised machine learning algorithms have been used for this purpose, such 
as support vector machines, neural networks and decision trees (Allison et al. 2006; 
Butte 2002; Causton et al. 2003; Quackenbush 2001).
1.3.2 Unsupervised analysis -  Class discovery
Unsupervised analysis of microarray data requires no prior knowledge of sample classes. 
The objective of such analyses is to ‘discover’ classes of genes and samples within a 
microarray dataset by identifying groups of genes and samples on the basis of their 
expression profiles. For this purpose, methods are used to find any underlying structure 
within the data with respect to shared patterns of gene expression.
Class discovery in microarray data was first described by Golub et al (Golub et al. 
1999), who achieved automated separation of acute myeloid leukaemia (AML) and 
acute lymphoblastic leukaemia (ALL), as well as differentiation between B-cell ALL 
and T-cell ALL, without requiring prior knowledge of these cancer classes. Indeed, class 
discovery has found much utility in studies of cancers, where morphological and 
histological methods may not provide adequate discrimination between tumour sub- 
types. For example, Alizadeh et al (Alizadeh et al. 2000) used hierarchical clustering to 
identify two previously unknown sub-groups of diffuse large B-cell lymphoma 
(DLBCL) samples. These new sub-groups corresponded to highly significant differences
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in patient survival rates and prognoses, even though the samples were not 
morphologically distinct. There are many other such examples in the published literature 
(Bittner et al. 2000; De Cecco et al. 2004; Ivshina et al. 2006; Perou et al. 2000).
Several different techniques have been used for class discovery in microarray data, such 
as clustering and self-organizing maps. Described below are two of the most popularly 
used clustering methodologies:
1.3.2.1 Hierarchical clustering
A key concept used by hierarchical clustering techniques is that of ‘distances’. These 
represent quantifications of the dissimilarity between any pair of genes or samples in a 
microarray dataset, based on their expression profiles. For this purpose, genes can be 
considered to be points in M-dimensional space, for an experiment with M number of 
samples (Kuruvilla et al. 2002). Similarly, samples can be considered to be points in N- 
dimensional space, where N represents the number of genes being considered. A number 
of distance metrics can be derived from this model, using, for example, the Euclidean 
distance between any two points, or the vector angle (as the cosine distance). One such 
popularly used distance measure is the Pearson’s correlation distance, which is 
equivalent to using the vector angle for mean-normalized data (Eisen et al. 1998).
Hierarchical clustering algorithms then use these distances to build a tree (‘dendrogram’) 
to represent the hierarchical structure of the data. The ‘nodes’ represent genes or 
samples and the ‘branch’ lengths are based on the pre-calculated distances. ‘Divisive’ 
hierarchical clustering methods start off by considering all objects (genes or samples) to 
be part of a single cluster and divide this into further sub-clusters. This is iterated by 
considering each sub-cluster separately till all objects are separated from each other. 
‘Agglomerative’ hierarchical clustering methods start by considering each gene/sample 
to be separate clusters. The most similar objects are then considered to be a single 
cluster and the distances between this cluster and all other objects are re-calculated. The
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object closest to the new cluster is added to this cluster; this is iterated till all objects are 
grouped in a single cluster. Using a pre-defmed distance, or one decided by the user 
having inspected of the dendrogram, the tree can be ‘cut’ at certain points to define the 
final clusters.
One technique that has widely been used for cluster analysis of microarray data (and in 
microarray data visualization schemes such as ‘heatmaps’) is agglomerative hierarchical 
clustering utilizing the Unweighted Pair Group Method with Arithmetic mean 
(UPGMA) method. This uses the average distance between every point in one cluster to 
every point in another cluster as the measure of cluster distance (‘average linkage’).
1.3.2.2 K-means clustering
K-means is a ‘partitioning’ clustering technique that differs from hierarchical clustering 
in that it does not produce a hierarchical structure of objects, does not require pre­
calculation of all pair-wise distances between objects, but does require a user-defined 
number of clusters (K). This is carried out by random (or heuristic) assignment of all 
objects to K number of clusters. The distances between each object and cluster center 
(‘centroid’) are calculated, and each object is re-assigned to the cluster with the nearest 
centroid. This is iterated by recalculation of centroids (of the newly formed clusters) 
until the centroids stabilize or a pre-defmed number of iterations is achieved.
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1.4 Biological interpretation of microarray data
The results derived from the strategies and data analysis pipelines described in Section
1.3 may be sufficient for certain microarray-based experiments. For example, having 
derived a list of genes that exhibit significantly differential expression levels across 
disease and non-disease samples, these genes may then be used as candidate biomarkers 
for the disease. However, in most cases, a natural progression would be to attempt to 
interpret these results in terms of their underlying biology. This could provide further 
insight into the biological mechanisms that are relevant to an experiment.
One of the most widely used strategies to achieve this is to investigate microarray data in 
the context of ‘biological themes’. Such themes include biochemical pathways and 
processes, and can be represented as sets of genes known a priori to be relevant to any 
particular theme (‘gene sets’). Investigation of microarray data in terms of biological 
themes can be termed as ‘gene set analysis’ (GSA), and currently there are many options 
for this purpose: Huang et al have identified and reviewed as many as 68 different 
methodologies (Huang da et al. 2009). Key to the utility of these methodologies has 
been the development of publicly available databases that store information regarding 
biological themes in an electronic format that allows for automated analyses. This 
section first describes these databases, and then introduces two broad categories of GSA 
techniques.
1.4.1 Gene annotation databases
The Gene Ontology database (Ashbumer et al. 2000) comprises of annotation data for 
genes of a wide range of species. This was created by using a controlled vocabulary to 
describe and represent a priori biological knowledge regarding these genes and their 
products. The components of this vocabulary (‘GO terms’) each have a unique identifier, 
and are grouped into three different categories, representing different types of
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information for any particular gene and gene product. The are biological processes, e.g. 
“apoptosis” (G0:0006915); molecular functions, e.g. “kinase binding” (G0:0019900); 
and cellular components, e.g. “plasma membrane” (G0:0005886). Each of these GO 
terms can be thought of as biological themes; thus any theme can be represented as the 
set of genes that are annotated with a particular GO term.
Other sources of gene sets that have been used as biological themes by GSA 
methodologies include biological pathway annotation databases such as the Kyoto 
Encyclopaedia of Genes and Genomes (KEGG) (Kanehisa et al. 2004) and Biocarta 
(BioCarta 2005).
A key difference between GO and other sources of gene sets is that GO includes a 
framework of relationships between terms. Typically, GO terms representing larger, 
more general themes are considered to be ‘parents’ of GO terms representing smaller, 
more specific themes. For example, all genes that are annotated with the GO term 
“neurogenesis” (G0:0048699) are also annotated with the parent of this term, which is 
“nervous system development” (G0:0007399), but not the other way around. Parent- 
child relationships between GO terms are arranged in the form of directed acyclic 
graphs.
1.4.2 Threshold-based’ gene set analysis
Many of the earliest methodologies to carry out GSA were Over-Representation 
Analysis (ORA) techniques that attempted to identify ‘enrichment’ of biological themes 
within lists of ‘interesting’ genes that had been derived by analysis of microarray data 
(‘genelists’); for example, a list of genes found to exhibit significantly different levels of 
expression across two experimental conditions, as assessed by a t-test. A considerable 
number of such tools are now available, and have been reviewed by Khatri (Khatri and 
Draghici 2005), Huang (Huang da et al. 2009) and Rivals (Rivals et al. 2007). Typically,
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these methods first identify the number of genes annotated to a particular biological 
theme that are present in the genelist from an experiment, and then use statistical tests to 
assess if this observed number is significantly greater than what might be expected by 
chance. Statistical models commonly used by these methods include the hypergeometric 
distribution, Fisher’s exact test, the x-squared test and the binomial distribution (Huang 
da et al. 2009; Khatri and Draghici 2005; Rivals et al. 2007).
ORA-based methods for GSA have been referred to as ‘threshold-based’, to indicate that 
these methods test genelists that have been derived using some statistical threshold (for 
example, using a p-value cut-off of <0.05 after testing all genes for differential 
expression). This is the key aspect that differentiates ORA-based GSA methods from the 
category o f GSA methods that is described below.
1.4.3 Threshold-free’ gene set analysis
This category of GSA methods does not require selection of genelists; rather many of 
them require as input a list of all genes considered in an experiment (i.e. all genes 
represented on a microarray) ranked according to their adherence to some pre-defined 
pattern of expression across all samples. As there is no implementation of a statistical 
cut-off to identify genelists for further investigation, these methods have been termed 
‘threshold-free’.
A particular issue regarding the use of genelists by the threshold-based methods 
described in the previous section is that there is bias for selection of genes that show the 
greatest levels of differential expression (for example, in terms of fold-change) into 
genelists. Such a strategy may fail to detect structure within the dataset that could be of 
interest to a researcher: for example, if a significant proportion of genes associated with 
a particular pathway show consistent changes of expression levels across experimental 
conditions, this pathway is likely to be of interest to a researcher. However if these
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changes are relatively small in magnitude, it is likely that these genes may not be 
selected into genelists and detection of this pathway may be missed altogether (Ben- 
Shaul et al. 2005; Breitling et al. 2004; Huang da et al. 2009; Nam and Kim 2008; 
Subramanian et al. 2005). Indeed, for small and noisy datasets, few or no genes may 
exceed threshold levels of significance. Another issue is the arbitrary nature of setting 
thresholds for selection of genelists -  changing threshold values could lead to different 
results from ORA-based GSA methods (Pan et al. 2005). Threshold-free methods 
attempt to mitigate these issues by doing away with the need for selection of a genelist.
Many such methods are now available (Nam and Kim 2008), and one of the most 
popular of these is Gene Set Enrichment Analysis (GSEA) (Mootha et al. 2003; 
Subramanian et al. 2005). This methodology can be summarized as follows: all genes on 
an array are first ranked according to their differential expression across two sample 
classes using some metric. The positions of genes associated with any one gene set are 
then identified in this ranking. To test whether the genes for this gene set are enriched 
toward the top or bottom of the ranked list, an Enrichment Score (ES) is calculated, 
which is equivalent to a weighted Kolmogorov-Smimov-like statistic. The significance 
of the ES value is estimated by comparison with a null distribution of ES values which is 
calculated by permuting sample class labels and recalculating ES values for that gene set 
for each permutation.
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1.5 Integration of microarray data from different experiments
Microarrays have proven to be highly popular tools for biological research, and this is 
reflected in the development of publicly available databases containing raw data derived 
from hundreds of microarray based experiments such as the Gene Expression Omnibus 
(GEO) (Edgar et al. 2002) and ArrayExpress (Parkinson et al. 2007). The previous 
section described how further biological insight could be obtained by the integration of 
the results of a microarray-based experiment with other sources of information, such as 
biological annotation. The availability of data from hundreds of microarray-based 
experiments then allows for the prospect of another level of integration: that of data 
from different microarray experiments. Such integration could provide opportunities for 
improved sensitivity and validation of the results of microarray experiments, as well as 
deeper biological insight than may be achieved through the analysis of a single 
microarray dataset in isolation.
1.5.1 The need for integration of microarray data
A significant issue regarding the results of any single microarray based experiment 
considered in isolation is that microarrays “sacrifice specificity for scale” (Troyanskaya
2005): the expression data derived from any experiment involves that of several 
thousands of genes, measured over a relatively small number of samples. The 
sophisticated statistical methodologies used to analyse microarray data offer limited 
control of noise and technical variation, often at the cost of sensitivity of detection. 
Furthermore, validation of the results derived from any microarray based experiment is 
required to be carried out using experimental procedures such as RT-PCR and Northern 
blotting.
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1.5.1.1. Validation of results of microarray based experiments
Validation of the results derived from statistical analyses of microarray data (for 
example, a list of differentially expressed genes) using experimental procedures is 
expensive and resource-intensive (Kim and Park 2004). Furthermore, such validation is 
typically carried out only on a non-randomly selected (and thus potentially biased) 
subset of these results (Moreau et al. 2003).
The integration of the results of any particular microarray based experiment with those 
of other biologically similar experiments could provide a resource-efficient and 
objective validation of these results. The rationale for such a strategy is that it could 
allow for control of laboratory and platform-specific effects. For example, if a group of 
genes is found to be differentially expressed in each of several similar experiments 
which have been carried out in different laboratories, with different experimental 
protocols and on different platforms, then this provides strong evidence of the biological 
relevance of these genes and of the reliability of these results (Aggarwal et al. 2006; de 
Magalhaes et al. 2009; Hu et al. 2005; Hwang et al. 2004; Keegan et al. 2007; Moreau et 
al. 2003; Schlicht et al. 2004; Wamat et al. 2005; Xu et al. 2005; Zhou and Gibson
2004).
1.5.1.2 Increasing sample size to achieve greater sensitivity
The key feature of statistical techniques that are used to identify relevant genes within a 
microarray dataset is to distinguish between ‘true’ biological variations and undesirable 
technical variations. However, due to the high levels of noise inherent to microarray 
datasets, the power to detect genes that exhibit changes in expression that are 
biologically relevant but low in magnitude is diminished. The statistical power of these 
analyses can be increased by increasing the sample size of an experiment; however, this 
is also limited by the costs of running more arrays as well as availability of samples. 
Integration of several different analogous microarray datasets could increase the power 
to detect differentially expressed genes by increasing the sample size for an experiment
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(Choi et al. 2004; Grutzmann et al. 2005; Hamid et al. 2008; Hu et al. 2005; Kim and 
Park 2004; Mulligan et al. 2006; Wang et al. 2004).
1.5.2 Methodologies and experimental strategies for integration of 
microarray data
1.5.2.1 Meta-analysis
‘Meta-analysis’ refers to the use of statistical techniques to combine the results of 
several different experiments. The first such meta-analysis of microarray data was 
carried out by Rhodes et al, who reanalyzed four prostate cancer datasets to determine 
genes that were differentially expressed in all the datasets (Rhodes et al. 2002). Meta­
analyses have subsequently been carried out successfully in many different studies, 
where they have been shown to provide significant improvements in terms of the 
reliability of results as well as sensitivity of statistical tests, as compared to analysis of 
single datasets in isolation. These include studies of gastric cancer (Aggarwal et al.
2006), pancreatic cancer (Grutzmann et al. 2005), breast cancer (Smith et al. 2008), lung 
cancer (Parmigiani et al. 2004), alcohol consumption (Mulligan et al. 2006), and 
Drosophila circadian rhythms (Keegan et al. 2007).
While meta-analytical techniques combine the results of analyses of different microarray 
datasets carried out separately, many studies have involved combining of the datasets 
themselves followed by a single analysis of the combined dataset (Borozan et al. 2008; 
Choi et al. 2003; Hu et al. 2005; Stevens and Doerge 2005; Wang et al. 2004; Wamat et 
al. 2005; Xu et al. 2005). While these studies have also described significant advantages 
as compared to analyses of single datasets in terms of reliable results, their particular 
strength is the increased power to detect relevant genes due to the considerable increases 
in sample size.
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1.5.2.2 Cross species integration o f microarray data
The development of databases such as Homologene (Wheeler et al. 2008), Resourcerer 
(Tsai et al. 2001) and Inparanoid (O'Brien et al. 2005), which store relationships 
between homologous genes across a wide range of species in an electronic format that is 
accessible and useable, has allowed for the performance of cross-species integration of 
microarray data.
The principle that core biological networks and pathways are evolutionarily conserved 
across species is the basis for the use of model organisms for the study of human 
diseases (for example, mouse models of cancer). On this same basis, cross-species 
integration of microarray data could be a powerful tool for validation of microarray data 
(for example, if similar sets of genes are found to be relevant within similar microarray 
experiments carried out on diverse species, it unlikely that these genes were selected due 
to chance or technical effects), as well as help understand evolution of these processes 
(Lee et al. 2005; McCarroll et al. 2004; Zhou and Gibson 2004).
Cross-species integration of microarray data have successfully been carried out in many 
studies, such as those of aging (de Magalhaes et al. 2009; McCarroll et al. 2004; 
Wennmalm et al. 2005), liver cancer (Fang et al. 2005; Lee et al. 2004), lung cancer 
(Sweet-Cordero et al. 2005), breast cancer (Chan et al. 2005), prostate cancer (Ellwood- 
Yen et al. 2003; Schlicht et al. 2004) and COPD (DeMeo et al. 2006).
7.5.2. J  Experimental integration o f microarray data
Integrative analysis of microarray data has not only been used for the purposes of 
validation or increasing sample size: often, such data integration may be an exploratory 
(hypothesis-generating) or a confirmatory (hypothesis-driven) experiment in itself:
Chang et al (Chang et al. 2004) used fibroblast gene expression profiles to derive a set of 
genes representing wound healing and applied it to several different cancer datasets;
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their subsequent findings supported their initial hypothesis of a link between wound 
healing and cancer.
Rhodes et al (Rhodes et al. 2004) carried out a large scale meta-analysis of -40 
microarray based studies of cancer to derive a common transcriptional profile for 
neoplastic transformation that was shared across a wide range of cancer types, regardless 
of cell of origin.
Using an approach termed ‘comparative functional genomics’, Lee et al integrated data 
from microarray based experiments of human hepatocellular carcinoma with those of 
several mouse models of the disease (Lee et al. 2004); using unsupervised class 
discovery techniques (such as those described in Section 1.3.2), they were able to 
identify ‘best-fit’ mouse models for the disease.
Sweet-Cordero et al integrated human and mouse microarray data (Sweet-Cordero et al.
2005) using GSEA and showed firstly that the KrasLA mouse model could successfully 
represent only human lung adenocarcinoma (as opposed to other lung cancers), and 
secondly that a link between KRAS2 mutations and human lung adenocarcinomas could 
only be established by integration with the mouse model data.
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1.6 Notes for readers
1.6.1 Thesis scope and structure
The work described in this thesis has been divided into two parts: A and B. Part A 
comprises of Chapters 2-5, which describe research involving cross-platform and cross­
species integration of microarray data using lists of differentially expressed genes. Part 
B comprises of Chapters 6-8, which describe the development and implementation of 
Gene Set Discovery (GSD), a novel methodology enabling performance of theme-based 
functional analysis of microarray data in an unsupervised fashion.
All research described in this thesis involves data derived from experiments carried out 
on the Asymetrix commercial microarray platform. However, all findings can, in 
principle, be applied to data derived from any other microarray platform.
1.6.2 Aims
Part A of this thesis (Chapter 2-5) describes explorations of the concept of integrating 
microarray datasets using solely their genelists. This prospect is particularly of interest 
because it is resource-efficient enough to allow large scale comparisons of many 
different datasets in an unsupervised fashion, which could in theory lead to the discovery 
of unexpected links between experiments. However, many studies have shown low 
levels of similarity between genelists even from very similar experiments. The main aim 
of Part A of this thesis is thus to explore whether, such a strategy could still be of use to 
researchers. This was carried out by carrying out comparisons between a large set of 
genelists, including cross-platform and cross-species comparisons. A secondary aim was 
to observe whether comparisons between genelists from species that are evolutionary
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distant could yield biologically meaningful results, and thus to assess the utility of such 
an approach.
Part B of this thesis describes the development of the GSD, a novel methodology which 
could allow for GSA of microarray datasets to be carried out in an unsupervised manner. 
The aims of these explorations were to firstly develop an appropriate metric to quantify 
the information content for any set of genes using simulated datasets with known 
information types and levels. Secondly, this approach would require to be validated on 
real-world microarray datasets to assess whether the method yielded biologically 
meaningful and useful results. Other aims included developing a metric that could allow 
for extraction of informative genes from within gene sets, and a visualization scheme 
that could present the diverse types of information involved to the user in an intuitive 
integrated format.
1.6.3 Terminology
The terms ‘microarray’, ‘array’ and ‘chip’ have been used interchangeably throughout 
this thesis. The term ‘GeneChip’ refers specifically to Affymetrix microarray platforms.
The term ‘genelist’ has been used to denote a set of genes that is derived experimentally 
through statistical analysis of microarray data, for example after testing for differential 
expression of genes.
The term ‘gene set’ has been used to indicate a set of genes that can be derived from 
gene annotation databases, such as Gene Ontology (GO) (Ashbumer et al. 2000), and 
typically represent biological themes such as pathways. These gene sets have been 
created using prior knowledge of the biological functions of these genes. The term ‘gene 
set analysis (GSA)’ has been used to refer to any methodology involving the study of 
biological themes, represented as gene sets, within microarray datasets. This included all
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threshold-based and threshold-free methods (see Section 1.4). The term ‘gene set 
enrichment analysis (GSEA)’ refers to a particular method to carry out threshold-free 
GSA (Subramanian et al. 2005). ‘Gene set discovery (GSD)’ is an unsupervised 
threshold-free GSA technique, the development and implementation of which is 
described in Part B of this thesis.
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Chapter 2: S trategies for large-scale  
in tegration  o f  m icroarray data
2.1 Introduction
2.1.1 Unsupervised integration of microarray datasets
Section 1.5 introduced the concept of integration of microarray data, that is comparison 
of microarray datasets from several different experiments, which could have been 
carried out in different laboratories, on different microarray platforms and on different 
species. Many different examples were cited to illustrate the utility of such an approach, 
both as a tool for validation and increasing the statistical power of analyses, as well as to 
provide deeper biological insight that may be achieved solely by the analysis of a single 
experiment. However, as Finocchiaro et al note, the majority of such integrative analyses 
select the datasets to be integrated using a ‘supervised’ approach: researchers often 
select the datasets that they wish to compare based on prior hypotheses that there is 
some common underlying biology between them (Finocchiaro et al. 2005). This is 
certainly the case for all the examples cited in Section 1.5. Indeed, careful selection of 
which datasets could be integrated is considered to be a pre-requisite for such 
approaches (Ramasamy et al. 2008).
However, as with most supervised methods, the possibilities for novel discovery may be 
somewhat limited. A more efficient utilization of the large amounts of information 
contained within a microarray dataset might be an unbiased exploratory analysis 
involving the comparison of the dataset with a diverse, unselected collection of datasets 
created without any prior assumption as to biological links between them. For example, 
having carried out a microarray-based experiment, a researcher might ask the question, 
“Which other experiments is my experiment similar to?” Carrying out an exploratory
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analysis such as described above could then provide the researcher with an unbiased way 
of finding other datasets not only with expected similarity (for example another very 
similar experiment), but crucially, this could also lead to unexpected links being found. 
The latter possibility is of particular significance as this could potentially lead to new 
discoveries and biological insight.
2.1.2 Using lists of differentially expressed genes as representatives 
of microarray experiments
As described in Section 1.1, a microarray-based experiment typically yields data from a 
few to several hundred arrays, each of which may contain expression data for thousands 
of genes, and analysis of such ‘raw’ microarray datasets is resource intensive. While 
most integrative studies of microarray data involve large-scale re-processing of raw 
experimental datasets, the numbers of datasets reanalyzed have been limited, since each 
of the datasets is pre-selected, usually on the basis of some hypothesized biological 
similarity.
However, an unsupervised meta-analysis of an experiment with, for example, all 
datasets available on a public repository like GEO is likely to involve a very significant 
computational workload. For example, even if we were to concentrate on solely the 
21434 Affymetrix hgul33a samples contained in GEO (as of 10th February 2009), with 
each array containing 22283 probesets, this would involve mining of 477,613,822 data 
points. The computational workload is also paralleled by a significant requirement for 
manual intervention during the process of microarray data analysis, which presents a 
particularly significant problem for scalability.
These considerations are a particularly acute problem for exploratory analyses, where it 
is expected that the majority of comparisons would not yield interesting data. It is then 
difficult to justify carrying out such a large number of complex and resource-intensive
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analyses where most results will not be of interest. This then raises the need for a ‘quick 
and easy’ exploratory analysis involving a first-pass filtering of potentially interesting 
links between experiments, with the assumption that once found, these can then be 
explored in greater detail by analyzing the raw datasets.
One potential solution involves data reduction and summarization: comparisons could 
then be carried out between summaries of datasets rather than between entire raw 
datasets. A popular summary of a microarray experiment that could be used for this 
purpose is the list of ‘interesting’ genes created during the analysis of microarray data, 
usually after tests for differential expression (See Section 1.3.1.1). Datasets containing 
potentially millions of gene expression values could then be reduced to a few hundred 
gene identifiers. This is, in fact, the workflow adopted by several groups (Cahan et al. 
2005; Finocchiaro et al. 2005; Newman and Weiner 2005; Yi et al. 2007), who have 
created databases of experimentally-derived genelists for the purpose of comparison. 
The basis of this workflow is the argument that similarity between two genelists could 
reflect similarity between the corresponding experiments, in turn reflecting some shared 
biology (Rubin 2005).
However, the use of genelists to compare microarrays is a controversial prospect. 
Several studies have shown that even similar experiments exhibit little overlap between 
genelists (Cahan et al. 2007; Cheadle et al. 2007; Ein-Dor et al. 2005; Jeffery et al. 2006; 
Manoli et al. 2006; Tan et al. 2003). These have been attributed to various factors, such 
as differences in laboratories, experimental protocols, microarray platforms and data 
analysis strategies. Studies have shown that similarity in the results of similar microarray 
based experiments can be induced by standardization of experimental protocols and data 
analysis algorithms (Bammler et al. 2005; Irizarry et al. 2005; Larkin et al. 2005). This 
then creates doubts regarding the reliability of using solely genelists to compare 
microarray experiments; the genelists archived in the databases cited above represent a 
diverse set of experiments carried out in a wide range of different laboratories, on 
different platforms and species, and created using different statistical methodologies.
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The primary aim of the work described in Part A of this thesis was thus to explore if the 
comparison of microarray experiments using genelists could be a feasible and reliable 
method to find links between disparate experiments in an unsupervised fashion, in light 
of the issues described above. It was intended to achieve this by carrying out 
comparisons between a diverse set of genelists derived from a number of different 
experiments (examining different biological themes) carried out in different laboratories, 
using different statistical methodologies. Examination of the results of these 
comparisons could then be carried out using both global (for example, by carrying out 
unsupervised hierarchical clustering [see Section 1.3.2.1] of genelists using a 
standardized measure of similarity, and examining the clusters for any dominant 
biological themes), and local (for example, focused examination of experiments found to 
have significantly similar genelists to detect shared underlying biology) strategies to 
assess whether these results were biologically meaningful and of use to researchers. 
Secondary aims included assessing how far across evolutionary distances could cross­
species comparisons be performed while still deriving biologically meaningful results.
This chapter, in particular, details the development of strategies to carry out comparisons 
between lists of differentially expressed genes. Two major issues are addressed, the first 
being the translation of genelists across chips and species: for example, how could a list 
of human genes and a list of C. elegans genes be made comparable? The second is that 
of assessing the statistical significance of the overlap between any two genelists, which 
would enable the detection of ‘real’ biological similarities as opposed to overlaps that 
could have been caused just by chance.
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2.2 Explorations and Results
2.2.1 Conversion of gene identifiers across array-types and species
The following explorations will use expression microarrays from Affymetrix to illustrate 
the principles and concepts, although similar issues would be faced with arrays produced 
by other companies. Affymetrix currently manufactures expression arrays for a wide 
number of species, ranging from humans and popular model animals like mice, rats and 
zebrafish, to plants and prokaryotes (see Table 2.1). Integration of lists of differentially 
expressed genes, especially across array-types and species, would require ensuring that 
the genelists are comparable. As explained in Section 1.2, the basic units of gene 
expression data within an Affymetrix array are the probesets, each of which has a unique 
ID label, and it is (usually) these identifiers that comprise lists of differentially expressed 
genes.
The first question addressed was whether these probeset IDs are shared across the 
different types of Affymetrix arrays. For this purpose, lists representing all probeset IDs 
for several chips were created and compared. Table 2.2 represents a selection of some of 
the most popular Affymetrix arrays for several different species and the number of 
probeset IDs that are shared between them. As can be seen, there is no overlap of 
probeset IDs across different species. Even within a species, there may be little or no 
overlap of probeset IDs between two different array-types, such as the human hgul33a 
and hgu95a arrays: these differ because they represent different generations of 
Affymetrix human arrays, and were created using different UniGene build versions 
(Affymetrix 2001). Thus, most genelists from microarray experiments carried out on 
different array-types (in particular, from different species) and comprising solely of 
probeset IDs are not directly comparable: any attempt to do so would result in no 
overlap between genelists. This then raises the need for some conversion of probeset IDs 
prior to cross-chip genelist comparisons.
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(1)
Species
(2)
Affymetrix GeneChip Expression 
Analysis Arrays
(3)
Bioconductor
name
(4)
Number of 
samples on 
GEO
(5) 
Number 
of series 
on GEO
Homo sapiens Human Genome U133 Plus 2.0 Array hgu133plus2 21434 743
Human Genome U133 Set Array - A hgu133a 19982 639
Human Genome U95 Set Array -A hgu95a/av2 5264 275
Human Genome U133 Set Array - B hgu133b 4420 109
Human Genome U133A 2.0 Array hgu133a2 2092 109
Human HG-Focus Target Array hgfocus 1935 47
Mus musculus Mouse Genome 430 2.0 Array mouse4302 10388 798
Murine Genome U74 Version 2 Set MG- 
U74A
mgu74av2 5490 435
Mouse Expression Array 430A and Mouse 
Genome 430A 2.0 Array
moe430a/a2 4797 378
Mouse Expression Array 430B moe430b 957 77
Rattus Rat Genome 230 2.0 Array rat2302 3107 168
norvegicus Rat Genome U34 Array Set RG-U34A rgu34a 3047 142
Rat Expression Set 230 Array RAE230A rae230a 2184 102
Rat Genome U34 Array Set RG-U34B rgu34b 456 10
Drosophila Drosophila Genome Array drosgenomel 1088 93
melanogaster Drosophila Genome 2.0 Array drosophila2 736 54
Arabidopsis Arabidopsis ATH1 Genome Array ath1121501 4325 330
thaliana Arabidopsis Genome Array ag 134 19
Yeast spp Yeast Genome S98 Array YG-S98 ygs98 1489 111
(S. cerevisiae; 
S.pombe)
Yeast Genome 2.0 Array yeast2 417 25
Other Soybean Genome Array soybean 3029 17
eukaryotes C.elegans Genome Array celegans 452 25
Zebrafish Genome Array zebrafish 423 37
Chicken Genome Array chicken 338 23
Wheat Genome Array wheat 315 11
Rhesus Macaque Genome Array rhesus 300 23
Maize Genome Array maize 249 16
Rice Genome Array rice 248 21
Porcine Genome Array porcine 237 12
Xenopus laevis Genome Array xenopuslaevis 198 20
Bovine Genome Array bovine 197 16
Barley Genome Array barleyl 184 13
Escherischia E. coli Antisense Genome Array ecoliasv2 672 38
coli E. coli Genome 2.0 Array ecoli2 204 26
Other Pseudomonas aeruginosa Array paegl 287 33
prokaryotes S. aureus Genome Array saureus 153 17
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Table 2 .1  A selection  o f Affymetrix g en e  expression  analysis arrays (in 
previous p age). The shortened names in column 3 are those used in the 
Bioconductor annotation packages for the respective arrays (arrays will be referred 
to by these names for the rest of the thesis). Column 4 represents the number of 
arrays for which data is available on the Gene Expression Omnibus, while Column 5 
displays the number of series of chips (where a series usually represents a set of 
arrays from the same experiment), as of 10th February 2009.
Translations of genelists can be made possible by utilizing the biological annotation that 
is associated with each probeset. Such annotation is available from sources such as the 
Affymetrix NetAffx annotation files (Liu et al. 2003) and the Bioconductor (Gentleman 
et al. 2004) annotation packages, which incorporate various annotation sources including 
the former (see Material and Methods). For example, while the hgul33a and hgu95a 
arrays contain distinct sets of probeset IDs, these can refer to the same genes. Thus, the 
hgul33a 222152_at and the hgu95a 37569_at probesets both represent the PDCD6 
programmed cell death 6 gene. Thus genelists from experiments carried out on two 
different array-types (but representing the same species) can be made comparable by 
converting probeset IDs into species-specific gene identifiers.
While several types of annotation are available for each probeset (for example, Unigene 
IDs, RefSeq IDs, Entrez Gene IDs and gene symbols), Entrez Gene IDs (EGIDs) were 
selected as the biological annotation of choice. There are two main reasons for this. First 
is that EGIDs (and gene symbols) are probably the most biologically-intuitive units of 
annotation, being gene-centric in focus, while the others are sequence-centric. The 
second reason is technical: more probesets are annotated with EGIDs than any other 
source (see Material and Methods), and probesets that are not annotated with an EGID 
also have no other annotation (data not shown). As a result, conversion of probeset IDs 
into EGIDs results in the least loss of information.
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Table 2.2 Probeset ID s that are shared across various A ffym etrix array- 
types. Numbers represent the percentage of (non-control) probeset IDs of row-wise 
arrays that are also found in column-wise arrays. Grey cells denote comparisons 
between arrays from the same species.
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However, conversion of probeset IDs to EGIDs alone would be insufficient translation 
for comparisons between genelists from experiments carried out on different organisms. 
EGIDs are species-specific and different species are each annotated with a distinct set of 
EGIDs. For example, the human GAPDH gene has the EGID of 2597, while the mouse 
homolog (Gapdh) has the EGID of 14433. There is thus a need for the conversion of the 
EGIDs of genes from one of the species into the EGIDs of the corresponding 
homologous genes of the other species. This could be carried out by using the 
homologous relationships between genes across different species that are recorded 
electronically in databases such as Homologene (Wheeler et al. 2008), Resourcerer (Tsai 
et al. 2001), and Inparanoid (O'Brien et al. 2005) (See Materials and Methods).
Direct comparison of lists of probeset IDs is sometimes possible, such as when 
comparing genelists from experiments carried out on the same array-type, or in those 
instances when all probesets of one chip are present in the other (for example the 
hgul33a and hgul33plus2 arrays, where the former is a subset of the latter). One 
complexity that the use of probesets introduce is that such analyses would be vulnerable 
to biases caused by genes which are represented by more than one probeset. For 
example, consider a gene that is represented in an array by 3 probesets. If this gene is 
differentially expressed in two experiments, we might expect all three probesets to be 
present in the genelists of both these experiments. Thus, in a comparison of these two 
genelists, the contribution of this gene to the overlap size would be three units 
(probesets), rather than the desired contribution of one unit (gene/EGID).
Figure 2.1 represents an exploration of all genes (represented as EGIDs) present on 
several arrays, and the number of probesets they are annotated to.
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Figure 2.1 Distribution of Entrez Gene IDs (EGIDs) according to  the number 
of p robesets annotated to  them . The x-axis denotes the number of probesets 
annotated to an EGID. The y-axis denotes the number of EGIDs in each category as 
percentages of total EGIDs on an array. In the legend, the upper number is the 
percentage of EGIDs having >1 probesets annotated to them; the lower number is 
the maximum number of probesets annotated to one EGID in that array.
As can be observed, as many as 59.4% of all EGIDs on an array can be linked to more 
than one probeset (as seen in hgul33plus2), and as many as 36 probesets can be 
annotated with the same EGID (as seen in xenopuslaevis).
These figures suggest that biases caused by the presence of more than one probeset 
representing a single gene are likely to occur. For this reason, it was decided that the 
strategy for comparing genelists from experiments carried out on the same array-type 
would require an initial step of converting lists of probeset IDs into unique lists of 
EGIDs to which those probesets are annotated to.
2.2.2 The need for assessm ent of significance of overlaps between 
genelists
A very simple metric to assess biological similarities between genelists would be the 
number of shared genes. For example, if genelist A and genelist B share x number of 
genes, and genelist A and genelist C share y  number of genes, and x>y, then we might 
infer that genelist A shows greater biological similarity with genelist B than with 
genelist C. However, the size of this overlap is likely to be affected not only by real 
biological similarities between the genelists, but also by systematic effects that depend 
on the lengths of the genelists being compared, and the size of the gene universe. The 
gene universe here refers to the set of all genes from which the genelists were selected.
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For example, if the genelists being compared are derived from experiments carried out 
on the same array-type, the gene universe for this comparison might be all the genes 
present on that array. These systematic effects exerted by genelist length and gene 
universe size on the size of overlaps between genelists were explored as follows.
The effect of genelist size would be exerted such that, when the universe size is constant, 
the larger are the genelists being compared, the larger we would expect that overlap to 
be. Consider a comparison of genelists A and B, where genelist B consists of 10% of 
genes on the entire array. Then, we would expect it to contain, on average, 10% of the 
genes in genelist A by chance alone. If genelist B were to have 20% of genes on the 
array, we would expect it contain, on average, 20% of the genes in genelist A and so on.
To explore this effect, the following simulation was carried out: a set of 20,000 arbitrary 
and unique identifiers was created, representing all the genes present on an imaginary 
array. From this, a total of 1000 identifiers were selected randomly and without 
replacement, representing a reference genelist of 1000 genes. Similarly, a series of ‘test 
genelists’, of sizes ranging from 10 to 20,000 identifiers were also selected. Each of 
these test genelists was compared to the reference genelist and the size of overlap for 
each comparison was recorded, and these have been displayed as grey dots in Figure 
2.2(a).
The positive linear relationship between the overlap size and length of test genelists is 
clearly observed, and the observed overlap sizes vary around the expected overlap sizes 
(represented by the red line). This expected overlap size is calculated by the formula 
(L\ * L2) ---------- where L \ and L2 are the lengths of the genelists being compared while N
N
represents the size of the gene universe. Thus, we find that in a gene universe of fixed 
size, the size of overlap between any two genelists is directly proportional to the lengths 
of the genelists.
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Figure 2 .2  -  S y stem a tic  e ffe c ts  o f (a ) g e n e lis t  length  and (b ) g en e  un iverse  
s iz e  on th e  s iz e  o f overlap  b etw een  g e n e lis ts . Figures are based on simulations 
carried out using a synthetic array represented by a set of unique and arbitrary 
identifiers, (a) Overlap sizes observed during comparisons of 'genelists' (created by 
random selection of identifiers from a synthetic array without replacement) of 
various sizes from a single synthetic array of constant size, plotted against the 
lengths of those genelists. (b) Overlap sizes observed when 'genelists' of constant 
size (selected randomly and w ithout replacement) from synthetic arrays of various 
sizes are compared, plotted against the inverse of the gene universe size (i.e. the 
number of genes present in the synthetic arrays). The grey points represent the 
observed overlap sizes, while the red lines represent the expected overlap sizes.
52
Chapter 2: Strategies for large-scale integration of microarray data
The formula to calculate the expected overlap size also suggests that the size of the gene 
universe is inversely proportional to the size of the expected overlap, i.e. the larger the 
size of the universe, the smaller would be the expected overlap between any two 
genelists, and vice versa. To explore this, sets of unique and arbitrary identifiers, 
representing a series of imaginary arrays of sizes ranging from 1000 to 20,000 genes was 
created. From each of these arrays, two ‘genelists’ of 1000 genes (identifiers) each were 
randomly selected (without replacement) and compared. The number of genes in each 
overlap was recorded and is displayed as the grey dots in Figure 2.2(b).
A positive linear relationship is observed between the overlap sizes and the inverse of 
the gene universe sizes, and again, the observed overlap sizes vary around the expected 
overlap sizes. Thus, it is found that during comparisons of genelists that are of constant 
lengths, but are selected from gene universes of varying sizes, the overlap size is 
inversely proportional to the size of the gene universe.
These findings suggest that the size of overlap between genelists alone would not be a 
suitable indicator of the biological relatedness between any two genelists, because it 
would be not be possible to distinguish biological effects from the systematic effects of 
genelist and universe sizes.
For the purposes o f genelist comparison, the systematic effects of universe size can be 
controlled for by keeping the gene universe size constant. There are several ways to 
achieve this: for genelists from the same array-type, the universe size for all 
comparisons could be all the genes on the chip; for comparisons between genelists from 
different array-types, the gene universe could be only those genes that are present on 
both array-types (and the genelists would be filtered to reflect this); for cross-species 
comparisons, the gene universe could consist only of genes for which homologues are 
present on both arrays (and the genelists would be filtered accordingly). However 
genelist sizes vary greatly and these steps would not address this.
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2.2.3 Selection of metrics for the assessm ent of the significance of 
overlaps between genelists
The size of the overlap between any two genelists will in part depend on the lengths of 
genelists involved. This therefore raises a need for a metric to assess the significance of 
the observed overlap, that is a metric that indicates if an observed overlap is any greater 
than would be expected by chance alone (and preferably to indicate by how much). 
Deviations of the observed overlap from the expected overlap can then be argued to 
have occurred due to real biological similarities between genelists with the magnitude of 
the deviation giving some indication of the degree of biological similarity (or 
dissimilarity).
Three metrics were initially chosen as potential candidates to assess the significance of 
overlaps between genelists. These were fold change, the binary similarity index and the 
hypergeometric distribution, and were tested as follows. A set of unique and arbitrary 
identifiers, representing a synthetic array of 20,000 genes, was created. From this, a 
reference genelist of 1000 genes was created by random selection of genes without 
replacement. Then, a set of test genelists, varying in length from 100 to 20,000 were 
created, again by random selection of genes without replacement. Each test genelist was 
compared to the reference genelist and the overlap size was recorded; all three metrics 
were calculated for each comparison. Each metric was then assessed for its dependency 
on genelist length and the results of these analyses are presented below.
2.2.3.1 Fold change
Fold change is a simple and intuitive metric, which is calculated as the observed overlap 
size divided by the expected overlap size, and provides the magnitude of the observed 
overlap size relative to the size of the expected overlap. Thus, a fold change value of 1 
would indicate that the observed and expected overlap sizes are the same, while a fold 
change value of 2 would indicate that the observed overlap is twice the expected size of
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overlap, and so on. In natural space, the scale of fold change values is asymmetrical (for 
example, a ten-fold increase in an observed value with respect to the expected value 
yields a fold change value of 10, while a ten-fold decrease would yield a value of 0.1), 
and for this reason, fold change values are usually converted to log space. Thus a log 
fold change value of zero indicates that the observed value is equal to the expected 
value, while positive and negative log fold change values indicate observed values that 
are greater and lesser than the expected values respectively.
Fold change values were obtained from the simulations described above, and these were 
transformed using the natural log. Figure 2.3(a) shows the histogram of these log fold 
change values. As the comparisons were carried out between lists of ‘genes’ that had 
been selected in a random fashion, it is expected that the majority of comparisons should 
show no appreciable difference between the observed and expected values. Indeed, the 
median of this distribution is a log fold change value of zero.
Figure 2.3(b) shows a Q-Q plot where quantiles of the distribution of log fold change 
values are plotted against those for a normal distribution. This was created to investigate 
whether the log fold change values are normally distributed. As can be observed, the 
distribution of log fold change values tends towards non-normality as the values become 
higher and lower than the median value of zero. Further light is shed in Figure 2.3(c), 
where the log fold change values are plotted against the lengths of the test genelists used 
in each comparison. It is observed that while the values vary around the median of zero, 
regardless of the length of the test genelists, the variability of log fold change values is 
greater for shorter test genelists than for longer test genelists.
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Figure 2.3 Log Fold Change values from  simulation experim ents, (a)
Histogram of log fold change values obtained from comparisons carried out between 
a reference 'genelist' and a set of test 'genelists' of varying lengths from a synthetic 
array represented as a set of unique and arbitrary identifiers. Reference and test 
genelists were selected randomly and w ithout replacement, (b) Q-Q plot for the log 
fold change values (Y-axis) versus the normal distribution (X-axis), (c) Log fold 
change values plotted against the length of test genelists. Red lines in all plots 
indicate the median of the distribution (i.e. zero).
This observed relationship between the variability of log fold change values and the 
length of test genelists is due to instability at low genelist lengths because of data 
granularity. For example, consider two short genelists that have an expected overlap 
value of 5. An observed overlap value of one gene greater than that expected value (i.e. 
6) would then yield a log fold change value of 0.18. Now consider two long genelists 
that are expected to have an overlap size of 500. In this case, an observed overlap size of 
one gene greater than expected (i.e. 501) would yield a log fold change value of 0.002.
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In effect, this property is undesirable as this makes the setting a cut-off log fold change 
value (for example, 2) to indicate significance problematic: such cut-offs may be too 
liberal for comparisons between short genelists and too conservative for comparisons 
between longer genelists. For this reason, log fold change values were not explored 
further.
2,23.2 Binary similarity index
The next metric tested was the binary similarity index, which is calculated as the size of 
the overlap divided by the total number of unique genes present in at least one of the two 
genelists. In set theory terms would translate as the size of intersect divided by the size 
of the union of the two genelists (see Materials and Methods).
Figure 2.4(a) shows the histogram of binary similarity values obtained from the 
simulations described above, while Figure 2.4(b) shows the Q-Q normality plot for the 
same and these indicate a skewed and non-normal distribution of values. More 
importantly, as can be observed in Figure 2.4(c), there is a strong, positive, non-linear 
relationship between the binary similarity values and the size of the genelists.
Due to this undesirable property, binary similarity indices were also not explored any 
further. It is noted that Cahan et al (Cahan et al. 2005) use this metric in the LOLA 
database not as the sole indicator of significance, but as a measure of “concordance”. 
Values for variance and p-values are provided to interpret the concordance values.
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Figure 2.4 Binary sim ilarity values from  simulation experim ents, (a)
Histogram of binary sim ilarity values obtained from comparisons carried out 
between a reference 'genelist' and a set of test 'genelists' of varying lengths from a 
synthetic array represented as a set of unique and arbitrary identifiers. Reference 
and test genelists were selected randomly and w ithout replacement, (b) Q-Q plot for 
the binary sim ilarity values (Y-axis) versus the normal distribution (X-axis), (c) 
Binary sim ilarity values plotted against the length of test genelists. Red lines in all 
plots indicate the median of the distribution.
2.23.3 Hypergeometric and Binomial distributions
The final metrics tested were derived from the hypergeometric probability distribution, 
which can be described as follows: consider an um (which in our case represents a 
microarray chip, i.e. the gene universe) filled with balls (genes), some of which are 
coloured black (genelist A), while the rest are coloured white. From this um a certain 
number of balls (genelist B) are selected. The hypergeometric distribution then predicts 
the probabilities of the number of black balls among those selected (i.e. the overlap 
between genelists A and B).
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The binomial probability distribution, which is used by the L2L database (Newman and 
Weiner 2005) to assess the significance of overlaps between genelists, is related to the 
hypergeometric distribution. It differs in one aspect; while the latter assumes trials 
without replacement, the former assumes trials with replacement. In terms of the um 
analogy explained above, this translates to the binomial distribution requiring previously 
selected balls to be put back into the um prior to any subsequent sampling, while the 
hypergeometric distribution expects any selected balls to be removed from the um and 
not be involved in subsequent selections. Thus in a binomial trial, the probability of 
selecting a black ball stays the same throughout the trial, while in a hypergeometric one, 
this probability changes after each successive selection.
While the binomial distribution becomes increasingly similar to the hypergeometric one 
as the size of the gene universe increases in relation to the size of the genelists being 
compared, the hypergeometric distribution is a theoretically better choice for these 
purposes. This is because sampling with replacement, as in binomial trials, would imply 
occasions where a gene is present in a genelist more than once; this does not happen, 
because each gene is required to be unique within a genelist. Thus, the binomial 
distribution was excluded from further analysis on theoretical grounds. Newman et al, 
regarding the L2L database, concede that for the purposes of comparing genelists, the 
hypergeometric distribution is “more accurate”, but did not select this for use in their 
database as it is “more difficult to calculate” (Newman and Weiner 2005).
Two metrics can be derived from the hypergeometric probability distribution. The first 
of these is a Z-score, which is the observed overlap that has been standardized, taking 
into account the lengths of the genelists being compared and the gene universe size. As 
an ‘effect size’, it is conceptually similar to fold change, but is calculated differently (see 
Materials and Methods).
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An overlap that yields a Z-score of zero indicates an overlap of expected size, while 
positive and negative Z-scores indicate overlap sizes that are greater and lesser than the 
expected overlap sizes respectively. The magnitude of Z-score values represents the 
extent of deviation of the observed overlap sizes from the expected overlap sizes. 
Hypergeometric Z-scores were calculated for the simulations described above.
Figure 2.5(a) shows the histogram of Z-scores derived from the simulation studies. This 
distribution is centered on a median Z-score of zero, indicating that on average, the 
overlap sizes are no different from what is expected by chance alone.
The Q-Q plot in Figure 2.5(b) indicates the Z-score distribution is very similar in shape 
to the normal Gaussian probability distribution. Also, like a standardized normal 
distribution, it is centered on a median of zero and has a standard deviation of —1. One of 
the properties of a normal distribution is that -95% of values can be found within the 
range of the median ± 2 times the standard deviation of the distribution. Indeed, it 
observed that 1899 of the 2000 calculated Z-scores (i.e. 94.95%) fall within this range.
This is a useful property, and can be exploited to set cut-off values for significance. For 
example, a cutoff value of the median + 2 times the standard deviation of the distribution 
would imply selection of Z-scores representing overlap sizes that have only a 2.5% 
probability of having occurred by chance alone. Also, as can be seen in Figure 2.5(c), 
there is no observable relationship between Z-scores and the lengths of the test genelists.
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Figure 2.5  H ypergeom etric  Z-scores and p -va lu es  from sim ulation  
ex p er im en ts ,  (a) and (d) show, respectively, the hypergeometric Z-scores and p- 
values obtained from comparisons carried out between a reference 'genelist' and a 
set of test 'genelists' of varying lengths from a synthetic array represented as a set 
of unique and arbitrary identifiers. Reference and test genelists were selected 
randomly and w ithout replacement, (b) and (e) represent Q-Q plots for the Z-score 
and p-value distributions respectively (Y-axes) versus the normal distribution (X- 
axes). (c) and (f) show the Z-score and p-values respectively, plotted against the 
lengths of test genelists. Red lines in all plots indicate the medians of the respective 
distributions. Broken red lines in (a) and (c) represent median ± 2*sd of the Z- 
score distribution. Broken black lines in (f) represent the theoretical minimum and 
maximum values of the p-value distribution.
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The second metric that can be calculated using the hypergeometric distribution is a p- 
value, which is a measure of the probability that an observed overlap size could have 
occurred by chance alone. These were calculated for the above simulations assuming a 
one-sided test i.e. testing only for how much greater an observed overlap is than the 
expected size, and not the other way around (see Materials and Methods). The resultant 
p-value distribution is centred on a median value of ~0.5, and ranges from the minimum 
and maximum possible p-values of 0 and 1 respectively (Figure 2.5(d)). As expected, 
setting a p-value cut-off of 0.05 (i.e. the theoretical value which no more than 5% of 
comparisons should yield lower p-values for, if the assumptions of the distribution are 
not violated), results in the filtering of 102 of the total 2000 comparisons (i.e. 5.1%). 
Also, no relationship is observable between the p-values and the lengths of the test 
genelists (Figure 2.5(f)).
Figure 2.6 illustrates the relationship shared between hypergeometric Z-scores and p- 
values. Thus comparisons that yield high Z-scores yield low p-values. Theoretically, 
setting a Z-score cut-off value of 2 (from a Z-score distribution with a median of zero 
and standard deviation of 1) is equivalent in effect to setting a p-value cut-off of 0.025 
(i.e.2.5%), as these parameters would only be exceeded by 2.5% of comparisons 
between randomly created lists of genes, and the empirically derived distributions 
appear to be in agreement with this (broken red lines in Figure 2.6 represent these cut­
off values).
Thus, because hypergeometric Z-scores and p-values appear not to be influenced by the 
lengths of genelists being compared, when the universe size is constant, both metrics are 
candidates for the purpose of comparison of genelists and were taken forward into the 
explorations described in subsequent chapters.
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Figure 2 .6  Relationship b e tw een  hypergeom etric  Z -scores  and p-values.
Values represent the same distributions illustrated in Figure 2.5. Broken red lines 
indicate the theoretically equivalent Z-score (vertical) and p-value (horizontal) 
values of 2 and 0.025 respectively.
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2.3 Discussion
The increasing use of microarray technology has led to massive amounts of 
experimental data being deposited in public databases like NCBI’s GEO (Edgar et al. 
2002). Access to this experimental data has allowed for integrative analyses of 
microarray experiments which involve the comparison of several datasets at the same 
time. This approach allows opportunities for knowledge validation and discovery, and 
several examples have been highlighted (see Section 1.5).
However, in such analyses, datasets to be analyzed are selected in a supervised fashion, 
i.e. the selection involves prior hypotheses and knowledge regarding shared underlying 
biology between the experiments being compared. This approach, while valid, is 
restricted in scope and might be more optimally utilized by using unsupervised 
approaches to data integration, for example, comparison of one experiment with, instead 
of a small pre-selected set of experiments, a large and non-selected set of experiments, 
such as found in a public database. Such an unsupervised approach has the potential to 
find unexpected links that could provide new knowledge and insight regarding the 
experiments in question (Finocchiaro et al. 2005).
However, such an approach would be highly resource-intensive. For this reason, there 
has been an interest in the comparison of summaries of an experiment, rather than 
comparisons between entire experimental datasets. Several groups have advocated the 
use of lists of differentially expressed genes as suitable summaries for this purpose, 
using the logic that similarity between genelists might imply similarity between the 
originating experiments (Cahan et al. 2005; Finocchiaro et al. 2005; Newman and 
Weiner 2005; Rubin 2005; Yi et al. 2007). Thus ranking genelists by order of similarity 
to a test genelist could provide researchers with prioritization of experiments with which 
to carry out more rigorous integrative analyses.
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However, the reliability of such an approach is questionable, given the frequent 
observation of low levels of similarity between genelists derived from even very similar 
experiments (Cahan et al. 2007; Cheadle et al. 2007; Ein-Dor et al. 2005; Jeffery et al. 
2006; Manoli et al. 2006; Shen et al. 2008; Tan et al. 2003). For this reason, one of the 
aims of this project is to assess whether this approach could be useful for researcher by 
carrying out all comparisons between genelists derived from a diverse array of 
experiments, carried out in a range of different laboratories and on different species, and 
examining the results. In this chapter, the strategies for carrying out genelist integration 
were studied and developed.
To minimize the potential confounding effects that could arise from differences between 
microarray platforms (for example, due to differences in experimental protocols, probe 
sequences, etc.), research focussed on integration of only those genelists that were 
derived from experiments carried out using Asymetrix microarrays. Affymetrix is one 
of the largest commercial microarray manufacturers and considerable numbers of 
experiments have been carried out on this platform. Furthermore, they represent 
standardized experimental protocols and technical aspects (such as probe sequences). 
However, the general principles derived should be broadly applicable to genelists 
derived from experiments carried out on other platforms.
Affymetrix currently provides expression arrays for a wide range of species, and the 
probeset identifiers differ across arrays for each species. Identifiers for a particular gene 
may also differ within a species; particularly between arrays from different generations 
(see Section 2.2.1). Comparison of genelists from different arrays within a species can 
be facilitated by converting probeset identifiers into Entrez Gene IDs for that species. 
This translation was also included in the strategy for comparison of genelists from the 
same array-type, because of the potential bias caused by groups of 2 or more probesets 
that represent the same gene. Cross-species genelist comparisons can in principle be 
carried out by converting one genelist into a set of homologous genes from the organism 
on which the other experiment was carried out on.
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It was shown that simple overlap size between genelists is not a suitable metric with 
which to measure links between experiments, as it is sensitive to the systematic effects 
of genelist length and universe size (see Section 2.2.2). While the latter does not 
theoretically pose problems with regards to genelist comparison because the universe 
size remains constant, the variability of genelist length is a more difficult issue.
Three metrics of similarity between genelists were tested for sensitivity to genelist 
length (see Section 2.2.3). Both fold change and binary similarity coefficients were 
found to be sensitive. However, the hypergeometric distribution yielded two metrics: p- 
values and Z-scores, which were found to have no dependency on genelist length. Thus, 
these metrics were selected for further explorations in subsequent chapters. The 
hypergeometric distribution has been popularly used in Over-Representation Analysis of 
genelists (Huang da et al. 2009; Khatri and Draghici 2005), which detects the 
enrichment of one set of genes (such as a pathway or GO term) within another (the 
experimentally-derived genelist). Finocchiaro et al also used this for assessing 
comparisons between experimentally derived genelists (Finocchiaro et al. 2005).
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Chapter 3: Com parison o f  lists  o f  
differentia lly  expressed  genes using  the  
hypergeom etric test
3.1 Introduction
The previous chapter introduced the concept of comparing lists of differentially 
expressed genes from microarray experiments, as opposed to resource-intensive 
comparative analyses based on the integration of primary experimental datasets. The 
studies described revealed general principles regarding the annotation levels at which to 
perform comparisons of genelists, together with information about the behaviour of key 
potential metrics to assess similarity between genelists. Whereas in Chapter 2 
explorations were based on lists of randomly selected genes (represented as unique and 
arbitrary identifiers), in this chapter genelist comparison strategies are applied to a set of 
real experimentally-derived lists of differentially expressed genes.
One might expect that genelists would be most comparable if they were created using 
similar normalization techniques and statistical tests, with standardized parameters and 
cut-offs (Bammler et al. 2005; Irizarry et al. 2005; Larkin et al. 2005). Carrying out 
manual re-analysis of data from potentially hundred of experiments to derive genelists is 
unfeasible, and the current data storage paradigms of public repositories (in particular, 
with respect to experimental design) prohibit the automation of such a procedure. 
Genelists were thus extracted manually from published scientific literature. Initially the 
database consisted of genelists derived from experiments carried out on the Affymetrix 
hgul33a array, which was at that time the most popular commercial microarray. More 
genelists derived from experiments carried out on a range of array-types and species
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were then provided by Miss Hui Sun Leong (Department of Pathology, Cardiff 
University) in our laboratory. Table 3.1 provides an overview of the final database.
Array-types Species Number of genelists
hgu133a Homo sapiens 38
hgu133plus2 Homo sapiens 19
mouse4302 Mus musculus 20
rat2302 Rattus norvegicus 11
drosgenomel Drosophila melanogaster 20
celegans Caenorhabditis elegans 11
ath1121501 Arabidopsis thaliana 20
Total: 7 array-types 6 species 139 genelists
Table 3.1 Summ ary of a database of g en e lists  manually extracted from  
published literature.
This chapter will describe the results of comparing all the genelists within the database 
with themselves. It was expected from the outset that judging the utility of such an 
approach solely from the results would be problematic as there is no biological ‘truth’ 
with which to measure sensitivity and specificity. However, one potential indicator of 
accuracy is if the similarities found between experiments are biologically plausible.
Another issue that it was hoped this analysis would address was how far across species 
could significant links be found. It might be expected that increase in evolutionary 
distance between any two species would be accompanied by both a decrease in the 
number of homologous genes shared between the species and greater differences in 
transcriptional regulation programmes. As the analysis involved comparison of all 
genelists in the database, across all the species represented, it provided an opportunity to 
observe if biological links could be found even between microarray experiments carried 
out on evolutionary distant species, for example between a human and Arabidopsis 
experiments.
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3.2 Technical Methodology
Development of methodologies for the comparison of genelists was based on the 
explorations of biological annotation and studies of the behaviour of similarity metrics, 
as described in Chapter 2.
The genelists collected within the database comprised of Affymetrix probeset identifiers. 
For comparisons between genelists derived from experiments carried out on the same 
species (Figure 3.1(a)), regardless of whether they were carried out on the same array- 
type or not, the original lists of probesets were converted into non-redundant lists of the 
Entrez Gene IDs (EGIDs) with which the probesets were annotated. If the genelists were 
derived from experiments carried out on the same array-type, the gene universe 
comprised of all the EGIDs present on that array-type. For comparisons between 
genelists from different array-types, the gene universe comprised of those EGIDs that 
were present on both the array-types. To reflect this, the genelists were then filtered to 
remove any EGIDs that were not present in that “common” gene universe. For 
comparisons between genelists from experiments carried out on different species (Figure 
3.1(b)), lists of probeset identifiers were first converted to lists of non-redundant 
species-specific EGIDs with which the probesets were annotated. The EGIDs of one 
genelist were then converted into EGIDs representing the species of the other genelist 
through the homologous relationships between EGIDs stored in the Homologene 
database (see Materials and Methods). Here, the gene universe comprised of those 
(homologous) EGIDs that were present on both the array-types. The genelists were then 
filtered to remove any EGIDs that were not present in that “common” gene universe.
The size of the overlap between any two pairs of genelists, as well as the gene universe 
size, was the used to calculate Z-scores and p-values, using the hypergeometric 
statistical test, to assess the similarity between the genelists.
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(a) (b)
Genelist 1 
(probeset IDs) 
Species A
Genelist 2 
(probeset IDs) 
Species B
Probeset to EGID 
mapping Species A 
Pro beset to 
EGID mapping
Species B 
Probeset to 
EGID mapping
Common gene universe filter 
(not required for genelists from —  
the same array-type)
Homologene database
Common gene universe filter
Hypergeometric test
Genelist 1 
(probeset IDs)
Genelist 2 
(probeset IDs)
Genelist 2 
(EGIDs)
Genelist 1 
(EGIDs)
Genelist 2 
( Filtered)
Genelist 1 
(Filtered)
Overlap between 
genelists 1 and 2
Overlap between 
genelists 1 and 2
Genelist 1 
(EGIDs) 
Species A
Genelist 2 
(EGIDs) 
Species B
Hypergeometric test
Genelist 1 
(EGIDs) 
Species A or B
Genelist 2 
(EGIDs) 
Species A or B
Genelist 2 
(Filtered EGIDs) 
Species A or B
Genelist 1 
(Filtered EGIDs) 
Species A or B
Figure 3.1 Strategies for comparison of genelists (a) within and (b) across species.
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3.3 Explorations and Results
3.3.1 An overview of all comparisons
Regarding the question of how far across evolutionary distance could biological 
similarity be found between genelists, partial insight can be gained prior to the 
comparison of genelists, by exploring the numbers of homologous genes (if any) that are 
shared across chips from different species. Table 3.2 shows the number of genes shared 
between the chips, represented as the percentages of the total number of genes on each 
chip. The numbers can fall quite low, for example, comparisons between genelists from 
the C. elegans celegans array with those from the A. thaliana athl 121501 array would 
involve a gene universe that consists of only 7.1% of genes on the athl 121501 array and 
9.9% of genes on the celegans array.
In Figure 3.2, these values are plotted against the evolutionary distance between the 
species (see Materials and Methods). It is observed that there is a general trend, as might 
be expected, of the number of shared genes falling with increase in evolutionary 
distance.
All possible pair-wise comparisons were then carried out between all 139 genelists in the 
database. Hypergeometric p-values and Z-scores were calculated for each of the 
comparisons. Following correction for multiple-hypothesis testing using the Benjamini- 
Hochberg method (see Materials and Methods), a p-value cutoff value of 0.05 was used 
to indicate statistically significant similarity between genelists. The number of 
comparisons found to have significant similarity under this criterion have been 
represented in Table 3.3 as the percentage of all comparisons between all genelists from 
any pair of array-types.
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m o u s e 4 3 0 2 50.7 67.1 100.0 52.9 21.3 13.9 13.1
ra t2 3 0 2 62.6 79.3 80.5 100 .0 27.0 17.6 16.8
d r o s g e n o m e l 31.3 38.0 37.0 30.9 100 .0 20.6 17.2
c e le g a n s 15.5 18.3 18.1 15.0 15.4 100.0 9.9
a th 1 1 2 1 5 0 1 10.6 12.4 12.2 10.3 9.2 7.1 100 .0
Table 3 .2  -  Num ber of g e n e s  shared  a cro ss  d ifferent array-types and 
sp e c ie s .  The numbers represent the percentage of genes of the row-wise chips that 
are present in the column-wise chips. Between array-types from the same species, 
they represent the number of shared genes (i.e. EGIDs). Between array-types from 
different species, they represent homologous genes (EGIDs after conversion across 
species by homology). Grey cells represent comparisons between arrays from the 
same species.
The proportion of comparisons found to have significant overlaps were highest when 
comparisons were carried out within a species. Interestingly, links between human 
genelists can be found with genelists from evolutionarily distant species such as the 
invertebrates Drosophila melanogaster and Caenorhabditis elegans, and even the plant 
Arabidopsis thaliana. In Figure 3.3, these values are plotted against the evolutionary 
distance between the species, and these exhibit a trend of decreasing with increase of 
evolutionary distance, similar to the behaviour of shared universe sizes in Figure 3.2.
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Figure 3 .2  D ecrease  in th e  num ber of g e n e s  shared b e tw een  sp e c ie s  with  
evolutionary d istance. Data points represent values displayed in Table 3.2. Y- 
axes represent the percentage of genes for each chip which is shared with the 
others. X-axes represent evolutionary distances scaled in units of expected fraction 
of amino acids changed, as calculated using the Dayhoff PAM matrix (see Materials 
and Methods).
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h g u 1 3 3 a 51.4 53.7 28.4 23.9 5.1 0.2 0.8
h g u 1 3 3 p lu s 2 53.7 69.6 44.7 38.8 3.4 0.0 1.3
m o u s e 4 3 0 2 28.4 44.7 64.7 35.5 4.0 0.0 0.3
ra t2 3 0 2 23.9 38.8 35.5 52.7 5.0 0.0 0.0
d r o s g e n o m e l 5.1 3.4 4.0 5.0 66.3 9.1 7.0
c e le g a n s 0.2 0.0 0.0 0.0 9.1 80.0 3.6
a th 1 1 2 1 5 0 1 0.8 1.3 0.3 0.0 7.0 3.6 72.6
Table 3 .3  -  C om parisons found to  sh o w  statistica lly  s ign ificant similarity.
Numbers represent the percentage of all comparisons between genelists that 
showed significant sim ilarity. Significance was detected using a hypergeometric p- 
value cut-o ff of 0.05 following Benjamini-Hochberg corrections (see Materials and 
Methods). Grey cells indicate comparisons between the same species.
These results appear to be biologically plausible: the decrease in the number of shared 
homologous genes with increase of evolutionary distance could be a consequence of the 
evolutionary changes to genome sequences. This factor, along with possible 
evolutionary changes to transcriptional regulation of biological pathways and networks 
could explain why the proportion of comparisons found to have significant similarity 
decreases as the evolutionary distance between the species being compared increases. 
However, a striking feature observed in the results is the very high proportion of 
comparisons that appear to have statistically significant overlap sizes when comparisons 
are carried out between genelists from the same species (or array-type). As can be seen 
in Table 3.3 (grey cells), 50-80% of all intra-species comparisons are classified as being 
significant.
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Figure 3 .3  D ecrease  in the  num ber of com p arisons sh ow ing  significant
similarity with evolutionary d istance. Data points represent values displayed in
Table 3.2. Y-axes represent the percentage of comparisons between genelists. X-
axes represent evolutionary distances scaled in units of expected fraction of amino
acids changed, as calculated using the Dayhoff PAM matrix (see Materials and
Methods).
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3.3.2 Excess similarity found between genelists from experiments 
carried out on the same array-type
It might reasonably be expected that lower proportions of cross-species comparisons 
would yield statistically significant similarity as compared to comparisons carried out 
between genelists from the same species (or array-type). This is likely to be caused by 
two effects of evolutionary changes across species. The first effect involves evolutionary 
changes to genome sequences. This limits the gene universe to only homologous genes 
that are present on arrays representing the both the species being compared. Prior to 
comparison, the genelists are required to be filtered to reflect this; very few genes may 
pass this filter if the shared universe between the species is small (for example, as 
previously pointed out, between the arrays representing C. elegans and A. thaliana). The 
second effect is more biological in nature, involving evolutionary changes to 
transcriptional regulatory mechanisms, which could cause divergence in biological 
pathways and processes between species.
While the results described in the previous section are in concordance with these 
expectations, the very high levels of similarity observed in comparisons of genelists 
from the same array-type (50-80% of comparisons are assigned significance when using 
the hypergeometric statistical test) are a cause for concern as such levels of similarity 
seem biologically implausible.
Hypergeometric Z-score distributions from all possible pair-wise comparisons carried 
out between genelists from experiments carried out on the same array-type are displayed 
in Figure 3.4. Control experiments, in the form of simulations, were carried out in 
parallel as follows: artificial arrays, represented as a set of unique and arbitrary 
identifiers, were created, of sizes equal to the number of unique Entrez Gene IDs 
(EGIDs) present on each real array. Genelists were then selected at random and without 
replacement from these artificial arrays, of the same lengths as those of the 
experimentally-derived genelists. These randomly created genelists were then compared,
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thus simulating each comparison of experimentally derived genelists. The grey lines 
represent the Z-scores distributions from these simulations. As expected, these are 
centred on medians of zero, implying that on average, there is no similarity between the 
genelists being compared.
It was expected that the majority of comparisons carried out between a diverse collection 
of genelists, such as those collected in the database, would yield no significant 
similarity between genelists, and that, like the simulations, these would yield Z-score 
distributions centred on medians of zero. However, as can be seen in Figure 3.4, the Z- 
score distributions from comparisons of the experimentally derived genelists (black 
lines) are markedly shifted away from those obtained from the simulations, and are 
centred on medians of 2 or more.
There are two possible interpretations of this observation. The first is that there is indeed 
some biology common to most, if not all, the experimentally-derived genelists; this 
seems somewhat biologically implausible when considering the diversity of experiments 
from which the genelists were derived. The second is that these could be artefacts caused 
by the violation of some assumption(s) of the hypergeometric statistical test.
To investigate whether this effect is prevalent in other collections of genelists, sets of 
genelists were downloaded from the L2L database (Newman and Weiner 2005). These 
are summarised in Table 3.4. All pair-wise comparisons were carried out between 
genelists from the same array-type and the resultant Z-score distributions are shown in 
Figure 3.5.
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Figure 3 .4  H ypergeom etric  Z-score distributions of com parison s of 
g e n e l is t s  from th e  sa m e  array-type. X-axes represent Z-scores;Y-axes denote 
distribution frequencies. Black lines represent comparisons of experimentally 
derived genelists. Grey lines represent simulations using random genelists using the 
same genelist and gene universe sizes as comparisons of real-world genelists. 
Broken lines represent medians of these distributions. Numbers within the plots 
signify the medians of the Z-score distributions from comparisons of experimentally 
derived genelists. For ease of visualization, Z-scores were capped at 10, such that 
all Z-scores >10 were set to 10. This causes some distributions to appear biphasic.
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Array-type Species Number of genelists
hgu133a Homo sapiens 37
hgu95a/av2 Homo sapiens 105
mgu74a/av2 Mus musculus 54
moe430a Mus musculus 13
Total: 4 array-types 2 species 209 genelists
Table 3 .4  Sum mary of g en e l is ts  dow nloaded  from the  L2L d atabase
hgu133a(L2L) hgu95a (L2L)
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Figure 3 .5  H ypergeom etric Z-score distributions of com parisons of  
g e n e l is t s  from th e  sa m e  array-type. X-axes represent Z-scores; Y-axes denote 
distribution frequencies. Black lines represent comparisons of experimentally 
derived genelists. Grey lines represent simulations using random genelists using the 
same genelist and gene universe size as comparison of real-world genelists. Broken 
lines represent medians of these distributions. Upper numbers in the plots signify 
the medians of the Z-score distributions from comparisons of experimentally derived 
genelists; lower numbers denote the percentage of comparisons found to be 
significant at p<0.05 (after FDR correction). For ease of visualization, Z-scores >10 
were set to 10. This may cause some distributions to appear biphasic.
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As can be seen, Z-score distributions are again positively shifted away from medians of 
zero in comparisons from genelists of experiments carried out on the hgul33a and 
moe430a arrays. However, in comparisons of genelists from experiments carried out on 
the hgu95a and mgu74a arrays, no such shift is observed. In this case the Z-score 
distributions, like those derived from the simulations, are centred on medians of zero.
These findings are in concordance with the proportions of comparisons which were 
found to have statistically significant overlaps between genelists (using a p-value cut-off 
of 0.05 after Benjamini-Hochberg correction): comparisons of genelists from 
experiments carried out on the hgul33a and moe430a arrays yielded significance for 
excessive proportions of comparisons (48% and 41% respectively), while the 
proportions for comparisons of genelists from experiments carried out on the hgu95a 
and mgu74a arrays that were found to have statistically significant overlap sizes were 
much more lower (14% and 11% respectively).
These results might suggest that one or more as-yet unidentified effects, which result in 
the apparent excess similarity amongst genelists from most of the array-types tested, are 
not prevalent in the hgu95a and mgu74a arrays. However, as is described in the next 
section, this does not appear to be the case.
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3.3.3 Link between significance of similarity and genelist length
Excess similarity between genelists from experiments carried out on the same array-type 
is observed in most of the array-types tested: the near-ubiquity of this phenomenon is 
consistent with this being a reflection of an unidentified systematic bias.
One observation in support of this hypothesis is the strong correlation found between the 
levels of excess similarity found within each array-type and the length of genelists. In 
Figure 3.6, the median Z-scores of comparisons of genelists within each array-type are 
plotted against the square root of median genelist lengths for each array-type. These 
values have a strong correlation to each other, having a correlation coefficient (r) of 
0.97. This correlation was also found to be highly significant: a Pearson’s product- 
moment test (see Materials and Methods) yielded a p-value of 1.13 x 10"6.
This apparent relationship then warranted investigation of the question of whether longer 
genelists tend to find more significant similarities with other genelists than shorter 
genelists. For this purpose, the median Z-scores of all comparisons of each genelist with 
all other genelists from the same array-type was recorded and plotted against the square 
root of the length of that genelist (Figure 3.7).
As can be seen in the figure, the majority of chip types appear to exhibit correlation 
between the median Z-scores from a genelist and the length of that genelist, though the 
strength of this correlation is highly variable. It should be noted that amongst the 
genelists from the L2L database that are derived from experiments carried out on the 
hgu95a and the mgu74a arrays, which had not shown the excess levels of similarity 
observed in the other sets of genelists, the correlation is highly significant.
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Figure 3 .6  Median Z-scores of intra-chip com parisons  plotted aga inst  the
square root of th e  median length  of all g e n e l is ts  from a particular array-
type. To avoid possible duplication of genelists, comparisons between genelists
from the in-house database and the L2L database were kept separate. Unless
indicated otherwise, points represent comparisons made between genelists from the
in-house database. The grey line is the line of best f it created by linear modelling of
the data.
82
Chapter 3: Comparison of lists of differentially expressed genes using the hypergeometric test
hgu133a hgu133plus2 mouse4302
CD -  
CO -
T* -
CM -  
O -
*
r= 0.75 
p= 5.76E-08
• • •
*
• •
h>- - 
CD -  
CD -  
-
CD -  
CM -
«
• •• .
•
« •
*
* * r= 0.78
p= 8.42E-05
# •
rs. -  
CD -  
ID -  
-
CD -  
CM -
•
r= 0.57
p= 0.008
•  *  •• • t
• ••
• •*** • • •
I I I I I 
10 20 30 40 50
rat2302
1 1 I I I  1 
10 20 30 40 50 60
drosgenomel
1 1 ‘ 1" 1 i i
10 20 30 40 50 60 
celegans
CD -  
-
CM -  
O -
*
•
* ♦
* r= 0.43 
p= 0.179
• 0 
2 
4 
6 
8
1 
I 
i 
i 
i 
i •
• »
• >
• •
* •
r= 0.62 
•  p= 0.004•
4 
6 
8 
10
i 
i 
i 
i r= 0.45 
p= 0.169
• l fk ^
♦ ♦ 
••
8 -  
w> _
o _
cn -
o  -
i i i r i i 
10 20 30 40 50 60
ath1121501
■ i r i i l l  
10 20 30 40 50 60
hgu133a (L2L)
I I ‘"I i i I I I  
10 20 30 40
hgu95a (L2L)
r= 0.67
p= 0.001
# ♦♦ •
.** v  •
00 - 
CO - 
-
CM - 
O -
*
• * * *  •« •  •
, r= 0.51
# p =0.001
• #*•
"a- - 
CD -  
CM -
T— —
o  -
¥"
• • •  •
5 4T*
• •• •• ****** * *
•V  ■» \  * r= 0.82
* p<2.2E-16
1 1 1 1 ' 1 i i
10 20 30 40 50 60 
mgu74a (L2L)
i i i i r
10 20 30 40 50
moe430a (L2L)
I I I I I 1 
5 1 0 15 20 25 30
.5 
0.5
 
1.5
 
2.
5
i 
i 
i 
i 
i 
i 
i ♦♦• * •
* * y  r= 0.74
p =1.1E-10
-
CD - 
CM -
O -
•• *•
*•
r= 0.77
p =0.001•
9 i i i I 
10 20 30 40
1 1 1 1 1 
5 1 0 1 5 20 25
Figure 3 .7  Correlation b etw een  g en e l is t  length  and significance. Data points 
represent the median hypergeometric Z-score of all comparisons carried out 
between any one genelist and all other genelists from the same array-type (Y-axes), 
plotted against the square root of the length of that genelist. Grey lines represent 
lines of best f it created by linear modelling of data points. In the plot, the upper 
number represents the correlation coefficient while the lower number is the p-value 
from the Pearson's product-moment test for correlation.
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This finding could explain why the shifts in Z-score distributions and excess similarity is 
not observed amongst the genelists from the hgu95a and mgu74a arrays that were 
downloaded from the L2L database but are seen in all sets of genelists from the in-house 
database and all other genelists downloaded from the L2L database: with median 
genelist lengths of 37 and 37.5 genes for the hgu95a and mgu74a sets respectively 
(whilst all other sets of genelists had median genelist lengths of 176-660 genes), most 
genelists in these sets were too short for any shift of Z-score distribution to become 
noticeable.
To test this, comparisons were carried out for these two sets again, but only using 
genelists of length greater than 50 genes (an arbitrary cut-off). The resultant 
hypergeometric Z-score distributions (Figure 3.8) now show shifts away from a median 
of zero. The proportion of comparisons found to have significant similarity (selected as 
having p<0.05 after Benjamini-Hochberg correction) are also much higher: 45% and 
32% for the hgu95a and mgu74a sets respectively (as opposed to 14% and 11% 
respectively observed prior to filtration of short genelists).
This relationship between genelist length and significance of overlaps between genelists 
was unexpected, because the hypergeometric test (see simulations described in Chapter 
2) is insensitive to genelist length. This length-dependency provides additional support 
for the hypothesis that the excess similarity observed between genelists from the same 
array-type reflects some systematic bias, for example, caused by the violation of some 
assumption(s) of the hypergeometric distribution.
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Figure 3 .8  -  H ypergeom etric Z -score d istributions of com p arison s of 
g e n e lis ts  from th e  sa m e array-type. X-axes represent Z-scores; Y-axes denote 
distribution frequencies. Black lines represent comparisons of experimentally 
derived genelists. Grey lines represent simulations using random genelists using the 
same genelist and gene universe size as comparison of real-world genelists. Broken 
lines represent medians of these distributions. Upper numbers in the plots signify 
the medians of the Z-score distributions from comparisons of experimentally derived 
genelists; lower numbers denote the percentage of comparisons found to be 
significant at p<0.05 (after FDR correction). For ease of visualization, Z-scores >10 
were set to 10. This may cause some distributions to appear biphasic.
The link between genelist length and significance also makes compensating for the 
excess similarity observed between genelists more difficult. If the effect of the observed 
systematic bias could be shown to be uniform, causing the shift of all Z-scores by the 
same amount or proportion, then the rank-order of comparisons on the basis of Z-scores 
would remain the same as when there was no bias, and the top-ranked comparisons 
could be selected for further analysis.
The following chapter describes explorations into the possible causes for the observed 
relationship between significance and genelist length.
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3.4 Discussion
This chapter explored the results of applying the hypergeometric statistical test to assign 
significance to overlaps between genelists, having carried out all possible pair-wise 
comparisons between all genelists from a database of genelists extracted manually from 
the published literature of microarray experiments carried out on a range of species. It 
was initially found that significant overlaps could be found even between genelists from 
experiments carried out on evolutionarily distance species, for example between 
genelists from the human hgul33a and the Arabidopsis athl 121501 Affymetrix 
platforms. It was also found that the proportions of comparisons found to be significant 
decreased with the evolutionary distances between the species from which genelists 
were being compared. These could reflect both the decrease in the number of 
homologous genes (due to evolutionary changes of genetic sequences), and evolutionary 
changes to transcriptional regulation of biological pathways.
However, very high levels of similarity were found for comparisons between genelists 
from the same chip type. This was reflected in both the high proportions of comparisons 
that exceeded thresholds of statistical significance and in hypergeometric Z-score 
distributions that were positively shifted away from an expected median of zero. These 
findings have several implications. The first is regarding practicality; for this approach 
to be of use it should highlight a relatively few interesting overlaps between genelists, 
which would be seen as occasional outliers (and detected as such). However, as the 
method finds the majority of comparisons to have significant similarity, it has limited 
practical utility. The second implication concerns the interpretation of these findings; 
while it is possible that the results reflect true biological similarities between the 
genelists, this seems somewhat implausible given the diversity of experiments from 
which the genelists were derived. A perhaps more likely scenario is that these are the 
results of some unidentified systematic effect, such as an erroneous assumption within 
the underlying statistical model.
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Subsequently, it was found that significance levels shared strong correlation with 
genelist length; longer genelists tended to be involved in more comparisons that showed 
significant similarity between genelists than did shorter genelists. When enough 
genelists were present in the set, comparisons between them would result in a Z-score 
distribution shifted well beyond a median value of zero. This is further evidence of some 
systematic effect, as the hypergeometric statistical test was chosen for the purpose of 
genelist comparison because the metrics involved are not sensitive to genelist length (in 
simulations using randomly created genelists -  See Section 2.2.3.3).
While it would be possible to quantify and compensate for this relationship between 
significance and genelist length, which then could result in fewer, more credible 
numbers of significant links being found, this was not carried out for the following 
reasons. Firstly, any modelling of the relationship would have been very ad hoc, and 
completely dependent on the data. Secondly (and more importantly), as the reasons for 
this bias were unknown, there would have been no theoretical grounds for trusting the 
results from such manipulation of the data.
For these reasons, further explorations focused on attempts to find the possible statistical 
errors that could have caused the observed relationship between genelist length and 
significance. Chapter 4 describes explorations of possible violations of assumptions of 
the hypergeometric distribution that could explain this relationship. It is shown that 
under the ‘biased urn’ model of the hypergeometric distribution, the excess levels of 
similarity observed in comparisons of experimentally-derived genelists from the same 
array-type can be simulated using randomly created genelists. Chapter 5 then explains 
why any ad hoc methods that attempt to quantify and control for the observed biases 
could be unreliable when using a single universe size for all comparisons of genelists 
from the same array-type.
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Chapter 4: M odelling v io lations o f  the
assum ptions o f the hypergeom etric  
distribution  using the ‘b iased urn’ m odel
4.1 Introduction
One aim of this thesis is to assess the viability and potential utility of comparing lists of 
differentially expressed genes as representatives of microarray experiments to find 
possible biological similarities and links between them. Chapter 2 described the 
development of strategies to translate genelists across different chips and species, and 
the selection of the hypergeometric statistical test to assess the significance of overlaps 
between genelists. Chapter 3 described the application of these methodologies to a local 
database of genelists manually extracted from the published scientific literature of 
microarray experiments carried out on Affymetrix GeneChip microarrays covering a 
range of species.
Excess levels of similarity were found for comparisons carried out between genelists 
from experiments carried out using the same type of GeneChip. Subsequently it was 
observed that there was a relationship between significance and genelist length, which is 
not predicted from a simple application of the hypergeometric distribution. These 
findings raised the possibility that the excess levels of similarity do not reflect any true 
underlying biology common to these genelists (which would be a somewhat implausible 
scenario, given the diversity of experiments represented by the genelists), but rather 
some inherent flaw within the statistical model used to assess significance of overlaps 
between genelists.
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This chapter describes explorations attempting to identify the cause of this observed 
bias, whereby longer genelists are involved in more comparisons that are called 
significant than shorter genelists. One possible cause is a violation of some 
assumption(s) of the hypergeometric statistical test. Such violations might not be totally 
unexpected in this system, given that a simple statistical model has been applied to the 
complex issue of gene expression patterns. One particular assumption is that all genes 
(in an array) have an equal probability of being selected into a list of differentially 
expressed genes. There are several gene regulation scenarios that violate this 
assumption.
One such category involves genes that are less likely to appear in a genelist because they 
are very rarely or never expressed. This may be due to trivial technical reasons (such as 
a badly designed probe to which the complementary mRNA does not hybridize), or for 
biological ones (for example genes that are only expressed in certain tissues and/or 
environmental conditions), or even a combination of the two (for examples, genes which 
are differentially regulated but have expression levels too low to be detected by current 
hybridization-based techniques). The presence of such genes then artificially increases 
the size of the gene universe, and could lead to erroneous assessment of significance 
when included in calculations of the hypergeometric statistical test.
To illustrate this, consider two genelists that do not share any underlying biology, and 
have an overlap of size jc, which is the expected size of overlap between two randomly 
created genelists selected from a gene universe that does not include genes in any o f the 
categories described above (i.e. a subset of the full gene universe). Now consider that 
the hypergeometric test is used to assess the significance of this overlap, and all genes 
represented on the array from which these genelists are derived are included in the gene 
universe. The hypergeometric test would then assume an expected overlap size of y , but 
this would be lesser than x, because, as described in Section 2.2.2, the expected size of 
overlap between genelists decreases with increased universe size (when genelist lengths
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are constant). Because significance is a function of the deviation of the observed overlap 
size from the expected overlap size, this comparison would be assigned greater 
significance (i.e. higher Z-score and lower p-value) than it ought to be. An increase in 
numbers of this category of (un-expressed/rarely-expressed) genes would result in a 
greater difference between the size of the ‘real’ gene universe (i.e. the set of genes which 
can be selected into a genelist) and the size of the gene universe used in the 
hypergeometric test (i.e. all genes on the array), which in turn would result in greater 
significance being assigned to any comparison of genelists.
A second category would involve those genes whose expression patterns are 
evolutionarily (or otherwise) constrained to be stable. This might potentially include 
housekeeping genes such as GAPDH, P-actin, or cyclophilin because the expression 
patterns of these genes may not be expected to show much change in response to 
experimental conditions (She et al. 2009). As most tests for differential expression 
assess the level of variability in expression levels between phenotype classes, such genes 
may be less likely to be selected into a genelist. The presence of this category of genes 
on an array would have a similar effect on the hypergeometric test as might be expected 
from the first category of genes.
A third category consists of those genes that show high levels of variability in their 
expression patterns across different phenotype classes i.e. those that are commonly 
subject to differential transcriptional regulation in response to experimental conditions. 
These genes would then be more likely to be selected by tests for differential expression 
into genelists than other genes. This then would result in an increased probability of 
these genes being found in common between genelists. In effect, these genes could 
artificially increase the overlap size between genelists, and cause the comparison to be 
assigned greater significance by the hypergeometric test than should be the case.
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While the above three categories of genes all violate an assumption of the 
hypergeometric test, namely that all genes have an equal probability of being selected 
into a genelist, a fourth category of genes violates another assumption: that genes are 
selected into genelists independently of each other. This category would include co­
regulated genes. For example, consider a group of three co-regulated genes, with such 
similar expression patterns that (if differentially expressed) they would always be 
selected together into a genelist. Thus the contribution of these genes to an overlap 
between two genelists that contain these genes would be a value of three (instead of the 
desired value of one).
More advanced models of the hypergeometric distribution, such as the Fisher’s and 
Wallenius’ non-central hypergeometric distributions (Fog 2007), do not make some of 
the assumptions as the simple hypergeometric model, such as the assumption that all 
genes have equal probability of being selected. However, their use in the analysis of 
microarray data has been limited, because these methods require precise quantifications 
of gene-selection probabilities that are currently unavailable. Due to this, researchers 
have used simple models like the hypergeometric distribution in microarray data 
analysis (for example in Over-Representation Analysis of GO terms or pathways within 
genelists), in the hope that major biological signals will overcome any deficiencies of 
the statistical models.
So far, no attempts have been made to quantify these complexities or the effects they 
could have on the results when using statistical models that ignore them. This chapter 
describes attempts to quantify the effect of these complexities on the naive 
implementation of the hypergeometric test to the comparison of lists of genelists using 
the ‘biased urn’ model.
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4.2 Explorations and Results
4.2.1 The ‘biased urn’ model
Advanced models of the hypergeometric distribution such as those mentioned above 
(Fog 2007), involve selection from what has been termed a ‘biased urn’. This is an 
allusion to the um-filled-with-balls analogy that is popularly used to describe the 
hypergeometric distribution (see Section 2.2.3.3), and refers to these methods’ use in 
cases where different balls in the urn have different probabilities of being selected. In 
order to quantify the net effect of complex gene expression patterns on the use of the 
simple hypergeometric model to assess similarity between genelists, a statistical model 
was used that also assumed a ‘biased urn’.
This model involves an urn (gene universe) that is filled with two sets of balls (genes): a 
set that can be selected into genelists, and a set that cannot. Consider that the size of this 
gene universe is x, and the size of the subset of the universe from which genes can be 
selected is y, such that x > y. Genelists were to be selected in a random fashion from 
amongst this subset of genes and then compared using the hypergeometric test.
However, the universe size to be used in assessment of significance is x rather than y. In 
such a scenario, the distribution of overlap sizes observed would vary around the overlap 
sizes expected when using a gene universe of size y. However the statistical test would 
assume overlap sizes expected when using a gene universe of size x. As shown in 
Section 2.2.2, the expected overlap size decreases with increase in the size of the gene 
universe (when genelist lengths are constant). Thus, on average, any comparison of 
genelists from this model would involve an observed overlap size which is greater than 
what the model expects, and assignment of greater significance to this comparison than 
would be warranted by a comparison of two randomly created genelists. This could then
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cause excess levels of similarity to be found between the genelists, similar to what was 
observed in the comparisons of literature-derived genelists described in Chapter 3.
This model represents a somewhat over-simplification of the complex expression 
patterns of genes (such as those described in the introduction to this chapter), and cannot 
be expected to accurately quantify these effects separately. However it is hypothesized 
that this model could allow some quantification of the net effect of these factors on the 
comparison of genelists.
4.2.1.1 Effect of universe size on significance in the biased urn model
It is expected that for a comparison of randomly created genelists using the biased urn 
model, the significance assigned to the comparison would increase with an increase of 
the universe size used in the calculations relative to the size of the ‘real’ gene universe 
from which the genelists were sampled.
For example, consider the following biased urn scenario: two genelists of 1000 genes 
each that have been selected from a gene universe of 10,000 genes. Then consider that 
the observed overlap size between them is exactly as expected i.e. 100 (as calculated 
using the formula described in Section 2.2.2). A hypergeometric test using the correct 
gene universe size of 10,000 (i.e. an unbiased urn) would yield a Z-score of zero for this 
comparison. However, a hypergeometric test that involves a universe size of 20,000 (i.e. 
a biased urn which has a further 10,000 genes which cannot be selected into genelists), 
would then assume an expected overlap size of 50, and assign this comparison a Z-score 
of 7.4. Similarly, using gene universe sizes of 25,000 and 30,000 would yield Z-scores 
of 9.9 and 11.9 respectively and so on.
To demonstrate this, simulations were carried out as follows. A set of 10,000 unique and 
arbitrary identifiers was created, representing the subset of a gene universe from which
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genes can be selected into a gene universe. Two genelists, each of 1000 genes each were 
then selected at random and without replacement for the gene universe, and the size of 
the overlap between them was recorded. This was carried out a thousand times.
Hypergeometric Z-scores were then calculated for this distribution of overlap sizes using 
gene universe sizes ranging from 10,000 to 40,000. Figures 4.1a and 4.1b display box- 
plots and density curves, representing the Z-scores distributions calculated using these 
different universe sizes, respectively.
As expected, the distribution calculated using the correct universe size (which represents 
an unbiased urn) is centred on a median of zero (broken black lines). The other 
distributions are increasingly shifted away (from a median of zero) as the universe size 
used for their calculations increase.
The medians of these distributions (horizontal black lines within box-plots) are equal to 
Z-scores calculated using an overlap size of 1000, as would be expected in two genelists 
of 1000 genes each randomly selected from a universe of 10,000 genes (red points in 
Figure 4.1a).
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Figure 4 .1  Effect o f u n iverse s ize  on sign ifican ce in th e  b iased  urn m odel.
(a) Box-plots and (b) density curves of Z-score distributions based on comparisons 
of two genelists of 1000 genes each selected at randomly from a hypothetical array 
(a set of 10,000 unique and arbitrary identifiers), iterated a thousand times, created 
using a range of gene universe sizes (denoted by the X-axis in (a) and the key in
(b)). Broken black lines in both figures mark a Z-score of zero. Red lines and points 
in (a) represent pre-calculated Z-scores expected for their respective distributions.
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4.2.1.2 E ffect o f genelist length on significance in the biased urn model
It is also expected that, in the biased urn model, genelist length is linked to significance. 
For example, consider the following biased urn model: an array of 20,000 genes of 
which only half can be selected into genelists. For a comparison between two randomly 
created lists of 1000 genes each, an overlap size of 100 genes is expected. Under the 
biased urn model the expected overlap size is 50 and this would yield a Z-score of 7.4. 
Similarly consider a comparison of two randomly created genelists of 2000 genes each 
that have an expected overlap size of 400 genes. The biased urn model would then 
expect an overlap size of 200 and yield an even more significant Z-score of 15.7. A 
comparison between two lists of 3000 genes (that have an overlap of the expected size) 
each would yield a Z-score of 24.9, and so on.
To demonstrate this, the following simulations were carried out: a set of 10,000 unique 
and arbitrary identifiers was created, representing the subset of a gene universe from 
which genes can be selected into a gene universe. Two genelists, each of 1000 genes 
each were then selected at random and without replacement for the gene universe, and 
the size of the overlap between them was recorded. This was carried out a thousand 
times. Hypergeometric Z-scores were then calculated for this distribution of overlap 
sizes using a gene universe size of 20,000 genes. This was repeated using a range of 
genelist lengths varying from 1000 to 2500 genes.
Box-plots and density curves of the resultant Z-score distributions are displayed in 
Figure 4.2a and 4.2b respectively. A shift of distributions towards increasing 
significance (Z-scores) with increased genelist size is seen. The medians of these 
distributions (horizontal black lines within box-plots) are equal to Z-scores calculated 
using an overlap sizes that are expected in a comparison of randomly created genelists of 
their respective lengths (red points in Figure 4.2a).
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Figure 4 .2  Effect of g en e lis t  length  on s ig n ifican ce  in th e  b iased  urn m odel.
(a) box-plots (b) and density curves of Z-score distributions based on comparisons 
of two genelists (of the same length), each selected at randomly from a 
hypothetical array (a set of 10,000 unique and arbitrary identifiers), iterated a 
thousand times. Calculations used a universe size of 20,000 genes and a range of 
genelist lengths (denoted by the X-axis in (a) and the legend in (b)). Red lines and 
points in (a) represent pre-calculated Z-scores expected for the respective 
distributions.
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4.2.1.3 Combined effect o f genelist length and universe size on significance in the 
biased urn model
The explorations described above illustrate how gene universe size and genelist length 
can independently influence significance when performing the hypergeometric statistical 
test using the biased urn model.
To investigate if (and how) these factors interact with each other, simulations were 
carried out as follows: a set of 10,000 unique and arbitrary identifiers, representing a 
hypothetical array was created. From this, a reference list of 1000 genes was selected 
randomly and without replacement. Then, a set of genelists of lengths ranging from 1000 
to 5000 genes were selected randomly and without replacement.
Each of these was compared to the reference genelist and the observed overlap size was 
recorded. Hypergeometric Z-scores were then calculated for each comparison using gene 
universe sizes of 10,000 (representing an unbiased urn), 15,000, 20,000 and 25,000 
genes. Figure 4.3a displays the density curves of the resulting Z-score distributions.
As expected, the distribution that was created using a universe size of 10,000 genes (i.e. 
an unbiased urn) is centred on a median of zero. As seen previously in the analysis 
described in Section 4.2.1.1, the Z-score distributions that were calculated using the 
biased urn model are shifted away from a median of zero, and the magnitude of this shift 
is proportional to the difference between the ‘real’ gene universe size of 10,000 and the 
universe size used in the calculations.
There is also a greater change in the shapes of the distributions derived from the biased 
urn model, as compared to the previous analysis, probably due to a range of different 
genelist lengths being used (as opposed to the fixed genelists lengths used in Section 
4.2.1.1).
98
Chapter 4: Modelling violations of the assumptions of the hypergeometric distribution using the
‘biased urn’ model
In Figure 4.3b the Z-scores are plotted against the square root of the lengths of the test 
genelists used in the comparisons. As expected, the distribution derived from the 
unbiased urn shows no influence of genelist length on magnitude. The distributions 
derived from the biased urn models show an increase of significance with increase of 
genelist length, which is in concordance with the analysis described in Section 4.2.1.2.
It is also seen that for models involving greater deviations of the gene universe size from 
the ‘real’ gene universe size of 10,000 genes, there is a more pronounced effect of 
genelist length on significance, as evidenced by the increased slopes of the lines of best 
fit.
Thus, while genelist length and universe size can both influence measures of 
significance in the biased urn model independently, in cases where both factors are 
variable, the magnitude of the effect of genelist length on significance depends on how 
biased the urn is (i.e. the magnitude of the difference in the size of universe used for 
sampling genelists, and that of the universe size used in the hypergeometric test).
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F igure  4 .3  C om bined  e ffe c t o f g e n e l is t  le n g th  an d  u n iv e rs e  s ize  on 
s ig n if ic a n c e  in th e  b ia se d  u rn  m o d e l, (a) Density curves of Z-score distributions 
of comparisons of a reference genelist to a set of test genelists of a range of 
lengths, all of which were selected randomly from hypothetical arrays (sets of 
unique and arbitrary identifiers) of different sizes, (b) Z-scores plotted against 
square root of test genelist lengths. Broken lines represent lines of best fit created 
by linear modelling. The different distributions were created by using different gene 
universe sizes in Z-score calculations (see figure legends.)
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4.2.2 Effective gene universe sizes range from only 35-65% of the 
genes on an array
The above explorations indicate that the biased urn model is able to simulate both the 
excess similarity, and the effect of genelist length on significance of comparisons, that is 
observed in comparisons of real-world genelists. This was achieved simply by changing 
the universe size used in calculating the hypergeometric Z-scores, thus violating the 
assumption that all genes in the universe are equally likely to be selected into genelists. 
In effect, additional genes are added to the universe that cannot be selected into 
genelists.
Application of this model to a comparison of literature-derived genelists does have some 
caveats. It involves something of an over-simplification of the complex expression 
patterns and interactions that occur between genes, in that it assumes only two 
behaviours: that a gene can be selected into a genelist or it cannot. It thus ignores the 
continuum of probabilities that quantify the ability of genes to be selected into genelists, 
and the likelihood that these probabilities may change under different experiments and 
conditions. The model also ignores the possibility that the gene universes are also likely 
to be different for different comparisons. For these reasons, it is not reasonable to expect 
the model to provide resolution and quantification of the many different gene expression 
behaviours (some of which may cause excess similarity between genelists, and some of 
which may decrease it). However, it could provide adequate quantification of the net 
effect of these phenomena in the terms of this model.
The biased urn model was applied to the comparison of literature-derived genelists as 
follows. Central to the application of this model is the assumption that when the ‘true’ 
gene universe size is used in the calculation of Z-scores, the resulting distribution would 
be centred on a median of zero, thus reflecting the reasonable expectation that in a 
collection of genelists from a diverse range of experiments, most genelists would not be
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similar to each other. Decreasing the size of the gene universe used in the Z-score 
calculation resulted in the shifting of the distribution backwards towards a median of 
zero. The universe size was iteratively decreased till the resulting distribution was 
centred on a median of as close to zero as possible. This process was carried out on the 
comparisons of all sets of genelists (except the L2L hgu95a and mgu74a sets, as their Z- 
score distributions were already centred on medians of zero), and the results are shown 
in Table 4.1.
Array-type MedianZ-score
Original gene 
universe size (number 
of genes on array)
Estimated 
‘real’ gene 
universe size
Estimated ‘true’ 
gene universe size 
(% of original)
hgu133a 2.48 13387 7784 58.1%
hgu133plus2 4.12 20080 9256 46.1%
mouse4302 3.32 20981 11794 56.%
rat2302 2.33 13784 7395 53.6%
drosgenomel 4.66 12049 7688 63.8%
celegans 3.83 16107 8650 53.7%
ath1121501 5.58 22568 9635 42.7%
hgu133a (L2L) 2.52 13387 5225 39.%
moe430a (L2L) 2.14 13419 4762 35.5%
Table 4 .1  Application of the biased urn m odel to  com parisons of literature- 
derived gen elists . 'T rue7 g en e  universe sizes w ere estim ated  by iteratively 
reducing th e  g en e  un iverse size used  in calculations of Z -scores till th e  resulting 
distributions w ere cen tred  on m edians of zero. A rray-types rep resen t s e ts  of 
genelis ts  (derived from th o se  array s) collected in th e  local d a tab ase  unless indicated 
o therw ise.
The estimated ‘true’ gene universe sizes imply that, on average, for any comparison of 
genelists, the net effect of the complex gene expression patterns that are ignored by the 
simple hypergeometric test is equivalent to only 35-65% of genes on an array being 
available for selection into genelists, in terms of the biased urn model.
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4.2.2 Randomly selected genelists show excess similarity using the 
biased urn model
Having estimated the ‘true’ gene universe sizes, it was then desired to estimate the 
extent to which the excess similarity observed for comparisons of the literature-derived 
genelists could be explained by the systematic effects of genelist length and gene 
universe size on significance, as a result of violations of the assumptions of the simple 
hypergeometric test. This was attempted by carrying out the following simulations: for 
each of the sets of genelists, a hypothetical array, represented by a set of unique and 
arbitrary identifiers, was created. The size of these arrays was that of the estimated ‘true’ 
gene universe sizes (e.g. to simulate a comparison of the hgul33a set of genelists, a 
hypothetical array of 7784 genes was used). Then a set of genelists was selected from 
this array at random and without replacement, with lengths matched to each of the 
literature-derived genelists of that set. These genelists were then compared using the 
hypergeometric test, but now using a gene universe size that was the original number of 
genes on the array (thus for simulations of comparison of the hgul33a genelists, a 
universe size of 13387 genes was used).
The resulting distributions are shown in Figure 4.4. It is found that the distributions from 
the biased um model are able to simulate the excess similarity observed in the 
comparisons of literature-derived genelists well. This is reflected both in the similarity 
of the shapes of the distributions, and also in the similarity in the median Z-scores for 
these distributions, and the proportions of comparisons found to be significant at p<0.05 
after Benjamini-Hochberg correction (Table 4.2).
From these observations, it was concluded that much of the excess similarity observed 
during comparisons of genelists derived from experiments carried out on the same type 
of GeneChip appears to be an artefact caused by violations of assumptions of the 
hypergeometric test.
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Figure 4 .4  M odelling com parisons of literature-derived  g e n e lis ts  using the  
biased  urn m odel. X-axes represent hypergeometric Z-scores; Y-axes denote 
distribution frequencies. Black curves represent Z-scores from comparisons of 
literature-derived genelists. Grey curves represent Z-scores from simulation studies 
using an 'unbiased7 urn (i.e. the universe size used for sampling genelists is the 
same as that used for calculations). Broken curves represent Z-scores simulations 
using a biased urn. Vertical lines represent medians of their respective distributions. 
For ease of visualization Z-scores >10 were set to 10. This may cause some 
distributions to appear biphasic.
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Array-type
Comparison of literature-derived 
genelists
Comparison of randomly 
created genelists using the 
biased um model
Median
Z-score
%of 
comparisons 
significant at 
p<0.05
Median
Z-score
%of 
comparisons 
significant at 
p<0.05
hgu133a 2.48 51.4% 2.51 52.3%
hgu133plus2 4.12 69.6% 3.51 66.1%
mouse4302 3.32 64.7% 3.37 64.7%
rat2302 2.33 52.7% 2.29 43.6%
drosgenomel 4.66 66.3% 3.43 73.2%
celegans 3.83 80% 3.8 74.5%
ath1121501 5.58 72.6% 5.69 78.9%
hgu133a (L2L) 2.52 48.3% 2.59 48.8%
moe430a (L2L) 2.14 41% 1.98 37.2%
Table 4 .2  -  Modelling com parisons of literature-derived gen elists  using the  
biased urn m odel. Median Z -scores and proportions of com parisons found to  be 
positive a t  p < 0 .0 5  (a fte r Benjam ini-H ochberg correction) for com parisons of 
litera tu re-derived  genelis ts  and from sim ulation stud ies using th e  biased urn model. 
T hese a re  derived from  th e  d istributions rep resen ted  a s  black and broken curves 
respectively  in Figure 4 .4 . A rray-types rep resen t s e ts  of th o se  genelists  (derived 
from  th o se  a rray s) collected within th e  in-house d a tab ase  unless indicated 
o therw ise.
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4.3 Discussion
As described in Chapter 3, comparisons between genelists derived from experiments 
carried out on the same GeneChip using the hypergeometric statistical test yielded 
excess levels of similarity between the genelists. This observation, along with the 
discovery of a relationship between genelist length and significance, led to the 
hypothesis that the excess similarity reflected the systematic effects of a flaw in the 
statistical model (possibly caused by violations of assumptions of the hypergeometric 
test), rather than any true underlying biology.
This chapter then described investigations of this hypothesis, which involved what has 
been termed the ‘biased urn’ model of sampling for the hypergeometric distribution. 
While the simple hypergeometric test assumes that all genes on an array have an equal 
probability of being selected into a genelist, the biased urn model forces a bias in the 
sampling probability, such that a certain proportion of genes on the array can never be 
selected. This model was used for the investigations because in this model, the 
significance metrics are functions of genelist length and universe size, and yield excess 
levels of similarity between randomly created lists of genes, as is seen in comparisons of 
experimentally-derived genelists.
To simulate the comparisons of experimentally-derived genelists, the biased urn model 
required three parameters: the genelists lengths (which would be the same as the lengths 
of the experimentally-derived genelists), the universe size used for calculations of 
significance (which would be the total number of genes on the array; this is the universe 
size used in comparisons of experimentally-derived genelists), and the ‘true’ gene 
universe size, which is the size of the subset of those genes on the array that can be 
sampled into genelists. The ‘true’ gene universe sizes were estimated on an ad hoc basis 
by iteratively re-calculating Z-scores from comparisons of experimentally derived 
genelists using different gene universe sizes till the resulting distribution was centred on
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a median of zero. This methodology was based on the assumption that as most genelists 
from a diverse set of experiments would not be similar to each other, they should yield a 
Z-score distribution centred on a median of zero, as is seen from comparisons of 
randomly created genelists.
The magnitude of the difference between these ‘true’ gene universe sizes and the total 
number of genes on the array could thus provide a rough quantification of the magnitude 
of the violation of assumptions of the hypergeometric distribution observed in the data. 
Strikingly, it was found that the net effect of these violations resulted in the equivalent 
of only 35-65% of the genes on an array being available for selection into genelists, in 
terms of the biased urn model.
Simulations carried out using the biased urn model with the parameters described above 
yielded Z-score distributions that were highly similar to those derived from the original 
comparisons of experimentally derived genelists. Thus, even though the biased urn 
model represents an over-simplification of the complex gene expression patterns that 
violate assumptions of the hypergeometric distribution (some of which are described in 
Section 4.1), it is able to replicate the excess levels of similarity observed amongst 
experimentally-derived genelists with a considerable degree of success.
Naive application of the hypergeometric distribution to the comparison of 
experimentally-derived genelists is likely, therefore, to yield unreliable results, because 
of the influence on genelist length on significance metrics. However, as the biased urn 
model is capable of simulating these effects relatively well, simply by forcing a 
difference between the sizes of the sampling universe and the size of the universe used 
in calculation of significance metrics, it can provide some potential solutions. One 
option may be to simply use the estimated true gene universe size in the hypergeometric 
test. Another option may be to predict the relationship between genelist length and Z- 
scores based on the difference between the two universe sizes. The observed Z-scores
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can be projected on this relationship and significance could then be calculated using the 
deviation of Z-scores from the predicted relationship. These two methods can only be 
used in cases where excess similarity is observed amongst genelists (i.e. Z-score 
distributions are shifted away from medians of zero), as both require estimation of the 
true gene universe size. Another option which could be of use, particularly in cases like 
the hgu95a and mgu74a sets of genelists from the L2L database (Newman and Weiner 
2005) and thus where the genelists are too short to cause shifts in Z-score distributions, 
would involve modelling the observed relationship between Z-scores and genelist 
lengths. For example, a line of best fit could be induced by linear modelling of the data, 
and significance could then be assigned depending on the deviation of Z-scores from this 
line.
However, there are issues regarding such solutions. Firstly, they are ad hoc and very 
dependent upon the data, and will thus be potentially prone to biases within the data. 
Secondly, and more importantly, as these methods use, for all assessments, a single 
estimated true gene universe size that would actually be the average gene universe size 
shared between any two experiments, they ignore the possibility that different 
comparisons are likely to involve different gene universes (which may be of different 
sizes). For example, it is likely that two experiments carried out on the same tissue type 
may share a much larger gene universe than those carried out on different tissue types. 
Estimating the correct universe size is crucial, as (in the biased urn model), it not only 
influences the significance metrics (see Section 4.2.1.1), but also influences the effects 
of genelist length on significance metrics (see Section 4.2.1.3).
For this reason, subsequent investigations focussed on estimation of gene universes for 
experiments. Chapter 5 describes these explorations, which indicated considerable 
diversity in gene universe sizes, which appear to be affected by both technical and 
biological (such as tissue-specificity) effects.
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Chapter 5: Exploring gene expression
patterns w ith  the GNF Expression Atlas
5.1 Introduction
Chapter 3 described explorations involving comparisons of genelists derived from 
experiments carried out on the same array-type, by using the hypergeometric statistical 
test to assess significance of overlaps. This revealed what appeared to be excess levels of 
similarity. Further work revealed a link between genelist length and the significance of 
comparisons, which is not expected from the hypergeometric test and thus suggested the 
existence of one or more flaws within the application of the statistical model. Chapter 4 
described explorations of possible violations of the hypergeometric test. A statistical 
model (called the biased urn) was used that could model the excess levels of similarity 
observed, as well as the relationship between genelist length and significance. It was 
found that the model, when using randomly created genelists, could provide a reasonable 
simulation of the significance distributions derived from comparison of experimentally- 
derived genelists. This was achieved by using a different sized gene universe in the 
statistical test to that from which the genes were sampled.
While the biased urn model represents an over-simplification of the various gene 
expression scenarios that could cause violations of the assumptions of the 
hypergeometric distribution, its ability to at least partially replicate the Z-score 
distributions derived from comparisons of experimentally-derived genelists does raise 
the question as to whether it might be possible to model (and thus compensate for) these 
violations. One concern is that such modelling is likely to be a highly ad hoc and very 
dependent on the data, and would be susceptible to any biases inherent in a particular 
dataset. Also, such modelling would require assumptions that may be plausible, but
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somewhat weak (for example, the assumption that comparisons carried out within a set 
of genelists from a diverse range of experiments would yield a Z-score distribution 
centred on a median of zero, as is seen from comparisons of randomly created genelists).
One particular concern would be if the same gene universe size (i.e. the subset of genes 
on an array from which genes can actually be selected into genelists) would need to be 
used for all comparisons, since from a biological perspective this does not seem 
justified. This issue is of particular concern because, as simulations described in 
Chapter 4 show, in the biased urn model, calculations of the significance metrics are 
sensitive to the size of the gene universe. This also affects the magnitude of the 
relationship between genelist length and significance. Thus, use of the correct gene 
universe size is crucial. While the model provides an estimate of the true gene universe 
size, this only represents the average size of the gene universe that is shared between any 
two experiments. It is not difficult to conceive of pairs of experiments having very 
different sizes of shared gene universes (for example due to tissue-specific gene 
expression). Thus, one might expect that two experiments carried out on similar tissue- 
types would share a larger gene universe than two experiments carried out on different 
tissue-types.
To investigate these issues in greater detail the following chapter reports explorations 
undertaken using the Genomics Institute of the Novartis Research Foundation (GNF) 
Expression Atlas (Su et al. 2004) dataset. This is a publicly available set of expression 
profiles of a wide range human and mouse tissues. By providing an opportunity to 
explore the number of genes expressed in different types of tissues, it allowed some 
semi-quantitative estimates to be derived as to potential gene universe sizes in different 
tissue types, and the number of expressed genes shared between the different gene 
universes.
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5.2 Results and Explorations
5.2.1 Explorations of gene universe sizes and gene expression 
frequencies across 68 different tissue-types
The explorations described below were carried out on a subset of the Expression Atlas 
(see Materials and Methods) that comprises of the expression profiles of 68 different 
normal human tissues (having excluded expression profiles derived from foetal tissues 
and cancerous cell-types) carried out on the Affymetrix human hgul33a array platform. 
As the experimental procedures carried out to generate the tissue expression profiles that 
comprise this dataset were all carried out within the same laboratory and on the same 
microarray platform, analysis of this dataset should minimise problems related to cross- 
platform and cross-laboratory data integration.
Each of the 68 tissue-types comprising this subset of the GNF Expression Atlas that was 
selected for further explorations described in this chapter is represented by the 
expression profiles of two microarrays. To avoid possible biases that might be 
introduced by instances of several probesets that represent the same gene (see Chapter 
2), Entrez Gene IDs were used to represent genes rather than probeset IDs. This was 
achieved by selecting for each of the Entrez Gene IDs represented on the array, the 
probeset that shows the greatest median expression levels over all the 68 different tissues 
(see Materials and Methods).
One estimate for the size of the gene expression universe (that is, the number of genes 
expressed) for each tissue sample could then be calculated based on the number of genes 
flagged as ‘Present’ by the MAS5 algorithm in at least one of the two arrays 
representing that tissue-type (see Materials and Methods). The sizes of the gene 
universes based on these criteria are displayed in Table 5.1, and the distribution of these 
sizes is shown in Figure 5.1.
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Tissue-type Size of gene universe (% of genes on array) Tissue-type
Size of gene universe ( 
% of genes on array)
Amygdala 46.0 PLACENTA 42.6
CerebellumPeduncles 32.4 Uterus 44.9
CingulateCortex 36.7 UterusCorpus 20.9
Hypothalamus 45.6 Prostate 44.2
MedullaOblongata 32.5 testis 38.5
OcdpitalLobe 39.8 TestisSeminiferousT ubule 35.2
OlfactoryBulb 37.9 TestisGermCell 44.2
ParietalLobe 31.7 Testislnterstitial 36.6
Pons 24.2 TestisLeydigCell 31.2
PrefrontalCortex 48.3 Heart 29.3
Temporal Lobe 27.4 atrioventricu lamode 18.3
Thalamus 39.2 Appendix 18.3
T rigeminalGanglion 14.8 721 _BJymphoblasts 52.8
WholeBrain 45.4 PB-CD19+Bcells 44.7
caudatenucleus 35.4 PB-CD4+Tcells 47.2
cerebellum 31.9 PB-CD56+NKCells 47.2
globuspallidus 27.6 PB-CD8+Tcells 48.6
subthalamicnucleus 29.8 PB-CD14+Monocytes 45.1
spinalcord 38.2 lymphnode 40.3
ciliaryganglion 21.4 Lung 40.7
SuperiorCervicalGanglion 13.1 Liver 27.6
PB-BDCA4+Dentritic_Cells 52.8 SkeletalMuscle 13.5
bronchialepithelialcells 41.2 SmoothMuscle 39.6
Pancreas 34.0 CardiacMyocytes 34.8
Pancreaticlslets 40.3 BM-CD33+Myeloid 43.9
BM-CD105+Endothelial 43.3 TONGUE 24.7
BM-CD34+ 50.0 salivarygland 31.0
BM-CD71 +Ear1yErythroid 36.1 Pituitary 36.1
bonemarrow 28.4 skin 21.2
WHOLEBLOOD 44.6 thymus 43.9
adrenalgland 33.3 Thyroid 48.3
AdrenalCortex 27.4 Tonsil 35.3
ADIPOCYTE 36.8 trachea 37.3
Ovary 25.7 kidney 32.4
Table 5.1 Numbers of g en es  exp ressed  in 68  normal human tissu es  from  
the GNF Expression Atlas. Numbers indicate percentages of the total number of 
EGIDs present on the hgul33a array. Expression universes were constructed for 
each tissue type by selection of genes flagged as 'Present' by the MAS5 algorithm. 
Tissue-type names were extracted from the names of the CEL files.
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Figure 5.1 Histogram of the number of g en es  expressed  in 68 normal 
human t issu e s  from the GNF Expression Atlas. These are represented as 
percentages of the total number of EGIDs present on the AfTymetrix hgul33a array. 
Expression universes were constructed for each tissue type by selection of genes 
flagged as 'Present' by the MAS5 algorithm.
The median size of the expression universe for these tissues corresponds to 36.6% of the 
genes (EGIDs) present on the hgul33a array. The number of genes expressed in the 
different tissues varies considerably, with a standard deviation for this distribution 
corresponding to approximately 10% of genes on the array. The universe sizes range 
from 13% of genes on the array, as seen for the superior cervical ganglion tissue, to 53% 
of genes on the array, as seen for the BDCA4+ dendritic cells.
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This analysis also provided the opportunity to investigate gene expression frequencies 
across these 68 tissue-types. These were calculated as the numbers of tissue-types that 
each of all the genes present on the hgul33a array were expressed in. To compare this 
with the distribution of gene expression frequencies expected if genes were selected into 
expression universes at random, a set of genelists was created, each of the size of one of 
the tissue gene expression universes, by selecting randomly and without replacement 
from the total set of genes present on the hgul33a array.
The distribution of gene expression frequencies from the random selection of gene 
expression universes appears to follow an approximately normal distribution as shown in 
Figure 5.2b and in the quantile-quantile (Q-Q) normal plot of this distribution in Figure 
5.2d. However, the distribution of gene expression frequencies observed in the 
Expression Atlas (see Figure 5.2a) appears to deviate noticeably from a normal 
distribution (see Q-Q normal plot in Figure 5.2c), due to the presence of large numbers 
of genes that are expressed in very few tissues, or in many tissues. Close to 15% of 
genes on the hgul33a array are not expressed in any of the tissues, and more than 32% 
of genes are expressed in 5 or less tissues. At the same time, more than 3% of genes on 
the array are expressed in all 68 tissues, while close to 10% of genes on the array are 
expressed in 65 or more tissues. In the distribution of gene frequencies of randomly 
selected genes, no genes cross any of the thresholds described above.
This highly non-normal and non-random selection of genes into expression universes as 
observed in these 68 tissue types is likely to cause the sort of expression patterns (some 
of which are described in Section 4.1) that cause violations of assumptions of the 
hypergeometric distribution when this is used to compare experimentally-derived lists of 
genes, and in particular, the assumption that all genes are equally likely to be selected 
into genelists.
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Figure 5.2 Gene expression frequencies observed in 68 d ifferent normal 
human tissue-types. (a) Histogram of gene expression frequencies for all genes 
on the hgu l33a array, i.e. the number of tissues in which each gene is found to be 
expression (on the basis of being called as Present by the MAS5 algorithm ); (c) 
shows the normal Q-Q plot for this distribution, (b) Histogram of gene frequencies 
derived from a simulation involving random selection of genes from the hgu l33a 
array into hypothetical expression universes of the same sizes as those derived from 
the 68 tissues under investigation; (d) shows the normal Q-Q plot for this 
distribution.
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5.2.2 Sizes of genes shared by expression universes of different 
tissues vary widely
In the previous section it was noted that that the sizes of the expression universes (i.e. 
the number of genes found to be expressed) for each of the 68 tissue types from the GNF 
Expression Atlas vary widely. This would then suggest that the number of genes shared 
between the expression universes of any pair of tissues is highly variable as well, as 
would be expected from relationship between genelist length and overlap size described 
in Section 2.2.2.
To investigate this, the number of genes shared between the expression universes (i.e. 
the sizes of the shared expression universes) was recorded for every possible pair of 
tissues from amongst the 68 normal human tissues of the GNF Expression Atlas under 
consideration. A control experiment was then carried out by creating another set of 
expression universes by randomly selecting from amongst all genes represented on the 
Affymetrix hgul33a array, sets of genes of the same sizes as the expression universes 
observed for each of the 68 normal human tissues. Overlap sizes between all pairs of 
gene sets were also recorded. Box-plots and density distribution curves for both the 
former (‘Observed’) and latter (‘Control’) sets of shared expression universe sizes are 
displayed in Figure 5.3a and 5.3b respectively.
Firstly, it is observed that distribution of observed overlap sizes is shifted away from that 
of the simulated overlap sizes: the former is centred on a median value of -25% of genes 
on the hgul33A array, which is nearly twice the median of the latter distribution 
(-12%). A paired t-test comparing these distributions yielded a p-value of < 2 x 10'16, 
indicating that the difference between the means of these distributions is highly 
significant. This is most likely to have occurred due to the highly non-random selection 
of genes into the expression universes of the 68 tissues, as was observed in Figure 5.3.
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Figure 5 .3 S izes  of express ion  un iverses  shared across  68 normal human  
t is su e s .  Box-plots (a) and density curves (b) of distributions of the sizes of 
overlaps between expression universes observed for 68 normal human tissues from 
the GNF Expression Atlas ('Observed') and from a simulation comparing universes 
created by selecting randomly from all the genes on the hgul33a array, of the same 
sizes as the observed expression universes ('Control'). Sizes are represented in 
terms of percentage of genes on the hgul33a array (Y-axis in (a) and X-axis in (b)). 
Broken vertical lines in (b) represent medians of the respective distributions.
Secondly, it is observed that the overlap sizes of gene expression universes are variable: 
the simulated overlap sizes have a standard distribution of 4.9% of genes on the array, 
while that of the observed overlap sizes is even greater (7.2%).
These observations are as expected because of the sensitivity of overlap sizes to the sizes 
of the expression universes. To demonstrate this, the overlap sizes were observed in 
relation to the sizes of the pairs of expression universes being compared. For this 
purpose, the overlap sizes from both distributions were plotted against the square root of 
the product of sizes of expression universes (Figure 5.4).
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Figure 5 .4  Effect of exp ress ion  universe s ize  on the  num bers of g e n e s  
shared b e tw een  un iverses . Points represent observed (red) and simulated (grey) 
overlap sizes for all pairs of expression universes for 68 tissues of the GNF 
Expression Atlas. The black line indicates overlap sizes expected between 
comparisons of universes of those sizes (calculated using the formula described in 
Section 2.2.2).
Here it is found that both overlap size distributions shown a noticeable positive 
relationship with expression universe size. The simulated overlap sizes (grey points in 
Figure 5.4) vary around the overlap sizes that are expected for each comparison of 
expression universes of those sizes (black line, calculated using the formula described in 
Section 2.2.2). The entire distribution of observed overlap sizes (red points) is shifted 
upwards of that of the simulated overlap sizes, reflecting that observed in Figure 5.3. 
Interestingly, it is also observed that the spread of observed overlap size values is much 
greater than that for the simulated values. This reflects a greater variability than can be 
attributed solely to the effects of expression universe size.
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5.2.3. Tissue-specificity has a marked effect on gene expression 
universes
Thus far, it has been observed that there is a considerable level of variability in the 
number of genes shared by expression universes for each of the 68 tissues in the GNF 
Expression atlas. Some of this variability can be attributed to the marked variability of 
the sizes of the expression universes. Furthermore, overlap sizes may also be sensitive to 
biological effects, such as tissue-specific gene expression; for example, the expression 
universes from two breast cancer experiments may have more genes in common than 
those shared between universes from a breast cancer experiment and a colon cancer 
experiment.
To investigate this requires a methodology that would, in an unbiased manner, find 
patterns of gene expression to allow creation of groups of tissues that have more 
similarity within their expression universes than with others. One such method to 
achieve this could be hierarchical clustering (see Materials and Methods), which would 
allow unsupervised classification of the 68 tissues under investigation, on the basis of 
some measure of the similarity of their gene expression universes.
The issue then arises of which measure of similarity could be used for hierarchical 
clustering. The absolute size of overlaps between expression universes would not be a 
good choice since, as has been shown in Section 5.2.2, these are strongly influenced by 
the sizes of expression universes being compared. Hypergeometric Z-scores are another 
option, as they would represent standardized effect sizes where the systematic effects of 
expression universe sizes have been accounted for. However, the non-normal and non- 
random gene expression frequencies described in Section 5.2.1 might well cause 
violations of the assumptions of the hypergeometric distribution, and result in Z-scores 
that are sensitive to the effects of expression universe sizes, as has been seen in the 
comparisons of experimentally-derived genelists (see Section 3.3.3).
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To account for the systematic effects of expression universe sizes on the size of their 
overlaps, an empirical sampling-based strategy was therefore adopted to create a 
measure of similarity that could be used for the purposes of hierarchical clustering. 
From each of the 68 different expression universes, which comprise the genes that are 
expressed in each of the 68 different tissues, a set of 1000 genes was selected randomly 
and without replacement. All pair-wise comparisons were performed and the sizes of 
overlap between the sets of genes were then recorded. This was repeated 1000 times, 
and the median size of overlaps for each pair-wise comparison was then used to perform 
hierarchical clustering of the 68 tissue-types.
Figure 5.5 shows the results of the clustering. As can be observed there are at least three 
major clusters that comprise primarily of similar tissue-types. These are a cluster of 
tissues that are of neuronal origin (including the non-neuronal tissue derived from the 
pituitary, a neuro-endocrine gland), a cluster of tissues from the testes, and a cluster 
based on cells from blood (many of which are involved in immunity functions).
Further analyses showed that the distributions of overlap sizes observed between gene- 
expression universes derived from tissues belonging to any of these clusters were 
centred on medians that were greater than the medians of distributions of overlap sizes 
from comparisons of these tissues with all other tissues that did not fall into their 
respective clusters (Figure 5.6). Unpaired t-tests were then used to assess the statistical 
significance of the difference of means between the distributions, and all three clusters 
yielded highly significant p-values (see legends in Figure 5.6).
These findings suggest that the numbers of genes shared between the expression 
universes of different tissues is affected not just by the systematic effects of variability 
of expression universe sizes, but also by biological factors such as tissue-specific gene 
expression patterns.
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Figure 5 .5  Hierarchical c lustering 68  different t is s u e s  from the GNF 
Expression Atlas. Clustering was carried out by using, as distances, the negative 
median overlap size shared between lists of 1000 genes selected randomly from the 
expression universes of each tissue carried out 1000 times for each possible pair of 
tissues. Linkage of clusters was performed using the McQuitty method.
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Figure 5 .6  Similar t is s u e s  share  more ex p ressed  g e n e s  than dissimilar  
t is su e s .  X-axes represent median overlap sizes shared between lists of 1000 genes 
selected randomly from the expression universes of each tissue carried out 1000 
times for each possible pair of tissues. Box-plots represent overlap sizes derived 
from comparisons between members of the same cluster (red), and from 
comparisons between members of the same cluster and all other tissues (grey), for 
the three clusters of sim ilar tissues derived from hierarchical clustering (see Figure 
5.5): (a) neuronal tissues, (b) testis tissues and (c) blood-derived tissues. Legends 
show p-values from unpaired t-tests comparing each pair of distributions.
122
Chapter 5: Exploring gene expression patterns with the GNF Expression Atlas
5.2.4 Simulating the effects of using an average gene universe size
The biased urn model described in Chapter 4 provides a potential ad hoc solution to the 
use of all genes represented on an array as the gene universe when using the 
hypergeometric distribution to assess the similarity between a pair of genelists, by the 
estimation of a gene universe size representing the ‘average’ number of genes that is 
shared by the gene universes of any two experiments. The estimation of the numbers of 
genes shared between the expression universes of each possible pair of the 68 tissues of 
the GNF Expression Atlas described in the preceding section of this chapter then 
provides an opportunity to explore the effects using an estimated average number of 
genes shared between expression universes to compare genelists.
For this purpose, it was desired to carry out comparisons of simulated genelists where 
the effect of genelist lengths was controlled for; this would allow for observation of the 
sole influence of gene universe size on the significance metrics calculated from the 
hypergeometric distribution (i.e. Z-scores).
One possible strategy is the creation of lists of randomly selected genes from the 
expression universes of each of the 68 tissues of the GNF Expression Atlas, and 
comparison of all possible pairs of genelists. However, an accurate assessment of the 
significance of the overlap between any pair of genelists would require using, as the 
gene universe, those genes that shared between the expression universes for those tissues 
that the genelists were sampled from. This would then involve removal, from both 
genelists, of any genes that are not present within that gene universe. Such filtration of 
genelists could cause variability in the sizes of the genelists being compared, which is 
undesirable.
For these reasons, simulations were carried out using the following strategy: the overlap 
between the expression universes for each possible pair of the 68 tissues in the GNF 
Expression Atlas were considered separately as gene universes, from which two
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genelists of equal length (500 genes) were selected randomly and without replacement. 
The observed as well as the expected overlap size between these genelists was then 
recorded; the latter value was calculated using the formula described in Section 2.2.2.
Using these overlap sizes, three sets of hypergeometric Z-scores could be calculated, 
each using a different gene universe size. The first set was calculated by using the ‘true’ 
sizes of gene universes from which each pair of genelists was sampled (i.e. the overlap 
of expression universes for each pair of tissues), which was different for each 
comparison; this was labelled as Set A. To simulate Z-scores as would be calculated 
using the biased urn model, the second set (Set B) was calculated using the same gene 
universe size for each comparison. The size used here was the average size of overlap 
between the expression universes for all pairs of tissues; this was -25% of genes on the 
array. The third set was calculated by using the same gene universe size for each 
comparison, but this time using the entire number of genes present on the hgul33a array 
(Set C). Density distributions for all three sets of Z-scores are shown in Figure 5.7.
As can be observed, Z-scores of Set A (black curve) exhibit a distribution that is centred 
on a median of zero. This is as expected from comparisons of genelists created by 
random selection of genes. Z-scores of Set C (blue curve) exhibit a distribution that is 
considerably shifted away from a median of zero. This distribution is centred on a 
median of 14. This can be thought of as representing the shifted Z-score distributions 
(indicating high levels of similarity), which were observed for comparisons of 
experimentally-derived genelists in Chapter 3. Z-scores of Set B (red curve) can be 
thought to represent Z-scores calculated using the biased urn model described in Chapter 
4. This distribution is similar to that obtained by using ‘true’ gene universe sizes, i.e. Set 
A in that, it is also centred on a median of zero. However it has a very different shape. 
To further investigate the effect of gene universe size on these three sets of Z-scores that 
were all derived using the same set of overlap sizes, all three sets were plotted against 
the ‘true’ gene universe sizes for each comparison (see Figure 5.7)
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Figure 5 .7  Effect of d ifferent universe  s iz e s  on hypergeom etric  Z -scores for 
the sa m e  s e t  of com parison s ( I ) .  Density curves of Z-scores derived from 
comparisons of pairs of genelists (of equal lengths) selected randomly and w ithout 
replacement from each gene-expression universe shared between 68 normal human 
tissues, calculated using three different universe sizes (see figure key). Vertical lines 
represent medians of the respective distributions.
As can be observed in Figure 5.7, the expected Z-scores calculated using the ‘true’ gene 
universe sizes appear to be unaffected by gene universe size: they are zero for all 
comparisons (black line), and the observed Z-scores from Set A vary around them (grey 
points). This is as expected, considering all the comparisons involved genelists that were 
created by random selection of genes. Z-scores from Set B were, like those from Set A, 
also found to also be centred on a median on zero in Figure 5.6. However, as can be 
observed in Figure 5.7, these exhibit a noticeable negative relationship with gene 
universe size (red points). While Set B Z-scores are similar to Set A Z-scores when the 
‘true’ gene universe size is equal to the estimated ‘average’ gene universe size (vertical 
green line), increasing differences between the ‘true’ gene universe sizes and the 
estimated ‘average’ gene universe size appears to cause increasing deviation of Set B Z- 
scores from the distribution of Set A Z-scores.
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Figure 5 .8  Effect of d ifferent un iverse  s iz e s  on hypergeom etric  Z -scores  for 
the  sa m e  s e t  of com parisons (I I) .  Points represent Z-scores derived from 
comparisons of pairs of genelists (of equal lengths) selected randomly and w ithout 
replacement from each set of genes shared between the expression universes for all 
pairs of 68 normal human tissues, calculated using three different universe sizes 
(see figure key). Black red and blue lines represent expected Z-scores for the 
respective distributions. The vertical green line represents the average size of gene- 
expression universes shared between any pair of the 68 tissues.
The distribution of Set C values is shifted further up from that of the Set A and Set B 
distributions (reflecting the shift observed in Figure 5.7). It also exhibits a negative 
relationship with gene universe size, similar to that of the Set B distribution.
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5.3 Discussion
The explorations described in Chapter 4 indicated that the ‘biased urn’ model could be 
used to control for possible violations of assumptions of the hypergeometric statistical 
test, when used for comparisons of genelists derived from microarray-based 
experiments. It involved the ad hoc estimation of an average gene universe size 
representing the number of genes on an array that could be selected into both genelists 
being compared. While this model could, in theory, mitigate much of the undesirable 
effects of using the entire set of genes represented on an array as the gene universe for 
all comparisons, one particular issue with such a technique is the use of a single gene 
universe size for all comparisons. This could then lead to erroneous results if the true 
gene universe sizes vary widely from the estimated average size.
This chapter then described explorations of this issue using a subset of the GNF 
Expression Atlas dataset (Su et al. 2004), which consisted of the microarray gene 
expression profiles for a wide range of normal human tissues. This dataset was created 
in the same laboratory, using the same microarray platform for all samples. Thus, the 
results of investigations carried out on this dataset would not be subject to the effects of 
cross-platform and cross-laboratory issues. The expression universes for each tissue (i.e. 
the genes that were found to be expressed in each tissue) were considered to be estimates 
of the gene universes for experiments that would be carried out on those tissues. This is 
because the first criterion in the selection of important genes from an experiment (such 
as DEGs) is to assess whether those genes are expressed. The overlap between the 
expression universes for any pair of tissues could then be considered to be the gene 
universes for the comparison of genelists derived from experiments carried out on those 
tissues. The findings described are summarized as follows:
• There is considerable variation in the numbers of genes shared between the 
expression universes of any pair of tissues. This is related to the variability in the 
number of genes that are expressed for each of the tissues.
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• Aside from systematic reasons, such as those mentioned above, the numbers of 
genes that are shared by the expression universes are also subject to biological 
factors, particularly tissue-specific gene expression: the gene universe for the 
comparison of genelists from a pair of experiments carried out on the same tissue- 
type is likely to be larger than that for two experiments carried out on different 
tissue-types.
• Simulations were carried out to observe significance values assigned to comparisons 
of genelists created using a range of differently-sized gene universes, but where the 
statistical model used for all comparisons the average gene universe size. It was 
found that such a strategy could produce erroneous results; the magnitude of error 
would depend on the magnitude of the difference between the true gene universe size 
for a comparison and the estimated average gene universe size.
Thus while the biased urn model can reduce the excess levels of similarity that may be 
observed when comparisons of genelists are carried out using a gene universe 
comprising of all genes on an array, it is still an unsatisfactory methodology due to the 
use of a single gene universe size for comparisons involving widely ranging universe 
sizes. In terms of the broader question of whether comparisons of genelists could be 
carried out as a less resource-intensive alternative to comparison of entire microarray 
datasets (investigated over Chapters 2-5), it can be concluded that genelists alone do not 
provide all the information that is required for an accurate comparison of experiments.
The investigations also indicate potential problems in how gene universes are defined 
for ORA techniques in general (for example, to assess enrichment of GO terms in 
genelists) (Khatri and Draghici 2005). Here, the presence of genes in the universe for an 
experiment is a binary concept: they are either present or absent. However, a more 
realistic and possibly more accurate representation is that of a continuum of probabilities 
reflecting the likelihood of genes to be selected as interesting (depending on the levels 
and variability of expression). This is further discussed in Chapter 9.
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Chapter 6: Gene Set D iscovery (GSD): 
U nsupervised identification  o f relevant 
biological them es w ithin  m icroarray datasets
6.1 Introduction
As described in Section 1.4, biological interpretation of data from microarray-based 
experiments has been aided significantly by the development of gene set analysis (GSA) 
methodologies. These techniques utilize electronically archived biological knowledge 
which is available on public databases such as Gene Ontology (Ashbumer et al. 2000), 
KEGG (Kanehisa et al. 2004) and BioCarta (BioCarta 2005). Using these techniques, 
researchers have been able to identify biological themes (such as pathways or processes) 
that may be of interest within a particular experiment.
Many of the popular tools to carry out GSA have typically involved over-representation 
analysis (ORA), which seeks to identify enrichment of biological themes within lists of 
differentially expressed genes (DEGs) (Huang da et al. 2009; Khatri and Draghici 2005; 
Rivals et al. 2007). These GSA techniques have been termed ‘threshold-based’, as they 
require prior definition of threshold values to identify DEGs. For example, in an 
experiment to identify genes that are differentially expressed between two classes of 
samples using a t-test, a p-value threshold of <0.05 may be used. More recently, there 
has been development of ‘threshold-free’ GSA techniques that do not require creation of 
lists of DEGs (Huang da et al. 2009; Nam and Kim 2008). One of the most popular of 
these, Gene Set Enrichment Analysis (GSEA) (Mootha et al. 2003; Subramanian et al. 
2005), uses instead a list of all genes on the array, ranked according to their correlation 
to a pre-selected expression pattern (for example, up-regulation in one class of samples
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and down-regulation in another class), and then tests for the enrichment of gene-sets 
towards the top and bottom of the list.
Thus, GSA methods have most often been used after carrying out ‘supervised’ analyses 
of microarray datasets, i.e. researchers have knowledge of the sample classes, and select 
DEGs or rank genes on the basis of pre-selected expression patterns across these known 
sample classes. However, GSA methods have found little utility in exploratory analyses 
such as those involving ‘class discovery’ (see Section 1.3.2). Such analyses are of 
particular importance in studies of cancer, where sample classes are often not known a 
priori, or where morphology-based classification methods have not successfully 
resolved sample classes (Alizadeh et al. 2000; Ivshina et al. 2006).
This chapter thus explores the possibility of developing a methodology that could allow 
identification of biologically relevant themes within a microarray dataset, without 
requiring prior definition of sample classes. The investigations described focus 
particularly on the use of hierarchical clustering techniques within ‘heatmaps’. This 
chapter will introduce and explore some of the underlying concepts, and subsequent 
chapters will describe the application of this methodology to several datasets.
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6.2 Results and Explorations
Heatmaps (together with hierarchical clustering) are popular tools to provide visual 
representations of microarray data and to display gene expression patterns (Eisen et al. 
1998). They typically comprise of a matrix where the columns represent samples and the 
rows represent genes. Each cell is coloured, based on the expression value of that gene 
in that sample, such that the colour indicates whether the gene is up or down-regulated 
(for example, compared to the experiment-wide mean), and the intensity of the colour 
indicates the extent of up- or down-regulation. In analyses of microarray data, usually 
those involving the identification of a set of genes defined as being of interest by the 
researcher (e.g. a list of DEGs), it is routine to create a heatmap using those genes as 
intuitive visual evidence that those genes exhibit the expression pattern of interest.
While clustering and heatmap visualisation have typically been used as ‘end stage’ tools 
to represent in visual terms the sets of genes that have been determined to be relevant 
within any particular experiment, these tools can also be used for de novo knowledge 
discovery. For example, manual inspection of the resultant heatmaps from an 
unsupervised clustering and visualisation of the data for an experiment for each of the 
many gene sets that represent biological themes and processes may then allow for visual 
identification of those gene sets that exhibit expression patterns that are of interest to the 
researcher. Such a process, although common, is somewhat unsatisfactory due to the 
element of manual inspection and pattern identification that it involves and the absence 
of any underpinning statistical methodology.
The investigations described here thus focussed on the identification of a metric that 
could allow some quantification of the levels of information within a heatmap, and that 
may therefore be used for identification of gene sets that may be of interest.
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6.2.1 Quantification of the information content of a heatmap
6.2.1.1 Hierarchical clustering o f gene and samples within heatmaps
Key to the visualization of expression patterns within heatmaps is the process of 
hierarchical clustering that brings together those genes and samples that exhibit similar 
expression patterns.
To demonstrate this, a hypothetical gene expression matrix comprising of 20 samples 
(represented as matrix columns) and 500 genes (represented as matrix rows) was 
created. To simulate DEGs within the matrix, 25 genes were randomly selected to 
exhibit up-regulation in 10 randomly selected samples and down-regulation in the other 
randomly selected 10 samples. Another 25 genes were randomly selected to exhibit the 
opposite expression pattern in terms of up- and down-regulation in the same samples as 
the first set of genes.
To represent log2 median-centred gene expression values, the matrix was initially 
populated with values sampled randomly from a normal distribution having a zero mean 
and standard deviation of 0.3 (see Materials and Methods). This provides a very simple 
data structure to model what is typically seen in a microarray experiment by way of 
noise. Values in cells representing up-regulated gene expression values were then 
replaced with values randomly selected from a normal distribution with a mean of 2 
(that is, a 4-fold up-regulation) and standard deviation of 0.3. Similarly, values in cells 
representing down-regulated gene expression values were then replaced with values 
randomly selected from a normal distribution with a mean of -2 and standard deviation 
of 0.3. Figure 6.1a represents a heatmap of this hypothetical gene expression matrix 
without any hierarchical clustering, i.e. the orders of genes and samples are the same as 
when it was created. Figure 6.1b represents a heatmap of the same matrix after 
hierarchical clustering of genes and samples. As can be observed, the expression 
patterns are clearly discernible in Figure 6.1b.
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(a) (b)
Figure  6.1 Visuali za t ion  of  g e n e  e x p r e s s io n  p a t t e r n s  t h r o u g h  h ie ra rch ica l  
c lu s te r ing .  Heatmaps of an artificial gene expression matrix where (a) no 
hierarchical clustering of genes or samples has been carried out and (b) both genes 
and samples have been clustered. Heatmaps represent log median-centred gene 
expression values ranging from -2 (bright green) through 0 (black) to 2 (bright 
red). Hierarchical clustering was carried out using correlation distance and average 
linkage.
The presence of expression patterns shared by many genes (which reflects differential 
expression of genes) within a heatmap indicates that information is contained within the 
gene set represented in that heatmap. Such an ‘informative’ gene set (i.e. one that 
contains DEGs) is likely to be of interest to a researcher. As hierarchical clustering is 
able to identify expression patterns that are shared between genes and samples (and 
thereby brings similar genes and samples together), efforts to identify a metric that can 
quantify information content within the expression matrix for a gene set focussed on this 
aspect.
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6.2.1.2 The effect o f information content on gene and sample distance distributions
Hierarchical clustering requires the calculation of ‘distances’ between each possible pair 
of genes and each possible pair of samples. These values represent the level of 
dissimilarity between the expression profiles of each pair of genes or samples (see 
Materials and Methods). Thus the distance value between a pair of genes or samples that 
exhibit similar patterns of expression would be lesser in magnitude relative to the 
distance value for a pair of genes or samples that exhibit dissimilar expression patterns. 
To investigate the sensitivity of these values to the presence of information content 
within a gene set, the following simulations were carried out:
First, a hypothetical gene expression matrix comprising of 30 samples (columns) and 
500 genes (rows) was created such that it contained no DEGs. Distance distributions for 
genes and samples were then recorded. A second matrix was created, identical to the 
first but with one DEG showing an expression pattern of up-regulation in 10 randomly 
selected samples, and down-regulation in another 10 randomly selected samples. The 
matrices were populated with gene expression values representing unchanged 
expression, up- and down-regulation using distributions similar to those used in 
simulations described in Section 6.2.1.1. A series of matrices was similarly created, by 
converting increasing numbers of genes into DEGs. Gene and sample distance 
distributions were recorded for each of these matrices.
Heatmaps of some of these matrices are displayed in Figure 6.2 while the distributions 
of sample and gene distances for those matrices are displayed in Figure 6.3a and Figure 
6.3b respectively. Means of the sample distance matrices (M-SDM) and gene distance 
matrices (M-GDM) for each of all the hypothetical matrices are plotted against the 
percentage of DEGs in Figure 6.4a as red and blue points respectively. Standard 
deviations of the sample distance matrices (SD-SDM) and gene distance matrices (SD- 
GDM) for each of all the hypothetical matrices are plotted against the percentage of 
DEGs in Figure 6.4b as red and blue points respectively.
135
Chapter 6: Gene Set Discovery (GSD): Unsupervised identification of relevant biological themes
within microarray datasets
n 111111 M rm i mii
25%
i i  i  i  i  i  i  i  i  i r  i  i  i  i  i i  i i
50%
100%
136
69999999
Chapter 6: Gene Set Discovery (GSD): Unsupervised identification of relevant biological themes
within microarray datasets
Figure 6 .2  Changing levels of information contained within a hypothetical 
gen e expression  matrix. Heatmaps represent a series of hypothetical gene  
expression matrices created with increasing numbers of DEGs. Numbers above the 
heatmaps indicate the percentage of genes that are DEGs. Heatmaps represent log 
median-centred gene expression values ranging from -2 (bright green) through 0 
(black) to 2 (bright red). Clustering was carried out using correlation distances and 
average linkage.
As can be observed, in case of the initial matrix with no DEGs (i.e. no information), the 
distances between all pairs of samples are similar, and the distribution of these distances 
has a single peak (black line in Figure 6.3a) at ~1. The inclusion of DEGs causes a major 
change in the shape of the distributions of sample distances. Three peaks are observed: 
one of the peaks comprises of short distances, and representing distances between 
samples showing similar expression patterns. This peak approaches a value of 0 (the 
theoretical minimum correlation distance) as the number of DEGs in the matrices 
increases. Another peak comprises of long distances, and represents distances between 
samples showing opposite expression patterns. This peak approaches a value of 2 (the 
theoretical maximum correlation distance) as the number of DEGs in the matrices 
increases. The third peak corresponds to the median distance of ~1, and represents 
distances from samples exhibiting no patterns of differential expression, both to all other 
samples as well as themselves. These observations demonstrate that increasing the 
number of DEGs results in the ‘strengthening’ of sample clusters, in that the intra-cluster 
distances decrease and inter-cluster distances increase.
As can be seen in Figure 6.4a, increasing the number of DEGs in the expression matrices 
has no effect on the M-SDM values: these remain stable at ~1. However, the variability 
of these distributions (SD-SDM) increases continuously, as can be see in Figure 6.4 b.
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Figure 6 .3  Effect o f  information leve ls  on sam ple  and g e n e  d istance  
distributions ( I ) .  Curves represent (a) sample and (b) gene distance distributions 
derived for each of the hypothetical gene expression matrices represented as 
heatmaps in Figure 6.2.
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Figure 6 .4  Effect o f information leve ls  on sam ple  and g e n e  d istance  
distributions ( I I ) .  Points represent (a) mean and (b) standard distribution values 
for gene and sample distance distributions of a series of hypothetical gene 
expression matrices created with increasing numbers of DEGs, some of which are 
represented as heatmaps in Figure 6.2.
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The gene distance distribution in the first matrix (i.e. with no DEGs) is similar to the 
sample distance distribution for it, having a single peak centred on a mean of ~1, 
indicating similar levels of similarity/dissimilarity between all genes (black curve in 
Figure 6.3b). The introduction of DEGs again changes the shape of the distribution: two 
peaks are now observed. One of the peaks is centred on a distance of ~0, and presumably 
comprises of distances between the DEGs themselves. The other peak, centred on ~1 
presumably comprises of distances from non-DEGs, both between themselves and to the 
DEGs. As would be expected, as the percentage of DEGs increases, the first peak 
increases in height, while the second decreases until no non-DEGs remain and all 
distances are ~0.
As can be observed Figure 6.4a (blue points), the M-GDM values of these distributions 
start from ~1, when there are no DEGs, and decrease continuously as the proportion of 
DEGs is increased. The variability of these distributions (SD-GDM) start low, and 
increase as the proportion of DEGs is increased to a particular point from where they 
decrease as the proportion of DEGs is increased (blue points in Figure 6.4b).
This observed sensitivity of distance distributions to the introduction of information (in 
the form of DEGs) within expression matrices raises the possibility that that attributes of 
these distributions (such as their mean values or variability) could be used to indicate the 
levels of information (i.e. proportion of DEGs) within these matrices. M-GDM and SD- 
SDM values exhibited relationships with the proportion of DEGs that were non-linear; 
but as these were unidirectional, both these metrics could be considered as possible 
candidates to indicate information levels in an expression matrix. For example, it may be 
possible to deduce that a gene set contains greater levels of information than another 
gene set, if the former yields a higher SD-SDM value or a lower M-GDM value. M- 
SDM values were not investigated further due to their apparent stability to changes in 
information levels. SD-GDM values were also disregarded in further analyses due to 
directional changes within their relationship with information levels.
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6,2.13 Presence o f more than one pattern within a gene expression matrix
The explorations described above identified SD-SDM and M-GDM values as metrics 
that could potentially be used to indicate levels of information with gene expression 
matrices. These explorations were carried out using simulations to observe the effects of 
changing the levels of information (i.e. the proportion of DEGs) on gene and sample 
distance distributions.
Another issue that required exploration was the nature of information within a gene 
expression matrix, and what effects this could have on the metrics under investigation. 
In the simulations described in the previous section, all DEGs were created to exhibit the 
same expression pattern. However, it is possible that there may be two or more groups of 
DEGs within a gene expression matrix, each of which exhibit different patterns of 
expression.
To illustrate this, a hypothetical gene expression matrix was created, comprising of 30 
samples and 500 genes and labelled as ‘HypMatl’. Half of these genes were randomly 
selected to represent a first group of DEGs, all of which showed the same expression 
pattern. This pattern was of up-regulation in the first 10 samples and down-regulation in 
the next 10 samples, and labelled as ‘ ExPat 1’. The matrix was populated with gene 
expression values representing unchanged expression, up- and down-regulation using 
distributions similar to those used in simulations described in Section 6.2.1.1. Two 
identical copies of HypMatl were then created, called ‘HypMat2’ and ‘HypMat3\
In HypMat2, the other half of genes were made to represent a second group of DEGs. 
On this second group, an expression pattern was imposed, that was different to ExPat 1, 
but corresponded to the same grouping o f samples. This pattern, labelled ExPat2, was of 
up-regulation in those samples which exhibited down-regulation in ExPat 1, and vice- 
versa.
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In HypMatS, these genes were also made to represent a second group of DEGs. 
However, the pattern of expression imposed on these genes, ExPat3, corresponded to a 
different grouping o f samples from what was observed in ExPat 1 (and ExPat2). This 
was achieved by randomly selected 10 samples to exhibit up-regulation, and another 10 
randomly selected samples to exhibit down-regulation. Heatmaps of HypMat2 and 
HypMat3 are displayed in Figure 6.5a and 6.5b respectively.
(a) (b)
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Figure 6 .5  P resen ce  o f d ifferent ex p ress io n  p attern s w ithin hypothetical 
g en e  ex p ress io n  m atrices. Heatmaps represent hypothetical gene expression 
matrices where all genes are differentially expressed. In both matrices, these 
comprise two equally sized groups, each exhibiting different expression patterns. In 
(a) both expression patterns correspond to the same grouping of samples. In (b) 
the expression patterns correspond to different groupings of samples. Heatmaps 
represent log median-centred gene expression values ranging from -2 (bright 
green) through 0 (black) to 2 (bright red). Clustering was carried out using 
correlation distances and average linkage.
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While both HypMat2 (Figure 6.5a) and HypMat3 (Figure 6.5b) have similar levels of 
information (i.e. the same number of DEGs), it can be argued that a researcher is likely 
to be more interested in a gene set that can be represented by HypMat2 rather than 
HypMat3. This is because it represents a single coherent expression profile (in terms of 
grouping of samples) that can be attributed to the biological theme represented by that 
gene set.
To observe the effect of changing expression patterns within a gene expression matrix 
on M-GDM and SD-SDM values, while the total level of information (i.e. number of 
DEGs) is constant, the following simulations were carried out: first, a hypothetical gene 
expression matrix comprising of 500 genes and 30 samples, was created such that 50% 
(i.e. 250) genes were DEGs, and all of which exhibited the expression pattern ExPatl. 
The matrix was populated with gene expression values representing unchanged 
expression, up- and down-regulation using distributions similar to those used in 
simulations described in Section 6.2.1.1. Two series of ten matrices were then created.
One of the series (labelled ‘Series A’) was created to represent changing expression 
patterns within a gene expression matrix but where the type of information (i.e. the 
grouping of samples) remained the same. This was carried out by changing the pattern of 
expression to ExPat2 of each of the DEGs, 25 genes at a time, till all DEGs exhibited 
ExPat2. Heatmaps of some of these matrices are displayed in Figure 6.6.
The other series of matrices (labelled ‘Series B’) was created to represent changing 
expression patterns within a gene expression matrix, each of which represented a 
different type of information (i.e. each expression resulted in a different grouping of 
samples). This was carried out by changing the pattern of each of the DEGs, 25 genes at 
a time. However for each set of 25 genes, an expression pattern was imposed that did not 
correspond to that of ExPatl (and ExPat2).
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Figure 6 .6  Changing expression patterns of DEGs w ithout changing typ es of 
information within hypothetical gen e expression m atrices. Heatmaps 
represent som e of a series of 10 hypothetical gene expression matrices (Series A), 
starting from one where 250 out of 500 gen es are DEGs, all of which exhibit the 
sam e pattern of expression. Subsequent matrices were created by changing the 
expression of 25 DEGs at a tim e, to show an expression pattern that is different to 
the first, but one that results in the sam e clustering of sam ples. Numbers above 
heatm aps represent the percentage of DEGs that exhibit the second expression  
pattern. Heatmaps represent log median-centred gene expression values ranging 
from -2 (bright green) through 0 (black) to 2 (bright red). Clustering was carried 
out using correlation distances and average linkage.
This was carried out by randomly selecting 10 samples to exhibit up-regulation, and 
randomly selecting another 10 samples to exhibit down-regulation, separately for each 
group of 25 genes. This was continued till a matrix was created where the 250 DEGs 
consisted of ten equally sized groups (of 25 genes each), each of which exhibited 
expression patterns that were different from ExPat, and also resulted in different 
classifications of samples. Heatmaps for some of these matrices are displayed in Figure 
6.7.
M-GDM can SD-SDM values were recorded for each of both series of matrices. M- 
GDM values for Series A and Series B are plotted against the percentage of DEGs with 
expression patterns that are different from ExPat as red and blue lines respectively in 
Figure 6.8a. SD-SDM values for Series A and Series B are similarly plotted as red and 
blue lines respectively in Figure 6.8b.
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Figure 6 .7  Changing expression  patterns of DEGs as well as the types of 
information within hypothetical g en e  expression m atrices. Heatmaps 
represent som e of a series of 10 hypothetical gene expression matrices, starting 
from one where 250 out of 500 gen es are DEGs, all of which exhibit the sam e 
pattern of expression. Subsequent matrices were created by changing the 
expression of 25 DEGs at a tim e, to show an expression patterns that are different 
to the first (and each other), and that result in different clustering of sam ples every 
time. Numbers above heatm aps represent the percentage of DEGs that exhibit the 
expression patterns other than the first. Heatmaps represent log median-centred 
gene expression values ranging from -2 (bright green) through 0 (black) to 2 
(bright red). Clustering was carried out using correlation distances and average 
linkage.
Thus, as is apparent from Figure 6.8, the presence of different expression patterns affects 
both M-GDM and SD-SDM values even though all matrices contain the same levels of 
information (all matrices have 250 DEGs). M-GDM values for both series of matrices 
show increases upon introduction of expression patterns that are different to ExPat 
(Figure 6.8a). This is can explained as follows: in the starting matrix where all DEGs 
exhibited ExPatl, distances between all pairs of DEGs were ~0 (the minimum possible 
correlation distance). In subsequent matrices, the distances between DEGs exhibiting 
different expression patterns results in replacement of those values with distances >0. 
The increase is much greater in Series A because ExPat2 represents the diagonally 
opposite expression pattern of ExPatl, and thus the distances between pairs of genes that 
exhibit ExPatl and ExPat2 are ~2 (the maximum possible correlation distance). The M- 
GDM values for Series A increase till reaching their zenith when equal numbers of 
genes exhibiting either expression pattern are present. Thereon the values drop in 
magnitude, as the number of genes exhibiting ExPat2 increases, back down to around 
the starting value, for the matrix where all DEGs exhibit ExPat2. However, in Series B, 
the M-GDM values continuously increase, because every successive matrix has an 
additional expression pattern, reaching their zenith when 10 patterns are present, each of 
which is exhibited by equal numbers of genes (25 genes each).
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Figure 6 .8  Effect of changing ex p ressio n  p attern s o f DEGs w ithin a g en e  
exp ressio n  m atrix. Points represent (a) M-GDM and (b) SD-SDM values calculated 
for two series of matrices, some of which are displayed in Figures 6.6 (Series A: 
same information) and 6.7 (Series B: different information).
148
Chapter 6: Gene Set Discovery (GSD): Unsupervised identification of relevant biological themes
within microarray datasets
As can be observed in Figure 6.8b, SD-SDM values, for Series A appear to be very 
similar to that of the starting matrix implying that they are not affected by increasing the 
numbers of genes exhibiting ExPat2. This is presumably because ExPat2 corresponds to 
the same groupings of samples as ExPatl. However, SD-SDM values show continuous 
decrease in Series B.
As mentioned earlier, a researcher may not just be interested in those gene sets that 
contain information, but also the expression patterns represented by that information. In 
particular, the researcher would be more interested in a gene set where the expression 
pattem(s) of all DEGs result in the same grouping of samples (i.e. they represent the 
same type of information) such as those represented in Series A, than in a gene set where 
different expression patterns can group samples differently (i.e. they represent different 
types of information) such as those represented in Series B. This is because the former 
case provides researchers with a simple, coherent relationship between the biological 
theme represented by that gene set, and the resultant classification of samples. The 
presence of several types of sample stratification schemes within a gene-set could be of 
lesser utility and interest to the researcher.
Thus, it is desirable that a metric is not sensitive to the presence of different expression 
patterns, if they all represent the same type of information (i.e. correspond to the same 
groups of samples). Similarly the metric should be sensitive to the presence of 
expression patterns that represent different types of information (i.e. correspond to 
different groupings of samples). For these reasons, M-GDM values were disregarded for 
further analyses, which focussed solely on the use of SD-SDM values.
149
Chapter 6: Gene Set Discovery (GSD): Unsupervised identification of relevant biological themes
within microarray datasets
6.2.2. Identification of possible confounding factors
Explorations described in the previous sections identified SD-SDM values as a metric 
that can potentially identify those gene sets that contain information (i.e. DEGs) 
particularly if the expression pattem(s) within the expression matrix represent the same 
type of information (i.e. correspond to the same groups of samples). However, another 
aspect that must be explored prior to their potential usage as tools for GSA is whether 
SD-SDM values are also subject to systematic effects of other factors, which may need 
to be controlled for.
6.2.2.1 E ffect o f gene set size on the distribution o f SD-SDM values
When testing a collection of gene sets for their relevance within any particular 
microarray experiment, the number of samples involved would be constant for all tests -  
thus, their influence on SD-SDM values would be uniform across all tests and might not 
require to be controlled for, as this would not affect the levels of SD-SDM values 
relative to each other. However, the sizes of gene sets tested could vary greatly. To 
explore the effect of gene-set size on SD-SDM values, the following simulations were 
carried out.
A hypothetical gene expression matrix, representing an entire microarray dataset 
comprising of 30 samples and 10,000 genes was first created. As it was desired to 
observe the effect of gene-set size alone (i.e. without any possible confounding effects of 
the presence of information), no genes were made to be DEGs. The matrix was 
populated with values sampled randomly from a normal distribution with a zero mean 
and standard deviation of 0.3. A series of gene sets was then created by randomly 
selecting from amongst those represented in the matrix, ranging in length from 20 to
10,000 genes (i.e. all genes in the matrix), in increments of 20 genes.
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SD-SDM values were calculated for each gene set. These values are plotted in Figure 
6.9a against the size of the gene sets. In Figure 6.9b, log SD-SDM values are plotted 
against logs of the gene set sizes.
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Figure 6.9 Effect of gene-set size on SD-SDM values in the absence of 
inform ation. Data represented was derived from a series of matrices created by 
randomly selecting a series of gene-sets of various sizes from a hypothetical gene 
expression m atrix containing no information. In (a) SD-SDM values are plotted 
against the number of genes, (b) represents the same data as (a) with both axes in 
log scale.
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As can be observed in Figure 6.9a, SD-SDM values decrease with increase of gene set 
size. This relationship is linear when SD-SDM values and gene set sizes are logged 
(Figure 6.9b). This systematic sensitivity of SD-SDM values to gene set size thus 
requires to be controlled for prior to use of SD-SDM values in GSA analysis.
6.2,2.2 Effect o f random selection o f informative genes on the distributions o f SD- 
SDM  values
If one assumes a linear relationship between log SD-SDM values and log gene-set size 
(as indicated by figure 6.9b), this can then allow for relatively simple and resource- 
efficient control of the systematic effect of gene-set size on SD-SDM values. However 
this assumption may not be valid when considering gene expression matrices with 
information content (i.e. with DEGs). Gene-sets sampled from such matrices could 
contain informative genes by chance alone (for example, if 10% of genes in the entire 
expression matrix are DEGs, we would expect 10% of any randomly selected set of 
genes to be DEGs), and these would exert their own influence on SD-SDM values. This 
could be further complicated if the information comprises of two or more different 
expression patterns, each of which could classify samples differently.
To observe the relationship between SD-SDM values and gene set size in the presence 
of information, first a hypothetical gene expression matrix was created comprising of 30 
samples and 10,000 genes, none of which were DEGs. Two identical copies of this 
matrix were created, labelled ExMatl and ExMat2. 1000 genes (i.e. 10%) from ExMatl 
were randomly selected to represent DEGs. An expression pattern of up-regulation in 10 
randomly selected samples and down-regulation in another 10 randomly selected 
samples was imposed on these genes. In ExMat2, 2000 genes (i.e. 20%) were randomly 
selected to represent DEGs and the same expression pattern was imposed on them. The 
matrix was populated with gene expression values representing unchanged expression, 
up- and down-regulation using distributions similar to those used in simulations 
described in Section 6.2.1.1.
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A series of gene sets was then created by randomly selecting from amongst those 
represented in the matrix, ranging in length from 20 to 10,000 genes (i.e. all genes in the 
matrix), in increments of 20 genes. Two SD-SDM values were calculated for each gene 
set: one each from ExMatl and ExMat2. These have been plotted in Figure 6.10a, 
against gene set sizes; SD-SDM values from ExMatl are coloured red while those from 
ExMat2 are blue. The same data is displayed in Figure 6.10b with both axes in log 
space.
As can be observed, the relationships between SD-SDM values and gene-set size in the 
presence of information (Figure 6.10) are markedly different from their relationships in 
the absence of information (Figure 6.9). In the absence of information, SD-SDM values 
showed a continuous decrease in value with increase of gene-set size; this relationship 
was linear when SD-SDM values and gene set sizes were logged. However, in the 
presence of information much of this length-dependency of SD-SDM values is lost. This 
occurs presumably because of random selection of DEGs into the gene sets. The 
difference in the levels of information between ExMatl (10% of genes are DEGs) and 
ExMat2 (20% of genes are DEGs) appears to shift the distributions their SD-SDM 
values, relative to gene set size, away from each other. This is due to the selection of 
greater numbers of DEGs into gene sets sampled from ExMat2 as compared to ExMatl.
Thus, we find that the SD-SDM values for any gene set are subject simultaneously to the 
systematic effects exerted by both gene sets size and any DEGs that may randomly be 
selected into a gene set. While effects of gene set size alone may be controlled easily 
through mathematical modelling of these effects, controlling for the effects of randomly 
selected DEGs is more complicated. Such modelling would require prior knowledge of 
both the number of DEGs, as well as all the different expression patterns exhibited by 
those genes. For any given dataset, such knowledge would not be available. For this 
reason, further investigations focussed on development of ad hoc methods that could 
control for both of these sources systematic effects on SD-SDM values.
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Figure 6 .1 0  Effect of g e n e -s e t  s iz e  on SD-SDM v a lu es  in th e  p resen ce  of 
inform ation. Data represented was derived from two series of matrices created by 
randomly selecting a series of gene-sets of various sizes from two hypothetical gene 
expression matrices (ExMatl and ExMat2) containing different levels of information. 
In (a) SD-SDM values are plotted against the number of genes, (b) represents the 
same data as (a) with both axes in log scale.
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6.2.3. Assessment of significance of SD-SDM values
Explorations described in the previous section showed that SD-SDM values alone may 
not be satisfactory metrics to identify gene sets that could be of interest to researchers. 
This is because of the observation that SD-SDM values are sensitive to gene set size and 
that this relationship is complicated by the possible presence of DEGs in within the gene 
sets by random chance. Mathematical modelling to control for these effects would 
require prior knowledge of both the level of information within a microarray dataset (i.e. 
the number of DEGs), as well as nature of this information (i.e. all possible groupings of 
samples based on the expression patterns of the DEGs).
Efforts were therefore focussed on an ad hoc method that did not require these 
parameters to be estimated. This involved creation of background distributions of SD- 
SDM values (i.e. null distributions) with which observed SD-SDM values could be 
compared, thus allowing for assessment of the significance of the observed SD-SDM 
values. Two methodologies that could be used for this purpose were identified: the first 
of these involves a strategy of randomization of values within the expression matrix for 
any given gene set. Such a strategy can be carried out in three different ways: values can 
be randomized for each gene (i.e. within each row), for each sample (i.e. within each 
column), or across both genes and samples. Iteration of this process and recording of the 
SD-SDM values for each matrix could then create a background distribution of null SD- 
SDM values with which to compare the SD-SDM value observed for a gene set.
The second strategy is of re-sampling, and involves random selection of gene sets of the 
same size as the one being tested, from amongst all genes represented in the entire 
experimental dataset. The background distribution would then comprise of the SD-SDM 
values for all the expression matrices for these randomly selected gene sets.
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Using these background distributions, two measures of significance can be calculated. 
The first of these is a Z-score, which represents the effect size i.e. the magnitude of the 
difference between the observed and expected SD-SDM value for gene-sets of a 
particular size (see Materials and Methods). The second is a p-value, representing the 
probability that the observed SD-SDM value could have occurred by chance alone.
Both the data randomisation and re-sampling methods for creating background 
distributions of SD-SDM values have advantages and disadvantages relative to each 
other. For example, it can be argued that because background distributions derived from 
the randomization strategy are derived from matrices comprising of the same set of 
values as that of the expression matrix of the gene set being tested, they may be more 
comparable to the SD-SDM value observed for that gene-set as compared to those 
derived from the re-sampling strategy because it involves expression matrices with 
different sets of values (as they represent different sets of genes). However, as indicated 
by explorations described in Section 6.2.2.2, DEGs may be present in a gene set simply 
by chance alone (and not for biological reasons). The randomization strategy may not 
allow control for their presence (and their influence on observed SD-SDM values) as it 
involves removal of all structure (brought about by the presence of information) within 
the expression matrix for a gene set.
To explore the feasibility of using either strategy to create background distributions to 
assess the significance of observed SD-SDM values, the following simulations were 
carried out. First, a hypothetical gene expression matrix representing an entire 
microarray dataset was created, comprising of 30 samples and 10,000 genes, none of 
which were DEGs. A second matrix was created, identical to the first, except that 2000 
genes (i.e. 20% of genes in the matrix) were selected at random to represent DEGs. An 
expression pattern of up-regulation in 10 randomly selected samples, and down- 
regulation in another 10 randomly selected samples was imposed on all the DEGs of the 
second matrix. The matrices were populated with gene expression values representing
156
Chapter 6: Gene Set Discovery (GSD): Unsupervised identification of relevant biological themes
within microarray datasets
unchanged expression, up- and down-regulation using distributions similar to those used 
in simulations described in Section 6.2.1.1.
A series of 100 gene sets, ranging in length from 10 to 1000 genes were then selected at 
random from both expression matrices. Two SD-SDM values were recorded for each 
gene-set: one from each parental expression matrix. Background distributions were then 
created for each gene set using the two candidate strategies identified. Using the re­
sampling strategy, for each gene set being tested, 1000 gene sets of the same size were 
sampled randomly from the entire expression matrix, and their SD-SDM values were 
recorded for each parental matrix. Three background distributions were created for each 
test gene set (for each parental matrix) using the randomization strategy, by randomizing 
expression values only within samples, only within genes and across both genes and 
samples 1000 times for each gene-set. Z-scores and p-values could then be calculated for 
each gene-set using each of these distributions.
Table 6.1 shows the number of gene sets assigned significance (i.e. had p-values of 
<0.05) before and after multiple hypothesis correction using the Benjamini-Hochberg 
method, for each strategy, and for each parental expression matrix.
Considering that all 100 tested gene sets comprised of randomly selected genes, it is 
desirable that a useable strategy to assess the significance of the SD-SDM values 
observed for these gene sets detects little or no significance for them. This appears to be 
the case for both the re-sampling and randomization strategies when the gene sets were 
sampled from the matrix that contained no information (i.e. no DEGs): very few gene 
sets were assigned p-values <0.05, and no gene sets were flagged as significant after 
multiple hypothesis correction of the p-values using the Benjamini-Hochberg correction. 
Similar results are obtained from the application of the re-sampling strategy to assess the 
significance of gene sets sampled from the expression matrix that contained information.
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Expression
Matrix Testing Strategy
Number of tests 
significant at 
p<0.05 
(uncorrected)
Number of tests 
significant at 
p<0.05 
(FDR-corrected)
Without
information
Re-sampling 4 0
Randomization
Only samples 3 0
Only genes 2 0
Genes and samples 2 0
With
information
Re-sampling 3 0
Randomization
Only samples 100 100
Only genes 100 100
Genes and samples 100 100
Table 6 .1  Numbers of gen e s e ts  (out of 100) found to  have significant SD- 
SDM values as a sse sse d  by re-sam pling and randomization strategies. Gene 
se ts  of different sizes were created by random selection of gen es from two 
hypothetical gene expression matrices, one of which contained information (i.e. 
DEGs), while the other did not.
However, all three versions of the randomization strategy assigned p-values of <0.05 to 
all test gene sets that were sampled from the expression matrix that contained 
information. Even multiple-hypothesis correction did not appear to have much impact on 
these results: all test gene sets were flagged as significant (at p<0.05) after FDR- 
correction of the p-values.
Thus, the re-sampling strategy appears to be insensitive to the presence of information 
within a gene expression matrix: no significance is detected using this strategy 
regardless of whether the expression matrix from which gene sets are sampled contained 
DEGs or not. To explore this, the observed SD-SDM values and background SD-SDM
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distributions created using the re-sampling strategy for gene sets sampled from the 
matrix without information (Figure 6.11a) and with information (Figure 6.11 b ) were 
plotted against gene set size.
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Figure 6 .1 1  R e-sam pling based  sign ifican ce  te s tin g . Grey points represent 
background distributions of SD-SDM values derived by re-sampling of gene sets to 
assess the significance of observed SD-SDM values (red points) for a series test 
gene sets of various sizes selected randomly from hypothetical matrices (a) without 
and (b) with information (i.e. DEGs), the results for which are displayed in Table 
6.1. Black lines represent the median background SD-SDM value for each size of 
gene set tested.
As can be observed in Figure 6.1 la, the SD-SDM values observed for the test gene sets 
sampled from the expression matrix with no information content fall well within the 
background distributions created using the re-sampling strategy. This reflects the 
absence of any significance detected for these gene-sets. The observed SD-SDM values 
in Figure 6.11b show a very different distribution to those seen in Figure 6.1 la. This is
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as expected from the explorations described in Section 6.22.2, where it was found that 
when gene sets are randomly sampled from an expression matrix containing information 
(i.e. DEGs), the DEGs that are randomly selected into the gene sets influence their SD- 
SDM values. However, the background distribution of SD-SDM values also shows a 
similar change due to which the observed SD-SDM values again fall within the 
background distributions. This is because the background distributions were created 
using gene sets that (like the test gene sets) contained information as well, due to 
random selection of DEGs into them. The test gene sets were created by random 
selection of genes and thus contained similar levels of information as those used to 
create the background distributions. As a result, no significance was assigned to them.
On the other hand, the introduction of information to the expression matrix from which 
gene sets are sampled randomly changes the results of the randomization strategy 
radically. To explore this, the observed SD-SDM values for all the test gene sets were 
plotted against gene set size along with background distributions calculated by 
randomization of expression values only within genes, only within samples, and across 
genes and samples in Figures 6.12a, 612b, and 6.12c respectively for gene sets sampled 
from the matrix with no information, and in Figures 6.12d, 6.12e and 6.12f respectively 
for gene sets sampled from the matrix containing information.
As can be observed from Figures 6.12a, 6.12b and 6.12c, when gene sets are sampled 
from expression matrices containing no information, the SD-SDM values observed for 
them fall well within the background distributions of SD-SDM values: thus, no 
significance is detected for any of them. However as can be observed in Figures 6.12d, 
6.12e and 6.12f, the change in the distributions of observed SD-SDM values for gene 
sets sampled from the matrix containing information relative to gene set size is not 
mirrored by changes to the background distributions: these remain similar to as when 
gene sets were sampled from the expression matrix with no information content.
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Figure 6 .1 2  Randomization based significance testing. Grey points represent 
background distributions of SD-SDM values derived by randomization of expression  
values (in three different ways) to a sse ss  the significance of observed SD-SDM 
values (red points) for a series of te st gene se ts  of various sizes selected randomly 
from hypothetical matrices with and without information (i.e. DEGs), the results for 
which are displayed in Table 6 .1 . Black lines represent the median background SD- 
SDM value for each size of gene se t tested .
This is presumably because the randomization strategy to create the background 
distributions involves the removal of all information, including that represented by 
randomly selected DEGs. Thus the random selection of DEGs into the test gene sets is 
not accounted for and as a result all test gene sets are assigned significance.
It is expected that the numbers of DEGs that are randomly selected into gene sets 
increase linearly in relation to increase of gene set size. Thus it was then desired to 
investigate if the presence of information within a gene expression matrix could result in 
the sensitivity of the significance of SD-SDM values (as assigned by the re-sampling 
and randomization strategies) to gene set size. In Figure 6.13, the Z-scores derived using 
the re-sampling strategy for test gene sets sampled from the expression matrices with 
(red points) and without information (grey points) are plotted against gene set size. As 
can be observed, both distributions are similar: neither set of Z-scores appears to be 
affected by gene set size. In Figure 6.14, the Z-scores derived using all three types of the 
randomization strategy for test gene sets sampled from the expression matrices with (red 
points) and without information (grey points) are plotted against gene set size. As can be 
observed, for the gene sets sampled from the matrix without information, the Z-scores 
show no apparent sensitivity to gene set size. However, for gene sets sampled from the 
matrix with information content, a strongly positive relationship is observed between the 
Z-scores and gene-set size.
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Figure 6 .1 3  R e-sam pling based  Z -scores. Points represent Z-scores derived by 
re-sampling of gene sets to assess the significance of observed SD-SDM values for a 
series test gene sets, the results for which are displayed in Table 6.1. Broken black 
lines indicate Z-scores of zero.
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Figure 6 .1 4  Random ization based  Z -scores. Points represent Z-scores derived 
by randomization of expression values (in three ways) to assess the significance of 
observed SD-SDM values for a series test gene sets selected from hypothetical 
matrices w ithout (grey points) and with information (red points) , the results for 
which are displayed in Table 6.1. Broken black lines indicate Z-scores of zero.
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These data argue that the randomization strategy is an unsatisfactory methodology with 
which to assess to significance of SD-SDM values observed for gene sets for two 
reasons. Firstly, the null hypothesis when using the randomization strategy is that a gene 
set contains no information at all. Thus, the randomization strategy could assign 
significance to a gene set in which DEGs are present simply by chance alone (and not 
for biological reasons): this would be a false positive result of no interest to the 
researcher. Secondly, the presence of information (i.e. DEGs) within an experimental 
dataset creates an indirect sensitivity of significance levels, as assigned by the 
randomization strategy, to gene set size (via the random selection of larger numbers of 
DEGs into larger gene sets).
On the other hand, the re-sampling strategy represents a more satisfactory methodology 
with which to assess the significance of SD-SDM values observed for gene sets. The 
null hypothesis in this case is that a gene set contains no greater level o f information 
than would be expected by chance alone, and could therefore allow for removal of gene 
sets containing DEGs simply by chance alone. Also, the levels of significance as 
assigned by the re-sampling methodology appear to be unaffected by gene set size, 
regardless of the presence or absence of information within a gene expression matrix.
Thus, the calculation of an SD-SDM value for a gene set, followed by testing of the 
significance of that value using the re-sampling strategy, comprise a methodology that 
could potentially be used to identify biological themes that may be of interest to a 
researcher in an unsupervised way. We term this approach Gene Set Discovery (GSD).
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6.3 Discussion
GSA methods, both threshold-based (such as ORA of lists of DEGs) (Khatri and 
Draghici 2005) and threshold-free (such as GSEA) (Subramanian et al. 2005), are 
usually carried out following supervised analyses of microarray data that require prior 
knowledge of sample classes. However, in many studies (particularly those of cancers) 
researchers may have no a priori knowledge of sample classes, or these may be poorly 
defined (Alizadeh et al. 2000; Golub et al. 1999; Subramanian et al. 2005). This chapter 
explored the possibility of developing a methodology that could allow GSA analysis of 
microarray data without requiring prior description of sample classes.
Investigations focussed on heatmaps (and their associated hierarchical clustering) that 
have typically been used as visually intuitive ‘end stage’ tools to display expression 
patterns of genes that are known to be relevant within an experiment (such as lists of 
DEGs) (Eisen et al. 1998). A particular idea that was explored was that, if manual 
inspection of a heatmap reveals ‘striking’ visual patterns indicative of expression 
patterns shared between many genes, this may imply that the gene set (which may be a 
biological theme) represented by that heatmap is informative (i.e. contains DEGs) and 
may thus be of interest to a researcher. However such a method would be somewhat 
unsatisfactory due to the element of manual inspection and the absence of any 
underpinning statistical methodology.
To summarise the explorations that were carried out to develop a methodology that 
could allow unsupervised automated discovery of possibly interesting gene sets:
• A metric, SD-SDM, was found to be suitable for this purpose (see Section 6.2.1) for 
two reasons. First, it was sensitive to the levels o f information within a gene set, i.e. 
the number of DEGs. Second, it was sensitive to the types o f information within a 
gene set, i.e. whether the patterns of expression of the DEGs corresponded to the 
same groups of samples or not.
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• SD-SDM values were found to be sensitive to the simultaneous effects of two 
possible confounding factors: gene set size and the possible random presence of 
DEGs within a gene set (see Section 6.2.2).
• To control for these factors, two strategies were investigated (see Section 6.2.3). The 
first of these was a strategy involving randomization of gene expression values. This 
was found to be unsatisfactory as it involved a null hypothesis that the expression 
data corresponding to a gene set contained no information at all, and thus failed to 
take into account the possible randomly-selected presence of information within a 
gene set. The second tested strategy involved re-sampling of gene sets (in a random 
fashion) from the entire dataset, and had a null hypothesis that a gene set contained 
levels o f  information that were no greater than would be expected by chance alone. 
Investigations of this strategy indicated that it could successfully control for the 
simultaneous effects of both confounding factors.
The calculation of SD-SDM values for a gene set, and the subsequent assessment of the 
significance of these values using the re-sampling strategy thus constitute a novel 
methodology called Gene Set Discovery (GSD). As will be explored in subsequent 
chapters, this method could potentially be used for the discovery of gene sets that may 
be of interest to researchers in an unsupervised fashion (i.e. without prior definition of 
sample classes).
While all explorations and investigations described in this chapter were carried out using 
hypothetical gene expression matrices with artificially introduced information, and gene 
sets comprising of randomly selected genes, evidence of the utility of this approach in 
the analysis of ‘real-world’ microarray datasets requires testing of the GSD methodology 
on such datasets. This is explored in the next chapter, which describes the 
implementation of the GSD methodology on four microarray datasets, and analysis of 
the results.
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Chapter 7: A pplication o f the GSD 
m ethodology to four m icroarray datasets
7.1 Introduction
Class discovery based on gene expression signatures in cancer datasets datasets is an 
important technique (see Section 1.3.2), with numerous published examples of datasets 
where the samples are morphologically homogenous, but show molecular heterogeneity 
and varying prognoses (Alizadeh et al. 2000; Bittner et al. 2000; De Cecco et al. 2004; 
Golub et al. 1999; Ivshina et al. 2006; Perou et al. 2000), and where the expression 
patterns provide prognostic information beyond what the histological classification is 
capable of providing.
In the previous chapter, explorations were described outlining the concepts that underpin 
Gene Set Discovery (GSD), a methodology that can be used simultaneously to identify 
gene sets (which may represent biological themes such as pathways or GO terms) that 
could be relevant within an experiment, as well as possibly identify functional classes of 
samples based on those gene sets. This was illustrated using hypothetical gene 
expression matrices and simulated patterns of gene expression. Because the GSD 
methodology does not require prior definition of sample/phenotype classes it was 
reasoned that it might be of particular use in analysis of cancer datasets, where sample 
classes may be unknown (or at least, where sample discovery is an aim), or where the 
classification of samples is problematic. An important feature of GSD is the potential to 
discover informative gene set signatures in such datasets that have a linking theme 
between the constituent genes, which in turn may identify opportunities for theme-based 
drug or prognostic marker development.
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This chapter now describes the implementation of the GSD methodology, and its 
application to four microarray datasets. The first of these is the GNF human tissue 
expression dataset (Su et al. 2004) which was introduced in Chapter 5. This dataset 
shows strong sample grouping based on tissue-specific expression patterns. The 
remaining three datasets that were chosen to illustrate the GSD methodology were 
cancer datasets; a set of Acute Myeloid Leukaemia (AML) samples from the St Jude 
Children’s Research Hospital (Ross et al. 2004), liposarcoma samples from a 
collaborator at the Memorial University Medical Centre (see Materials and Methods), 
and breast cancer samples from Uppsala (Ivshina et al. 2006).
7.2 Technical methodology
The development of the GSD methodology was based on the explorations described in 
Chapter 6. Figure 7.1 displays how the methodology was applied to four datasets. CEL 
files, which consisted of the raw expression data, were obtained for each experiment. 
The MAS5 algorithm was used to extract expression summary values from the CEL 
files, which was then logged and median-centred to yield the gene expression matrices 
to which the GSD methodology was applied. The gene set database used for all analyses 
was that of Gene Ontology Biological Process (GOBP) terms (see Materials and 
Methods). Only gene sets that consisted of a minimum of 5 genes were utilized, and 
those gene sets that were greater in size than 10% of all genes represented on array were 
excluded. SD-SDM values were calculated for each gene set. Background distributions 
were created using the re-sampling strategy: for each unique size of the GOBP gene sets,
10,000 gene sets of that size were selected at randomly and without replacement from 
amongst all genes represented on the array. SD-SDM values were calculated for each of 
these gene sets and these made up the background distributions for each size of gene set 
tested. By comparing the observed SD-SDM values with the background distributions it 
was possible to derive Z-scores and empirical p-values for each GOBP term. A p-value 
cutoff of <0.01 after FDR correction was used for all datasets.
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CEL Files (raw data)
MAS5 normalization
Log + median center
Gene-set database 
(GOBP terms)
Calculate SD-SDM 
for each gene set
Gene expression matrix
10,000x permutations for 
each unique gene-set size
Observed 
SD-SDM values
I________
Background distribution 
of SD-SDM values
Derive empirical p-values + 
Multiple testing correction
Gene-sets found to be 
significant at p<0.01
Figure 7 .1  Im plem entation  of  th e  GSD m ethodology .
Testing the efficacy of methods for the analyses of microarray data is problematic due to 
the absence of ‘truth’ with which results can be compared. Assessment of the GSD 
methodology was based on the biological plausibility of the results and/or whether these 
results are in concord with prior analyses of these datasets.
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7.3 Results and Explorations
7.3.1 Analysis of the GNF human tissue expression dataset
The first dataset analyzed using the GSD methodology was from the GNF tissue 
expression database. The distribution of SD-SDM values observed for all the GOBP 
terms tested relative to the background distribution of SD-SDM values to which they 
were compared is displayed in Figure 7.2. A total of 51 GOBP terms (out of 1397) were 
found to have FDR-corrected p-values less than the significance threshold of 0.01.
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Figure 7 .2  Selection  of GOBP term s in GSD ana lys is  of th e  GNF human  
t is su e  exp ress ion  d ataset .  Grey points represent log SD-SDM values observed for 
each tested GOBP term. Encircled grey points represent those terms with FDR- 
corrected p-values of less that 0.01. The red line indicates the median of the 
background distribution of SD-SDM values for each gene set size. Broken black lines 
indicate the median ± 2 standard deviations for the background distributions.
Chapter 7: Application of the GSD methodology to four microarray datasets
While 34 terms had p-values of zero, a more precise ordering of the terms according to 
their significance could be achieved by using their Z-scores. Table 7.1 displays the top 
20 terms selected by GSD analysis of this dataset when ranked by Z-score.
Gene Ontology Biological P rocess Term Z-score
p-value
(FDR
corrected)
G0:0048731_system  development 9.3 0
G0:0007399_nervous system development 9.2 0
G0:0030333_antigen processing 8.9 0
G0:0019882_antigen presentation 8.8 0
G0:0019883_antigen presentation, endogenous antigen 8.5 0
G0:0019226_transmission of nerve impulse 8.4 0
G0:0019885_antigen processing, endogenous antigen via MHC class I 8.4 0
G0:0007268_synaptic transmission 8.4 0
G0:0019886_antigen processing, exogenous antigen via MHC class II 7.2 0
G0:0019884_antigen presentation, exogenous antigen 7.1 0
G0:0006412_protein biosynthesis 7.0 0
G0:0007417_central nervous system development 6.7 0
G0:0009059_macromolecule biosynthesis 6..4 0
G0:0050877_neurophysiological process 6.1 0
G0:0030182_neuron differentiation 5.9 0
G0:0048699_neurogenesis 5.8 0
G0:0015672_monovalent inorganic cation transport 5.5 0
G0:0006812_cation transport 5.2 0
G0:0030154_cell differentiation 5.1 0
G0:0030001_metal ion transport 5.0 0
Table 7 .1  Top 20 GOBP term s, se lec ted  by GSD analysis , of th e  GNF human  
t is su e  exp ress ion  dataset .  Terms are ranked by Z-score values. Terms 
highlighted in blue represent those processes involved in functions within the 
nervous system, while those in red are specific to the immune system.
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As can be observed, the list is dominated by terms representing processes involved 
functions of the nervous system and of the immune system. This observation is of 
interest as it could be a reflection of the fact that samples from brain/neuronal tissues 
and from blood/immunity-related tissues comprise the two largest groups of similar 
tissue-types within this dataset. Indeed, terms associated with nervous system processes 
make up more than a third of all terms selected. On inspection of parent-child 
relationships between these terms (displayed in Figure 7.3), it is found that nearly all of 
their ancestral terms that were tested were also selected by GSD analysis. Investigation 
then focussed on the heatmaps of these selected terms that are associated with nervous 
system processes. Some of these are displayed in Figure 7.4, together with ‘picketplots’ 
to indicate the clusters in which each of the samples was found in the analysis described 
in Section 5.2.3. Three of the clusters comprised of samples from similar tissues: 
‘Brain/neuronal’, ‘Blood/immune’ and ‘Testis’; all other tissue samples were classified 
as ‘Miscellaneous’. Considerable proportions of genes exhibit strong and consistent 
patterns of up-regulation in the samples from the Brain/neuronal cluster.
Investigation of heatmaps of terms associated with immune system processes (some of 
which are displayed in Figure 7.5) also similarly revealed many genes within these terms 
exhibited higher levels of expression in samples from the Blood/Immune cluster, as well 
as in samples from other tissues in the Miscellaneous class that are associated with the 
immune system, (i.e. those labelled as ‘tonsil’, ‘lymph node’ and ‘thymus’). Heatmaps 
of all other GOBP terms selected by the GSD analysis (a subset of which are displayed 
in Figure 7.6) exhibited strong, consistent gene-expression expression patterns that were 
in concord with the tissue-type based clusters of samples.
Thus, it appears that the GSD methodology is successfully able to detect, without prior 
information regarding the groups of similar tissues, those biological processes that are 
specific to the two largest groups of functionally similar tissue-types within the dataset.
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Figure 7 .3  GOBP term s se lec ted  by GSD analysis  of the  GNF human t is su e  
exp ress ion  d a ta se t  which are involved in nervous sy ste m  p ro cesse s  (and  
their ancestral term s) .  Nodes represent GOBP terms while the edges represent 
parent-child relationships between terms. Orange nodes represent terms selected 
by GSD analysis. Blue nodes represent terms that were tested but not selected. 
Grey nodes represent untested terms.
G0:0007399_nervous system  development
Blood,Immune 
BrainMeuronal 
Testis 
M iscellaneous
IIIBIIIIIIIIIIIIII
G0:0006813_potassium ion transport
Bloodlmmune
BrairvTJeuronal
Testis
Miscellaneous
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G0:0048667_neuron m orphogenesis during differentiation
G0:0007268_synaptic transm ission
Blood.lmmune 
Brain Neuronal 
Testis 
Miscellaneous
Figure 7 .4  S e lec ted  GOBP term s specific  to nervous sy s te m  p r o c e s se s  
d etected  by GSD analysis  of th e  GNF t is su e  exp ress ion  d a ta se t .  Heatmaps 
represent log median-centred MAS5 normalized data ranging in value from -2 
(bright green) through 0 (black) to 2 (bright red), and were created using 
correlation distance and average linkage. Values greater than 2 and less than -2 
were set to 2 and -2 respectively. Black bars in the 'picketplots' below the heatmaps 
indicate which tissue-specific clusters the respective samples are grouped into in the 
analysis described in Section 5.2.3.
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G0:0019882_antigen presentation
Blood/Immune .............  . . . . . .
Brain/Neuronal l l l l l l l ^ l ^ l l l l l l ^   ^ II
M iscellaneous I........................................................................................ ........................................
G0:0030333_antigen processing
^ ^ ■ n u  »»»■ » ■ in ■■■■■■■ III MIL.
Blood/Immune
Brain/Neuronal
Testis
Miscellaneous
Figure 7 .5  S e lected  GOBP term s specific  to  im m une sy s te m  p r o c e s se s  
d etected  by GSD analysis  of the  GNF t is su e  exp ress ion  d a tase t .  Heatmaps 
represent log median-centred MAS5 normalized data ranging in value from -2 
(bright green) through 0 (black) to 2 (bright red), and were created using 
correlation distance and average linkage. Values greater than 2 and less than -2 
were set to 2 and -2 respectively. Black bars in the 'picketplots' below the heatmaps 
indicate which tissue-specific clusters the respective samples are grouped into in the 
analysis described in Section 5.2.3.
176
Chapter 7: Application of the GSD methodology to four microarray datasets
G0:0006412_protein biosynthesis
Blood.lmmune L________________
Braintleuronal llllllllllllllllll
Testis
Miscellaneous I_________________ I
G0:0030154_cell differentiation
Blood.lmmune
Braintieuronal
Testis
Miscellaneous
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G0:0007155 cell adhesion
Blood.lmmune
Brain/Neuronal
Testis
Miscellaneous
G0:0016043_cell organization and biogenesis
IIIBIIIIIIIIIIIIIIBlood/ImmuneBraintleuronal
Testis
Miscellaneous
F igure  7 .6  O th e r  s e le c te d  GOBP te r m s  d e te c te d  by GSD a n a ly s i s  of th e  GNF 
t i s s u e  e x p re s s io n  d a t a s e t .  Heatmaps represent log median-centred MAS5 
normalized data ranging in value from -2 (bright green) through 0 (black) to 2 
(bright red), and were created using correlation distance and average linkage. 
Values greater than 2 and less than -2 were set to 2 and -2 respectively. Black bars 
in the 'picketplots' below the heatmaps indicate which tissue-specific clusters the 
respective samples are grouped into in the analysis described in Section 5.2.3.
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7.3.2 Analysis of the Ross AML dataset
The next dataset analyzed using the GSD methodology comprised 130 samples from 
paediatric patients with Acute Myeloid Leukemia (AML), created at the St Judes 
Children’s Research Hospital (Ross et al. 2004). Of these, 83 samples could be classified 
into one of five known genetic sub-types of AML: cases with t( 15; 1 l)[PML-RARa] (15 
samples), t(&;2l)[AMLl-ETO] (21 samples), inv16[CBF$-MYHl 1] (14 samples), MLL 
chimeric fusion genes (23 samples), and acute megakaryocytic morphology (FAB-M7) 
(10 samples).
To reduce the complexity of analysis, implementation of the GSD methodology was 
restricted to these 83 samples, while the other 47 samples that could not be classified in 
the original study into any genetic subtype of AML were discarded. This therefore 
allowed GSD to be assessed as to whether it could discover the known classes within 
this dataset. The distribution of SD-SDM values observed for all the GOBP terms tested 
relative to the background distribution of SD-SDM values to which they were compared 
is displayed in Figure 7.7. A total of 12 GOBP terms (out of 1397) were found to have 
FDR-corrected p-values that were less than the significance threshold of 0.01. These are 
shown in Table 7.2.
As can be seen, other than the term for “translational initiation”, all of the selected 
GOBP terms can be considered to be involved in processes of immune response -  and as 
is displayed in Figure 7.8, are all descendants of the term “response to stimulus”. Given 
that the samples comprise of mononuclear cells from purified from the bone marrow/ 
peripheral blood samples from paediatric AML patients; and that these cells represent a 
critical component of the immune system, it seems plausible that the dominant theme to 
arise from this dataset relates to the immune response.
Investigations then focussed on the heatmaps derived from these terms, some of which 
are displayed in Figure 7.9.
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Figure 7 .7  S election  of GOBP term s in GSD analysis  of th e  Ross AML 
d ataset .  Grey points represent log SD-SDM values observed for each of the GOBP 
terms tested. Encircled grey points represent those GOBP terms found to exhibit 
FDR-corrected p-values of less that 0.01. The red line indicates the median of the 
background distribution of SD-SDM values for each gene set size. Broken black lines 
indicate the median ± 2 standard deviations for the background distributions.
As most these terms are closely related within the GOBP hierarchy, they share many 
genes. As a result, most of the heatmaps derived from the terms appear very similar to 
each other. The patterns of expression observed appear to correlate strongly with the 
known genotypic classes of AML.
Amongst most of the heatmaps, it is generally observed that the pattern involving the 
greatest number of genes splits the samples into two major clusters: one which is 
comprised mostly of samples of the l(\5\\l)[PML-RARo], t(%,2\)[AMLl-ETO\, and 
FAB-M7 subtypes, while the other cluster is dominated by samples of the 'mvI6[CBF$- 
MYH11] and MLL subtypes.
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Gene Ontology Biological Process Term Z-score
p-value
(FDR
corrected)
G0:0009607_response to biotic stimulus 12.8 0
G0:0006952_defense response 12.4 0
G0:0006955_immune response 11.6 0
G0:0051707_response to other organism 10.2 0
G0:0009613_response to pest, pathogen or parasite 10.1 0
G0:0019882_antigen presentation 8.3 0
G0:0006950_response to stress 8.2 0
G0:0009611_response to wounding 7.8 0
G0:0009605_response to external stimulus 7.6 0
G0:0030333_antigen processing 7.5 0
G0:0006413_translational initiation 7.2 0
G0:0006954_inflammatory response 6.3 0
Table 7 .2  GOBP term s se lec ted  by GSD analysis  of the  Ross AML dataset.
Terms shown are those found to have FDR-corrected p-values of less than 0.01. 
Terms highlighted in blue are those that are specific to immune system processes.
Other smaller patterns of expression are also observed that appear to be specific to AML 
sub-types within the first cluster. As a result, all of the X{\5\\l)[PML-RARa] samples, all 
the of the FAB-M7 samples and most of the t(&;2l)[AMLl-ETO] are grouped 
respectively into three well-differentiated sub-clusters.
No obvious expression patterns that could differentiate amongst the subtypes of samples 
in the second major cluster (i.e. inv16[CBFfi-MYHl 1] and MLL) were discernible. This is 
reflected in the grouping of samples within this cluster -  there is relatively little 
discrimination between samples of these sub-types.
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antigen presentation antigen processing inflammatory response
response to pest, pathogen or parasite response to woundingimmune response
defense response response to stress
response to biotic stimulus response to external stimulus
physiological process
biological.process
response to stimulus
organismal physiological process
response to other organism
Figure 7 .8  GOBP term s se lec ted  by GSD analysis  of th e  Ross d a tase t  (and  
their ancestral term s) .  Nodes represent GOBP terms while the edges represent 
parent-child relationships between terms. Orange nodes represent terms selected 
by GSD analysis. Blue nodes represent terms that were tested but not selected 
(there are no such terms here). Grey nodes represent untested terms. All terms 
selected represented with the exception of'translational in itiation7.
G0:0006955.immune resp o n se
CBFB.
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G0:0006413_translational initiation
CBFB,
G0:0009605_response to external stim ulus
Figure 7 .9  S e lected  GOBP term s d etected  by GSD an a lys is  o f  th e  R oss AML 
datase t .  Heatmaps represent log median-centred MAS5 normalized data ranging in 
value from -2 (bright green) through 0 (black) to 2 (bright red), and were created 
using correlation distance and average linkage. Values greater than 2 and less than 
-2 were set to 2 and -2 respectively. Black bars in the 'picketplots' below the 
heatmaps indicate which of five genetic sub-types of AML that each of the samples 
was classified as in the original study.
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This could be a reflection of the observation made in the original study that there is 
considerable molecular heterogeneity amongst samples of these AML sub-types, which 
implied the possibility of molecular sub-groups within these sub-types. The reason for 
this heterogeneity could also not be explained by the relatively more supervised and 
focussed analyses carried out in the original study.
Only the GOBP term for translational initiation exhibited a considerably different 
clustering of samples, which is not unexpected as it comprises a very different biological 
theme (consisting of a different set of genes) from all the other selected terms. The 
heatmap for this term (also displayed in Figure 7.9) reveals that there a relatively few 
informative genes, but strong expression patterns exhibited by these genes results in 
significantly strong clustering of samples. However the resultant samples clusters do not 
appear to be in agreement with the known AML genetic sub-types.
In summary, it was found that the majority of gene sets selected by GSD analysis of this 
dataset represented biological themes that can plausibly be linked to the biology within 
the dataset. The samples comprised mononuclear cells, which are a critical component 
of the immune system, and the dominant theme indicate by GSD analysis is that of the 
immune responses. Furthermore, the information within these gene sets (i.e. the patterns 
of expression) reflected known phenotypic classes of AML.
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7.3.3 Analysis of the Broccoli liposarcoma dataset
The third dataset analyzed using the GSD methodology was a set of 31 liposarcoma 
samples created using the Affymetrix hgul33plus2 platform. This dataset was provided 
by a collaborator at the Memorial University Medical Centre (see Materials and 
Methods). Liposarcomas are a relatively understudied type of cancers, and are of 
adipocytic origin. Each of the samples could be classified into four sub-types based on 
histological profiles: well differentiated (WD), myxoid (MYX), de-differentiated (DD) 
and pleomorphic (PLEO) samples. WD samples represented low grade tumours, while 
PLEO and DD samples represented high grade tumours.
A total of 1492 GOBP terms were tested on the Broccoli liposarcoma dataset using the 
GSD methodology. The distribution of SD-SDM values observed for all the GOBP 
terms tested relative to the background distribution of SD-SDM values to which they 
were compared is displayed in Figure 7.10. A total of 30 GOBP terms were found to be 
exhibit FDR-corrected p-values that were less than the significance threshold of 0.01. 
These terms are displayed in Table 7.3, ranked by their Z-score values. As can be 
observed, all the terms selected can be grouped into at least three major biological 
themes: cell division, metabolism (in particular, metabolism of fatty acids and 
carbohydrates) and the immune response. Relationships between terms for each of these 
themes are displayed in Figure 7.11.
Investigations then focussed on the heatmaps of these terms. Heatmaps of cell division 
terms (some of which are displayed in Figure 7.12) showed that most of the information 
for these terms appear to be limited to sets of genes that share a single expression 
pattern: of down-regulation in most of the WD samples, and up-regulation in most of the 
PLEO and DD samples. This is consistent with the tumour behaviour; the high-grade 
(PLEO and DD) samples exhibit greater levels of proliferative activity than the low- 
grade WD samples.
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Figure 7 .1 0  Selection  of GOBP term s in GSD ana lys is  of th e  Broccoli 
liposarcom a d atase t .  Grey points represent log SD-SDM values observed for each 
of the GOBP terms tested. Encircled grey points represent those GOBP terms found 
to exhibit FDR-corrected p-values of less that 0.01. The red line indicates the 
median of the background distribution of SD-SDM values for each gene-set size. 
Broken black lines indicate the median ± 2 standard deviations for the background 
distributions.
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Gene Ontology Biological P rocess Term Z-score p-value (FDR corrected)
GO:0000087_M phase of mitotic cell cycle 11.2 0
G0:0006091_generation of precursor metabolites and energy 11 0
G0:0007067_mitosis 10.9 0
G0:0015980_energy derivation by oxidation of organic compounds 10.8 0
G0:0006066_alcohol metabolism 10.7 0
G0:0000278_mitotic cell cycle 9.9 0
G0:0007051_spindle organization and biogenesis 9.5 0
G0:0006955_immune response 9.4 0
GO:0000279_M phase 9.4 0
G0:0006629_lipid metabolism 9.1 0
G 0:0009607_response to biotic stimulus 8.8 0
G0:0006112_energy reserve metabolism 8.7 0
G 0:0006952_defense response 8.7 0
G0:0019883_antigen presentation, endogenous antigen 8.5 0
G0:0006082_organic acid metabolism 8.5 0
G0:0019752_carboxylic acid metabolism 8.4 0
G0:0030333_antigen processing 8.1 0
G0:0006631_fatty acid metabolism 8 0
G0:0005975_carbohydrate metabolism 8 0
GO:0019882_antigen presentation 7.9 0
G0:0051301_cell division 6.9 0
G0:0019318_hexose metabolism 6.7 0
G0:0044262_cellular carbohydrate metabolism 6.6 0
G0:0007049_cell cycle 6.6 0
G 0:0006006_glucose metabolism 6.6 0
G0:0044255_cellular lipid metabolism 6.1 0
G0:0009056_catabolism 5.1 0
G 0:0009613_response to pest, pathogen or parasite 4.8 0
G0:0009058_biosynthesis 4.4 0
G 0:0050896_response to stimulus 4.3 0
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Table 7.3 GOBP term s se lected  by GSD analysis of the Broccoli liposarcom a 
dataset. Terms are ranked by Z-score values. Terms highlighted in blue represent 
those processes involved in metabolism functions, while those in red are specific to 
cell division processes. The remaining terms are involved in immune response 
processes.
Heatmaps of the metabolism terms (some of which are displayed in Figure 7.13) also 
appeared to indicate that much of the information content within these terms was limited 
to genes that shared a single expression pattern. This pattern was the inverse of what was 
observed in the heatmaps of cell division terms, i.e. here the expression pattern was of 
up-regulation in most of the WD samples, and down-regulation in most of the PLEO and 
DD samples. This is, again, a biologically plausible finding. These liposarcomas are of 
adipocytic (fatty tissue) origin, and thus the well-differentiated WD samples might be 
expected to show higher levels of (lipid) metabolism than the poorly differentiated 
PLEO and DD samples.
Expression patterns observed in heatmaps of the immune response terms (some of which 
are displayed in Figure 7.14) do not appear to be specific to the known sample classes. 
There are several possible explanations for this. The samples used were gross biopsies, 
and no attempt was made to isolate RNA purely from the cancer cells. Thus, if any of 
the samples contained tumour-infiltrating lymphocytes or showed substantial 
vascularisation then cells of the immune system would be included in the sample that 
was analysed. Indeed, several of the samples show strong expression for 
immunoglobulin light chain (K), a B cell restricted marker that is strongly suggestive of 
a proportion of the sample being composed of immune cells (see Figure 7.15a). As 
such, the expression values for immune response pathways may not be strongly 
correlated with the cancer stage, since it is hypothesised that the signal is derived largely 
from non-cancer cells.
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(b) Mitosis/ cell division
(c) Immune response
mitosis
M phase
cell cycle
immune response
defense response
response to stress
cell division
biological_process
antigen processingantigen presentation
response to stimulus physiological process
cellular process
mitotic cell cycle
response to biotic stimulus
response to other organism
biological_process
physiological process
organismal physiological process
response to pest, pathogen or parasite
antigen presentation, endogenous antigen
M phase of mitotic cell cycle
cellular physiological process
Figure 7 .11  Dominant biological th e m e s  of GOBP term s se le c te d  by GSD 
an alysis  of th e  Broccoli liposarcom a dataset .  Nodes represent GOBP terms 
while the edges represent parent-child relationships between terms. Orange nodes 
represent terms selected by GSD analysis. Blue nodes represent terms that were 
tested but not selected. Grey nodes represent untested terms.
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G0:0051301_cell division
PLEO
DD
MYX
G0:0007051_spindle organization and biogenesis
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G0:0007067_mitosis
PLEO
DD
MYX
Figure 7 .1 2  S elected  GOBP term s specific  to  cell division p r o c e s s e s  
d etec ted  by GSD analysis  of th e  Broccoli d a tase t .  Heatmaps represent log 
median-centred MAS5 normalized data ranging in value from -2 (bright green) 
through 0 (black) to 2 (bright red), and were created using correlation distance and 
average linkage. Values greater than 2 or less than -2 were set to 2 and -2 
respectively. Black bars in the 'picketplots' below the heatmaps indicate categories 
of liposarcoma that each of the samples were classified histologically.
G0:0044255_cellular lipid metabolism
PLEO
DD
MYX
WD
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G0:0005975_carbohydrate metabolism
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G0:0006631_fatty acid metabolism
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G0:0006112_energy reserv e  metabolism
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Figure 7 .1 3  S e lec ted  GOBP term s  specif ic  to  m etab o lism  p r o c e s se s  d e tected  
by GSD analysis  o f  th e  Broccoli d a ta se t .  Heatmaps represent log median- 
centred MAS5 normalized data ranging in value from -2 (bright green) through 0 
(black) to 2 (bright red), and were created using correlation distance and average 
linkage. Values greater than 2 or less than -2 were set to 2 and -2 respectively. 
Black bars in the 'picketplots' below the heatmaps indicate categories of liposarcoma 
that each of the samples were classified histologically.
194
Chapter 7: Application of the GSD methodology to four microarray datasets
G0:0006955Jmmune resp o n se
PLEO
DD
MYX
WD
G0:0019883_antigen presentation, endogenous antigen
PLEO
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MYX
WD
Figure 7 .1 4  S e lected  GOBP term s  specif ic  to  im m un e r esp o n se  p r o c e sse s  
d etec ted  by GSD analysis  of th e  Broccoli d a ta se t .  Heatmaps represent log 
median-centred MAS5 normalized data ranging in value from -2 (bright green) 
through 0 (black) to 2 (bright red), and were created using correlation distance and 
average linkage. Values greater than 2 or less than -2 were set to 2 and -2 
respectively. Black bars in the 'picketplots' below the heatmaps indicate categories 
of liposarcoma that each of the samples were classified histologically.
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Figure 7 .1 5  G ene ex p ress io n  le v e ls  for th ree  b iom arker g e n e s . Figures show 
log MAS5 data for markers for (a) B-Cells, (b) proliferation and (c) adipocytes.
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7.3.4 Analysis of the Ivshina breast cancer dataset
The final microarray dataset on which the GSD methodology was tested was the 
Uppsala breast cancer cohort (Ivshina et al. 2006), which comprised of a total of 249 
samples. Using the Nottingham Grading System, which is based on microscopic 
evaluation of morphological and cytological aspects of tumour cells, each of the samples 
was classified in the original study into one of three grades. Grade 1 (Gl) samples 
comprised well-differentiated, slow-growing tumours; untreated patients with this grade 
of tumour have -95% 5-year survival rates. Grade 2 (G2) samples were moderately 
differentiated, while grade 3 (G3) samples were poorly differentiated, highly 
proliferative tumours, and untreated patients with these two grades of tumours have 5- 
year survival rates of -75%  and -50% respectively.
The authors showed that G2 tumours could be sub-classified into two categories 
depending on the similarity of their expression profiles to those of Gl and G3 samples. 
Using class prediction algorithms, they discovered a set of classifier genes which could 
accurately discriminate between the 68 Gl and 55 G3 samples. They used this gene set 
to classify the 126 G2 samples into 83 grade 2a (G2a or 1-like), and 43 grade 2b (G2b or 
3-like) samples based on the similarity of their expression profiles to the Gl and G3 
samples respectively. Subsequent survival analyses and studies of other clinical 
variables supported this discrimination, showing significant differences between the two 
new sub-classes.
GSD analysis was carried out on this dataset. The distribution of SD-SDM values 
observed for all the GOBP terms tested relative to the background distribution of SD- 
SDM values to which they were compared is displayed in Figure 7.16. A total of 50 
GOBP terms were found to be significant, as they exhibited FDR-corrected p-values of 
less that 0.01.
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Figure 7 .1 6  S e lectio n  o f GOBP term s in GSD a n a ly sis  o f th e  Ivsh ina  b reast  
can cer d a ta se t. Grey points represent log SD-SDM values observed for each of the 
GOBP terms tested. Encircled grey points represent those GOBP terms found to 
exhibit FDR-corrected p-values of less that 0.01. The red line indicates the median 
of the background distribution of SD-SDM values for each gene set size. Broken 
black lines indicate the median ± 2 standard deviations for the background 
distributions.
As was the case in the analysis of the GNF human tissue expression dataset, the p-values 
exhibited by the selected terms were very similar and a more precise ranking of these 
terms according to their significance could be achieved by using their Z-scores. Table 
7.4 shows the top twenty selected terms when ranked by their Z-scores.
As can be seen, the table is comprised entirely of GOBP terms representing two distinct 
biological themes: immune system and cell division processes. These themes make up 
the majority of GOBP terms selected, and the relationships between terms from either 
theme are displayed in Figure 7.17.
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Gene Ontology Biological Process Term Z-score
p-value
(FDR
corrected)
G0:0009607_response to biotic stimulus 21.1 0
G0:0006952_defense response 21.1 0
G0:0006955_immune response 20.9 0
G0:0051707_response to other organism 13.8 0
GO:0009613_response to pest, pathogen or parasite 13.8 0
G0:0007067_mitosis 11.6 0
G0:0000278_mitotic cell cycle 11.6 0
GO:0000087_M phase of mitotic cell cycle 11.4 0
G0:0006950_response to stress 11.1 0
GO:0000279_M phase 9.8 0
G0:0009605_response to external stimulus 9.7 0
G0:0009611_response to wounding 9.6 0
G0:0051301_cell division 8.8 0
G0:0007049_cell cycle 8.8 0
G0:0019882_antigen presentation 8.5 0
G0:0006954_inflammatory response 8 0
G0:0007017_microtubule-based process 7.7 0
G0:0006968_cellular defense response 7.3 0
G0:0030333_antigen processing 7.2 0
G0:0000819_sister chromatid segregation 7 0.008
Table 7 .4  Top 20 GOBP term s s e le c te d  by GSD an a ly sis  o f th e  Ivsh ina  
b reast can cer d a ta se t . Terms are ranked by Z-score values. Terms highlighted in 
blue represent those processes involved in functions in immunity processes, while 
those highlighted in red represent processes that take place during cell division.
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[Im m u n ity ]
defense mechanism (sensu Vertcbrata)
antigen presentation humoral immune defense response, response to virus[cel
to pest, pathogen or parasite [responsecel activation
to other organism response to to chemical stimulus
to abioticto biotic stimuiusi to external
to stimulus
“ T "■
[Cell d iv ision ]
mitosis
> t
M phase of mitotic cell cycle regulation of progression through cell cycle
1 X  J
sister chromatid segregation mitotic ce l cycle M phase regulation of cell cycle
\  1 ------------------------------ ^
chromosome segregation c e l cycle [ cell division regulation of cellular physiological process
___ —  ^ -a ^  ^^ _______________
celular physiological p rocess | regulation of cellular process I regulation of physiological process
cellular p rocess physiological p rocess regulation of biological process
biological _process
Figure 7 .1 7  D om inant b io lo g ica l th e m e s  o f GOBP term s s e le c te d  by GSD 
a n a ly s is  o f th e  Iv sh in a  d a ta se t . Nodes represent GOBP term s while the edges 
represent parent-child relationships between terms. Orange nodes represent terms 
selected by GSD analysis. Blue nodes represent term s that were tested but not 
selected. Grey nodes represent untested terms.
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Materials and Methods), and five terms were found to be significant, exhibiting I 
corrected p-values of less that 0.01 (see Table 7.6). All five terms represented mi 
and cell division processes, and had been selected in the GSD analysis.
These findings indicate that this biological theme of mitosis/cell division is likely 1 
relevant to the discrimination between low and high grade breast cancer samples 
investigate this, inspection of heatmaps of these GOBP terms specific to cell div 
processes was then carried out. Some of these heatmaps are displayed in Figure 
along with ‘picketplots’ that indicate which tumour grade each of the samples 
classified into in the original study using the Nottingham Grading System.
In the heatmaps of all the selected terms that represented mitosis/cell division proce 
two major clusters of samples could be observed. In every case, one of the clu 
appeared to include the majority of G1 samples, and the other appeared to includi 
majority of G3 samples. It can also be observed that much of the apparent inform; 
within these heatmaps involves genes exhibiting an expression pattern of d< 
regulation in most G1 samples, and up-regulation in most G3. This is biologi 
plausible, considering that G3 samples represent high-grade tumours which are i 
proliferative than the low-grade tumours represented by G1 samples; thus g 
involved in cell division processes may be expected to show higher levels of expres 
in G3 samples than in G1 samples.
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EGID Symbol Description GOBP terms
23397 BRRN1 barren homolog 1 (Drosophila)
G0:0016043_cell organization and biogenesis
G0:0007049_cell cycle
G0:0051301_cell division
G0:0007067_mitosis
G0:0000087 M phase of mitotic cell cycle
GO:0000279_M phase
G0:0000278_mitotic cell cycle
G0:0006996_organelle organization and biogenesis
G0:0051276_chromosome organization and biogenesis
G0:0007059_chromosome segregation
G0:0000819_sister chromatid segregation
G0:0000070_mitotic sister chromatid segregation
G0:0007076_mitotic chromosome condensation
G0:0030261_chromosome condensation
55143 CDCA8
cell division 
cycle 
associated 8
G0:0051301_cell division
4605 MYBL2
v-myb 
myeloblastosis 
viral oncogene 
homolog 
(avian)-like 2
G0:0006366_transcription from RNA polymerase II 
promoter
G0:0006915 apoptosis
G0:0016265_death
G0:0012501 programmed cell death
G0:0008219_cell death
G0:0042981_regulation of apoptosis
G0:0043067_regulation of programmed cell death
G0:0048519_negative regulation of biological process
G0:0043118_negative regulation of physiological
process
G0:0048523_negative regulation of cellular process 
G0:0007049_cell cycle 
G0:0051726_regulation of cell cycle 
G0:0051243_negative regulation of cellular 
physiological process
G0:0000074_regulation of progression through cell 
cycle
G0:0006916_anti-apoptosis 
G0:0043066_negative regulation of apoptosis 
G0:0043069_negative regulation of programmed cell 
death
2354 FOSB
FBJ murine 
osteosarcoma 
viral oncogene 
homolog B
G0:0006366_transcription from RNA polymerase II 
promoter
G0:0007610_behavior
G0:0048519_negative regulation of biological process 
G0:0043118_negative regulation of physiological 
process
G0:0048523_negative regulation of cellular process
G0:0007049 cell cycle
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G0:0051726_regulation of cell cycle 
G0:0051243_negative regulation of cellular 
physiological process
G0:0000074_regulation of progression through cell 
cycle
G0:0016481_negative regulation of transcription 
G0:0045934_negative regulation of nucleobase, 
nucleoside, nucleotide and nucleic acid metabolism 
G0:0009892_negative regulation of metabolism 
G0:0031324_negative regulation of cellular metabolism 
G0:0006357_regulation of transcription from RNA 
polymerase II promoter
G0:0045892_negative regulation of transcription, DNA- 
dependent
G0:0000122_negative regulation of transcription from 
RNA polymerase II promoter
6790 AURKA aurora kinase A
G0:0006468_protein amino acid phosphorylation 
G0:0006796_phosphate metabolism 
G0:0016310_phosphorylation 
G0:0043412_biopolymer modification 
G0:0006793_phosphorus metabolism 
G0:0006464_protein modification 
G0:0016043_cell organization and biogenesis 
G0:0007242_intracellular signaling cascade 
G0:0007049_cell cycle 
G0:0007067_mitosis 
G0:0000087 M phase of mitotic cell cycle 
GO:0000279_M phase 
G0:0000278_mitotic cell cycle
G0:0007010_cytoskeleton organization and biogenesis 
G0:0006996_organelle organization and biogenesis 
GO:0019932_second-messenger-mediated signalling 
G0:0048015_phosphoinositide-mediated signalling 
G0:0007017_microtubule-based process 
G0:0007051_spindle organization and biogenesis 
G0:0000226_microtubule cytoskeleton organization and 
biogenesis
G0:0031647_regulation of protein stability
1062 CENPE
centromere 
protein E, 
312kDa
G0:0016043_cell organization and biogenesis
G0:0007049_cell cycle
G0:0051641_cellular localization
G0:0051649_establishment of cellular localization
G0:0046907_intracellular transport
G0:0051301_cell division
G0:0007067_mitosis
G0.0000087 M phase of mitotic cell cycle
GO:0000279_M phase
G0:0000278_mitotic cell cycle
G0:0007010_cytoskeleton organization and biogenesis 
G0:0006996 organelle organization and biogenesis
203
Chapter 7: Application of the GSD methodology to four microarray datasets
G0:0051276_chromosome organization and biogenesis 
G0:0006461_protein complex assembly 
G0:0007059_chromosome segregation 
G0:0007017_microtubule-based process 
G0:0051640_organelle localization 
G0:0051656_establishment of organelle localization 
G0:0007018_microtubule-based movement 
G0:0030705_cytoskeleton-dependent intracellular 
transport
G0:0000819_sister chromatid segregation 
G0:0000070_mitotic sister chromatid segregation
7272 TTK TTK protein kinase
G0:0006468_protein amino acid phosphorylation 
G0:0006796_phosphate metabolism 
G0:0016310_phosphorylation 
G0:0043412_biopolymer modification 
G0:0006793_phosphorus metabolism 
G0:0006464_protein modification 
G0:0008283_cell proliferation 
G0:0016043_cell organization and biogenesis 
G0:0048518_positive regulation of biological process 
G0:0043119_positive regulation of physiological 
process
G0:0048522_positive regulation of cellular process 
G0:0051242_positive regulation of cellular physiological 
process
G0:0008284_positive regulation of cell proliferation 
G0:0042127_regulation of cell proliferation
G0:0007049_cell cycle 
G0:0051726_regulation of cell cycle 
G0:0000074_regulation of progression through cell 
cycle
GO:0007067_m itosis 
G0:0000087 M phase of mitotic cell cycle 
GO:0000279_M phase 
G0:0000278_mitotic cell cycle
G0:0007010_cytoskeleton organization and biogenesis 
G0:0006996_organelle organization and biogenesis 
G0:0007017_microtubule-based process 
G0:0007052_mitotic spindle organization and 
biogenesis
G0:0007051_spindle organization and biogenesis 
G0:0000226_microtubule cytoskeleton organization and 
biogenesis
G0:0007088_regulation of mitosis 
G0:0000075_cell cycle checkpoint 
G0:0007093_mitotic checkpoint
57758 SCUBE2
signal peptide, 
CUB domain, 
EGF-like 2
NA
2353 FOS v-fos FBJ
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murine 
osteosarcoma 
viral oncogene 
homolog
G0:0043412_biopolymer modification 
GO:0006259_DNA metabolism 
G0:0006950_response to stress 
G0:0006366_transcription from RNA polymerase II 
promoter
G0:0006954_inflammatory response 
G0:0009605_response to external stimulus 
G0:0009611_response to wounding 
G0:0051707_response to other organism 
G0:0006952_defense response 
G0:0006955_immune response 
G0:0009607_response to biotic stimulus 
GO:0009613_response to pest, pathogen or parasite 
G0:0006357_regulation of transcription from RNA 
polymerase II promoter 
G0:0043414_biopolymer methylation 
G0:0006304 DNA modification 
G0:0006306 DNA methylation 
GO:0006305_DNA alkylation
G0:0040029_regulation of gene expression, epigenetic
22974 TPX2
TPX2,
microtubule-
associated,
homolog
(Xenopus
laevis)
G0:0008283_cell proliferation
G0:0007049_cell cycle
G0:0007067_mitosis
G0.0000087 M phase of mitotic cell cycle
GO:0000279_M phase
G0:0000278_mitotic cell cycle
2305 FOXM1 forkhead box M1
G0:0042221_response to chemical stimulus 
G0:0006950_response to stress 
G0:0009628_response to abiotic stimulus 
G0:0006366_transcription from RNA polymerase II 
promoter
G0:0006979_response to oxidative stress 
G0:0006800_oxygen and reactive oxygen species 
metabolism
9833 MELK
maternal 
embryonic 
leucine zipper 
kinase
G0:0006468_protein amino acid phosphorylation 
G0:0006796_phosphate metabolism 
GO:0016310_phosphorylation 
G0:0043412_biopolymer modification 
G0:0006793_phosphorus metabolism 
G0:0006464_protein modification
83461 CDCA3
cell division 
cycle 
associated 3
NA
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Table 7 .5  Classifier g en es  that differentiate betw een G1 and G3 breast 
cancer sam ples. This was created using the PAM and SWS class prediction 
algorithm in the original study by Ivshina e t al. Of the original 18 genes, only those 
13 are shown that are represented on the h gu l33a  platform. Only those GOBP 
term s are shown that were tested  during the GSD analysis. Terms highlighted in red 
indicate those selected  by GSD analysis of this dataset.
GOBP term Hypergeometric p-value 
(FDR corrected)
G0:0007067_mitosis 0.00026
GO:0000087_M phase of mitotic cell cycle 0.00026
GO:0000279_M phase 0.00053
G0:0000278_mitotic cell cycle 0.00053
G0:0007049_cell cycle 0.00054
Table 7 .6  GOBP term s found to  be enriched in th e classifier gen e  set. ORA
analysis of the gene se t shown in Table 7 .5  was carried out using the 
hypergeometric test. Terms displayed are those that were found to have FDR- 
corrected p-values of less than 0 .01 .
The heatmaps also indicate that the G2 samples do not appear to show any tendency to 
cluster separately from samples representing other tumour grades: they show apparently 
random ordering within each of the two major clusters. In the original study, the 
classifier gene set that could discriminate between G1 and G3 samples was used by the 
authors to stratify G2 samples into two groups: G2a (Gl-like) and G2b (G3-like). Also, 
in the original study, ORA analysis of genes found to be differentially expressed 
between G2a and G2b samples detected enrichment of terms specific to cell division and 
cell cycle processes. It was therefore investigated whether the mitosis/cell division terms 
selected by GSD analysis could also stratify G2 samples.
206
i
Chapter 7: Application of the GSD methodology to four microarray datasets
G0:0007067 m itosis
Grade 3 
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G0:0051301 cell division
Grade 3 I I I  I I  I I HU I
Grade 2 mi ii iii iii i i i i i  ii i i n i  ill i i ii ii in it i i i  iiiiii ii i i  ii ni 
Grade 1 I l l l l l l l l  I I I I  I II  Mil  I I  III IIII II I II I I  I I I II II 11
207
28
Chapter 7: Application of the GSD methodology to four microarray datasets
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Figure 7 .1 8  S e le c ted  GOBP term s sp ec ific  to  cell d ivision  p r o c e sse s  
d etected  by GSD a n a ly sis  o f th e  Ivsh ina  B reast Cancer d a ta se t. Heatmaps 
represent log median-centred MAS5 normalized data ranging in value from -2 
(bright green) through 0 (black) to 2 (bright red), and were created using 
correlation distance and average linkage. Values greater than 2 and less than -2 
were set to 2 and -2 respectively. Black bars in the 'picketplots' below the heatmaps 
indicate the tumour grade in which each of the samples was classified in the original 
study using the Nottingham Grading System for breast cancers.
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For this purpose, the positions of samples that were classified in the original study as 
G2a and G2b, within the hierarchical clustering of samples produced for each of the 
mitosis/cell division terms selected by GSD analysis, were investigated. To illustrate 
this, displayed in Figure 7.19 are the cluster dendrograms from the heatmaps for some of 
these terms, along with picketplots supplemented with information regarding which 
samples were classified as G2a and G2b in the original study.
As can be seen in Figure 7.19, the clustering of G2 samples appears to be in concord 
with the sub-classes assigned in the original study: most G2a samples appear to be 
interspersed within the cluster that is also contains the majority of G1 samples. 
Similarly, most G2b samples are found interspersed within the cluster that includes the 
majority of G3 samples.
To statistically assess the enrichment of tumour grades within these clusters, the number 
of samples of each tumour grade within each of the first two hierarchical clusters 
exhibited by each of the cell division specific GOBP terms was counted. Tests were 
then carried out, to detect over-representation of each tumour grade within that cluster 
where the majority of samples for that grade were found, using the hypergeometric 
statistical test (see Materials and Methods).
These results are displayed in Table 7.7. In every case there is highly significant 
enrichment of tumour grades within the respective clusters. These findings imply that 
the grouping of tumour grades, as provided by hierarchical clustering for these terms, is 
non-random and unlikely to have occurred by chance. This then highlights the 
importance of the biological theme in the differentiation between low (G1 and G2a) and 
high (G2b and G3) grade breast cancer samples.
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Figure 7 .19  Stratification of Grade 2 breast cancer sam ples by hierarchical 
clustering using GOBP term s specific to  m itosis /ce ll division processes.
Figures display dendrograms representing hierarchical clusters of sam ples classes. 
Also displayed are picketplots where the tumour grade of each sample is indicated 
by the presence of coloured bars. Black bars indicate tumour grades G l, G2 and G3, 
which were assigned to sam ples in the original study through morphological and 
cytological a ssessm en ts using the Nottingham Grading System . Coloured bars 
indicate sub-classes of G2 sam ples that were discovered de novo in the original 
study using a gene set created using class discovery techniques.
Patient survival data was also available for each sample within the dataset, and in the 
original study this was used to display the highly significant difference in survival rates 
between patients with different grades of tumours. Assessment of the difference in 
survival rates between patients with tumours classified in the original study as either G1 
or G2a and those with G3 or G2b tumours using the Cox proportional-hazards regression 
model (see Materials and Methods) yielded a highly significant p-value of 2.1e-06.
To investigate if the relevance of the biological theme of cell division within this 
experiment could be reflected in patient survival rates, the following analysis was 
carried out: for each of the cell division specific GOBP terms selected by the GSD 
analysis of the dataset, two groups of samples were created by selecting the first two 
hierarchical clusters (as was done in the explorations displayed in Table 7.7).
The difference in survival rates of patients represented by the samples in each of the two 
groups was then assessed using the Cox proportional-hazards regression model. Kaplan- 
Meier survival curves are plotted for the two groups of samples created for each of the 
GOBP terms in Figure 7.20, along with the survival curves for the groups of samples 
based on tumour grades assigned in the original study.
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Gene Ontology Biological Process Term
Cluster A Cluster B
G1 G2a G3 G2b
G0:0007067_mitosis 79.4%
(1.3e-08)
75.9%
(1e-08)
90.9%
(3e-13)
90.7%
(5e-10)
G0:0000278_mitotic cell cycle 82.4%
(8.1e-09)
81.9%
(6.4e-11)
94.5%
(1.7e-17)
86%
(5.5e-09)
GO:0000087_M phase of mitotic cell cycle 77.9%
(2e-08)
77.1%
(3.6e-10)
92.7%
(7.7e-14)
95.3%
(5.1e-12)
G0.0000279_M phase 79.4%
(8.7e-09)
74.7%
(3.1e-08)
90.9%
(4.9e-13)
90.7%
(7.1e-10)
G0:0051301_cell division 89.7%
(1.9e-09)
91.6%
(1.4e-13)
90.9%
(1e-19)
76.7%
(3.5e-08)
G0:0007049_cell cycle 91.2%
(1.2e-11)
88%
(4.3e-12)
90.9%
(5.3e-18)
86%
(4.5e-11)
G0:0051726_regulation of cell cycle 82.4%
(3.2e-10)
74.7%
(5.1e-08)
94.5%
(7.8e-16)
88.4%
(5.8e-09)
G0:0000074_regulation of progression 
through cell cycle
85.3%
(3.7e-11)
74.7%
(3.4e-07)
92.7%
(2.2e-15)
86%
(1.5e-08)
G0:0000819_sister chromatid segregation 80.9%
(3.1e-08)
84.3%
(5.6e-13)
96.4%
(8.4e-19)
88.4%
(7.4e-10)
G0:0007018_microtubule-based movement 79.4%
(3.2e-08)
77.1%
(5.5e-09)
89.1%
(1.7e-12)
90.7%
(2.5e-10)
Table 7 .7  Enrichment of tum our grades within hierarchical clusters of 
sam ples created by GOBP term s specific to  cell division processes.
Hierarchical clustering of sam ples was carried out using correlation distance and 
average linkage for each of the gene se ts  representing GOBP term s specific to cell 
division processes that were selected  by GSD analysis of the Ivshina breast cancer 
datasets. Sam ples were then divided by selecting the first two hierarchical clusters 
(Clusters A and B) for each gene set separately. Figures indicate the percentage of 
sam ples of the dominant tumour grades within those clusters. Also displayed are 
hypergeometric p-values calculated to a sse ss  the enrichment of the tumour grades 
within those clusters.
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Figure 7 .2 0  Survival curves for p a tien ts  stratified  by h ierarchical c lusterin g  
of sa m p les  using g e n e  s e t s  sp ec ific  to  cell d iv ision  p r o c e sse s . Hierarchical 
clustering of samples was carried out using correlation distance and average linkage 
for each of the gene sets representing GOBP terms specific to cell division processes 
that were selected by GSD analysis of the Ivshina breast cancer datasets. Broken 
survival curves represent patients grouped in each of the firs t two hierarchical 
clusters for each gene set. Solid curves represent groups of patients created 
according to tumour grades assigned in the original study. P-values in the top right 
corner indicate the significance of the difference in survival rates of cluster-based 
groups of patients, using the Cox proportional-hazard regression model.
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As can be observed, there is considerable difference in survival rates of patients 
represented in each of the clusters; assessment of the statistical significance of these 
differences yields highly significant p-values for all tested gene sets.
Thus, the results of the implementation of the GSD methodology on this dataset are in 
concord with the findings of the original study on two major aspects: The first is that the 
GOBP terms selected by the analysis include many that are specific to cell division 
processes, which was found in the original study to be the most important biological 
theme with regard to discrimination between high and low grades of tumour.
The second is the finding in the original study that there is no apparent continuum of 
gene expression levels in G2 samples as they progress from G1 to G3 stages; rather G2 
samples appear to comprise at least two distinct molecular sub-classes, G2a and G2b, 
depending on the similarity of their gene expression profiles to those of G1 and G3 
samples respectively. This is supported by the findings that when the hierarchical 
clustering of samples is carried out using GOBP terms specific to cell division 
processes, there is a marked tendency for the majority of G1 and G2a samples to cluster 
together, and for the G2b and G3 samples to cluster together. This is further supported 
by survival analyses carried out both here and in the original study.
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7.4 Discussion
The previous chapter described explorations leading to the development of the GSD 
methodology using hypothetical gene expression matrices, randomly selected gene sets 
and artificially imposed information. This chapter then described the results of the 
application of the methodology to the analysis of four microarray datasets using gene 
sets based on GOBP terms. Assessment of a methodology like GSD, which is 
essentially exploratory in nature, is problematic as there is no known ‘truth’ regarding 
these datasets. It was thus hoped that some indication of the accuracy and reliability of 
results could be achieved by investigating whether the results of the analyses were 
biologically plausible and/or they were in agreement with the results of prior analyses of 
these datasets using other methodologies.
7.4.1 Overview of results
The GNF human tissue expression dataset (Su et al. 2004), which was used in Chapter 5 
to explore tissue-specific gene expression patterns was selected for analysis using GSD 
because it contains strong tissue-specific expression signatures that lead to clustering of 
samples based on tissue types. Inspection of the GOBP terms selected by GSD analysis 
of this dataset revealed considerable numbers of terms specific to immune and nervous 
system processes. These results most likely reflect the observation that tissues specific to 
these processes comprise the two largest groups of tissues of similar origin and/or 
function.
The next three datasets analyzed involved samples from cancer patients: this was 
because it is expected that the ability of the GSD methodology to identify potentially 
relevant biological themes within a dataset without requiring prior definition of sample 
classes could be of utility particularly in the analysis if cancer datasets where sample 
classes may not be known, or where the samples are difficult to classify.
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GSD analysis of the Ross AML dataset (Ross et al. 2004) resulted in selection of many 
immunity-specific GOBP terms, consistent with the biological nature of the samples 
(mononuclear cells that involved in immunity functions). Inspection of the heatmaps of 
the selected GOBP terms revealed gene expression patterns that resulted in groupings of 
samples that agreed with the five different known genetic sub-types of AML represented 
within the dataset.
Next, GSD was applied to a liposarcoma dataset provided by a collaborator at the 
Memorial University Medical Centre. Two out of the three major biological themes 
selected by GSD for this dataset are biologically plausible in the context of the tumour 
grades of the samples: genes comprising the mitosis/cell division theme exhibited 
expression patterns of up-regulation in the high-grade tumour samples and down- 
regulation in the low-grade samples. The opposite pattern was exhibited by genes 
comprising the lipid metabolism theme. The third theme, that of immunity, is likely to 
have been selected as a consequence of the possible presence of cells involved in the 
immune system within the samples.
Finally, GSD analysis of the Ivshina breast cancer dataset (Ivshina et al. 2006) revealed 
at least two major biological themes. One of these was cell division; this finding is 
biologically plausible (as high-grade tumours are typically more proliferative than low- 
grade tumours) and in agreement with the results of more supervised analyses carried 
out in the original study that took into account the histological grades of the samples. 
Further analyses carried out appear to highlight the importance of discovering relevant 
biological themes within a dataset — simple hierarchical clustering of samples using the 
GOBP terms specific to cell division could differentiate between patients into groups 
with statistically significant differences in survival rates.
Thus it is found that the GSD methodology can provide plausible and useable results. 
The potential utility of this technique is further discussed in Chapter 9.
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7.4.2 Genes and expression patterns shared by selected gene sets
Having identified the possibly relevant biological themes within a dataset (which may 
have been achieved by GSD or any other gene set analysis method), there are at least 
two issues that need to be addressed in order to help researchers further analyze these 
results.
The first of these is that, as can be observed in heatmaps of most selected gene sets, 
much of the information is restricted to only a proportion of genes within a gene set, i.e. 
only a sub-set of genes are DEGs. This then raises the need for a methodology to 
identify these informative genes within the selected gene sets.
The second issue is that of comparison of gene expression patterns within the selected 
gene sets: a researcher would be interested in knowing all the different types of 
information that are represented by the selected gene sets. Some gene sets may exhibit 
the same type of information as each other i.e. they could contain expression patterns 
that result in similar hierarchical clusters of samples. This may be because they represent 
similar biological themes and share many genes (for example, as would be seen for GO 
terms that share parent-child relationships). More interestingly, these may represent 
disparate biological processes (and thus do not share genes) but are affected in the same 
way by the experimental conditions.
The next chapter describes explorations to resolve both these issues. It first describes a 
methodology that could allow for ranking (and subsequent selection) of genes based on 
their information content. It then describes the implementation of a scheme that allows 
for simultaneous visualization of all gene expression patterns exhibited by all selected 
gene sets, indication of which patterns are exhibited by which gene sets, and the 
relationships between the gene sets (based on shared genes).
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Chapter 8: E xtraction  o f inform ative genes 
and v isu a lization  o f  GSD resu lts
8.1 Introduction
Chapter 6 described the development of GSD, a methodology that could identify 
potentially relevant biological themes within a microarray dataset. Chapter 7 then 
described the application of this methodology to four microarray datasets.
Visual inspection of heatmaps of gene sets selected by GSD analysis showed that in 
many cases much of the information within a gene set appeared to be contained in the 
expression values for only a subset of the genes. Ostensibly, only these ‘informative 
genes’ would be of interest to the researcher and this then raises the need for a 
methodology for extraction of these genes from within a heatmap.
One of the key differences between the GSD methodology and other gene set analysis 
methods is that it is unsupervised in terms of the relationship between expression 
patterns and classes. Typically, supervised gene set analyses of a datasets utilizing prior 
knowledge of sample classes would involve identification of gene sets that exhibit a 
single expression pattern (for example, differential expression between tumour and 
normal tissue). In contrast, GSD analysis attempts to identify those gene sets that exhibit 
significantly strong expression patterns, regardless of what the expression pattern is, and 
it is possible that gene sets identified by GSD analysis could exhibit several different 
expression patterns. This raises the need for identification and comparison of the 
expression patterns exhibited by gene sets selected by GSD analysis.
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This chapter describes the development of a methodology that attempts to identify 
informative genes within selected gene sets. It then describes the results of the 
application of this methodology to the gene sets selected by GSD analysis of the four 
datasets described in Chapter 7.
Also described is the implementation of a strategy for visualization of the results of GSD 
analysis that can present the results, together with information that is likely to be of 
interest to researchers, in an integrated format. This allows for simultaneous 
visualization of the different gene expression patterns exhibited by the selected genes, 
indication of which gene sets each of the selected genes belongs to, and the relationships 
between the gene sets (based on shared genes).
220
Chapter 8: Extraction of informative genes and visualization of GSD results
8.2 Results and Explorations
8.2.1 Quantifying the prevalence of an expression pattern
The information content of any gene expression matrix is typically limited to groups of 
genes that exhibit very similar expression patterns. The consistency of these expression 
patterns leads to strong clustering of samples, which in turn leads to the selection of the 
gene set by the GSD methodology.
The hierarchical clustering of genes within a heatmap requires the calculation of 
distances between each possible pair of genes to yield a gene distance matrix (similar to 
the sample distance matrix used in the hierarchical clustering of samples, which is 
utilized by the GSD methodology). As these distances quantify the similarity between 
the expression profiles of any pair of genes, it was reasoned that they could be used to 
identify informative genes, i.e. those that share expression patterns with many other 
genes in that gene set.
Each row and column of a gene distance matrix consists of a vector of values of 
distances of any one gene to all other genes in that gene set. It was hypothesised that the 
variability of this distribution of distances of one gene to all others could indicate how 
informative a gene is. The reasoning behind this is similar to that of the use of SD-SDM 
values in GSD analysis: if the expression pattern of a gene is shared by many other 
genes, then the distance distribution for that gene would contain higher levels of short 
distances (to genes with similar expression patterns) and long distances (to genes 
exhibiting dissimilar or even opposite expression patterns) as compared to the distance 
distributions of genes that exhibit random expression patterns (i.e. uninformative genes).
To test this hypothesis, a hypothetical gene expression matrix consisting of 30 samples 
and 500 genes was created by randomly selection from a normal distribution with a zero 
mean and standard deviation of 0.3 (similar to the scheme used in Chapter 6 — see
Chapter 8: Extraction of informative genes and visualization of GSD results
Materials and Methods). 200 genes were then randomly selected to exhibit an expression 
pattern of up-regulation, down-regulation and no change in 10 samples each. Another 50 
genes were randomly selected to exhibit a different pattern of expression. Correlation 
distances were than calculated for every possible pair of genes. The standard deviation 
of the gene distance vectors (SD-GDV) were then recorded for each of the genes. Figure 
8.1 shows the heatmap of this matrix, along with SD-GDV values for each of the genes.
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Figure 8 .1  H eatm ap of a h yp oth etica l g e n e  ex p ress io n  m atrix w ith  
artificially in troduced  inform ation co n ten t. The heatmap represents log 
median-centred gene expression values ranging from -2 (bright green) through 0 
(black) to 2 (bright red). Hierarchical clustering of genes and samples was carried 
out using correlation distance and average linkage. Also displayed is a plot of SD- 
GDV values for each of the genes at the ir respective positions within the heatmap.
222
Chapter 8: Extraction of informative genes and visualization of GSD results
Two observations can be made: firstly, SD-GDV values for genes into which 
information was experimentally introduced are higher than for the other genes. 
Secondly, the SD-GDV values for the informative genes are greater when the expression 
pattern is shared by a greater number of genes: the SD-GDV values for each of the 
larger set (n=200) of informative genes is 0.55, while that of each of the smaller set 
(n=15) of informative genes is 0.45. The median SD-GDV for all other genes is 0.16. 
The distance distributions for each of these sets of genes are displayed in Figure 8.2.
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Figure 8 .2  G ene d ista n ce  d istr ib u tion s for in form ative and uninform ative  
g e n e s . Curves represent gene distance distributions for the gene expression matrix 
represented in Figure 8.1. Broken vertical line represents the median gene distance 
for all pairs of genes.
These results suggest that SD-GDV values may be used to quantify how informative a 
gene is, and thus possibly allow for the extraction of informative genes from within gene 
sets.
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To investigate if similar results could be obtained from ‘real-world’ data, the GO term 
for mitosis, which was found to be highly significant in GSD analysis of the Ivshina 
breast cancer dataset was used. The heatmap for this term is displayed in Figure 8.3, 
along with the SD-GDV values calculated for each of the genes.
*«&&&* . . .  I 1 .f- mi i  ~ 4 .1 * . ,1 .  i. m „  ,,
K »■ Hj v*. i f  *.rr* /  -ft. * f. qVt
— i— i— i— i— r 
0.10 0.20 0.30
SD-GDV values
Figure 8 .3  Heatm ap of th e  term  G 0 :0 0 0 7 0 6 7  (m ito s is )  on th e  Ivshina  
breast cancer d a ta se t .  The heatmap represents log median-centred gene 
expression values ranging from -2 (bright green) through 0 (black) to 2 (bright 
red). Hierarchical clustering of genes and samples was carried out using correlation 
distance and average linkage. Also displayed is a plot of SD-GDV values for each of 
the genes at the ir respective positions within the heatmap.
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Again, it is observed that there is a tendency for SD-GDV values to be higher in those 
genes that are visually informative, as compared to those that are not. For these reasons, 
SD-GDV values were presumed to be suitable for the purpose of extracting informative 
genes from within gene sets; the next section describes the implementation of this 
technique on the GSD results of datasets analyzed in Chapter 7.
8.2.2 Extraction of informative genes using SD-GDV values
The extraction of informative genes from within gene sets selected by GSD analyses was 
implemented using a ‘global’ strategy in order to capture relationships between genes (in 
terms of their expression patterns) across the different gene sets.
Thus SD-GDV values were calculated for genes of all gene sets selected by GSD 
analysis of a microarray dataset taken together (that is, the SD-GDV value was 
calculated for each gene using a vector of distances of that gene to all other genes from 
all gene sets selected by GSD). This was performed for each of the four microarray 
datasets described in Chapter 7. In each case, the genes were ranked in decreasing order 
of their respective SD-GDV values, and then grouped into quintiles (such that the first 
quintile comprised of 20% of the genes with the highest SD-GDV values). The heatmaps 
for each of these quintiles is displayed in Figure 8.4.
As can be observed, there appears to be a gradient of information in the quintile 
heatmaps: the proportion of genes that are informative (i.e. show consistent and strong 
expression patterns) appears to be highest in the first quintiles. This proportion decreases 
in successive quintiles till there are few or no apparent informative genes in the fifth 
quintiles.
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GNF human tissue 
expression dataset
Ross AML 
dataset
Ivshina breast 
cancer dataset
Broccoli liposarcoma 
dataset
Quintile 1 Quintile 1 Quintile 1 Quintile 1
Quintile 2 Quintile 2 Quintile 2 Quintile 2
p a r
Quintile 3 Quintile 3 Quintile 3 Quintile 3
Quintile 4Quintile 4 Quintile 4 Quintile 4
Quintile 5Quintile 5Quintile 5 Quintile 5
Figure 8 .4  Quintile h ea tm ap s  of g e n e s  from all g e n e  s e t s  se le c te d  by GSD 
analys is  ranked by SD-GDV v a lu es .  Heatmaps represent log median-centred 
gene expression values ranging from -2 (bright green) through 0 (black) to 2 
(bright red). Hierarchical clustering of genes and samples was carried out using 
correlation distance and average linkage.
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Figure 8.5 shows the distributions of distances between all pairs of genes for each of the 
quintiles. There is a marked decrease in the variability of the distributions moving from 
the first to the last quintiles implying that the strength of gene clustering is highest in the 
first quintile, and decreases with each successive quintile. Figure 8.6 shows the 
distributions of distances between all pairs of samples for each of the quintiles. Here, a 
noticeable decrease in the variability of the distances can be observed, moving from the 
first to the fifth quintiles. These indicate that clustering of samples is strongest in the 
first quintile, and this decreases with each successive quintile.
Thus, ranking of genes according to their SD-GDV values appears to result in the 
enrichment of informative genes at the top of the order. The issue then arises regarding 
cut-off SD-GDV values that would need to be set to extract the most informative genes 
for each dataset. It is apparent (as might be expected) that the number of informative 
genes varies across datasets. While the vast majority of informative genes appear to be 
contained within the first two quintiles for the cancer datasets, informative genes can be 
observed as far as the fourth quintile for the GNF tissue expression dataset (because 
large numbers of genes exhibit tissue-specific expression patterns).
As ‘customized’ extraction of informative genes for each of the datasets is subject to 
possible user bias, an arbitrary selection of the top 20% of genes (i.e. the first quintile) 
when ranked by SD-GDV values was implemented for each of the datasets in the 
subsequent explorations.
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(a) GNF gene distances
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(c) Ivshina gene distances
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Figure 8 .5  Gene d istan ce  d istr ibutions of g e n e  quintiles. Distributions 
represent distances between all possible pairs of genes for each o f the quintiles 
displayed in Figure 8.4. Variability of the distributions (measured as standard 
deviation) is indicated in the figure keys.
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(a) GNF sample distances
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(c) I v s h in a  s a m p l e  d i s t a n c e s
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Figure  8 .6  S a m p l e  d i s t a n c e  d i s t r i b u t i o n s  of  g e n e  qu in t i l e s .  Distributions 
represent distances between all possible pairs of samples for each of the quintiles 
displayed in Figure 8.4. Variability of the distributions (measured as standard 
deviation) is indicated in the figure keys.
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8.2.3 Visualization of the results of GSD analysis
Having identified possible relevant biological themes and extracted potentially 
informative genes by implementing the GSD methodology on three public datasets, 
efforts then focussed on how these results could be presented to a researcher in a format 
that could integrate all the different types of information.
Visualization of the different expression patterns prevalent in the dataset could be 
achieved by way of heatmaps of all the informative genes, as these involve hierarchical 
clustering of genes and samples according to their expression patterns. In a similar 
approach to the use of picketplots to indicate sample classes (for example, as used with 
the heatmaps in Chapter 7), a gene-based picketplot was used to show the links between 
each genes and their corresponding annotation metadata (i.e. GOBP terms). Hierarchical 
clustering of the terms could be carried out according to the genes shared by them and 
ordered accordingly in the gene picketplot (see Materials and Methods). The 
relationships between the terms as identified by the hierarchical clustering could be 
visualized using dendrograms.
8.2.3.1 Results o f  GSD analysis o f  the GNF human tissue expression dataset
The 51 GOBP terms selected by GSD analysis of the GNF human tissue expression 
dataset comprised of a total of 4123 genes. All possible pair-wise distances between 
these genes were calculated. An SD-GDV value was derived for each gene using the 
vector of distances of that gene to all other genes. Genes were then ranked in decreasing 
order of their SD-GDV values and the first quintile (which consisted of 825 genes) was 
selected for visualization.
The visualization of these genes based on the scheme described above is shown in 
Figure 8.7.
232
Chapter 8: Extraction of informative genes and visualization of GSD results
r
GO:0019882_antigen presentation 
G0:0019883_antigen presentation, endogenous antigen 
G0:0030333 antigen processing 
G0:0000398_nuclear mRNA splicing, via spliceosome 
G 0 :0016071 _m R N A m etabolism 
G0:0006412_protein biosynthesis 
G0:0044249_cellular biosynthesis 
G 0 :0009058_biosynthesis 
GO:0007155 cell adhesion 
GO: 0030154_ceirdifferentiation 
G0:0048468 cell development 
G 0 :00074U9_axonogenesis 
G0:0031175_neurite morphogenesis 
G0:0048666_neuron development 
GO:0030182_neuron differentiation 
G0:0048699_neurogenesis 
GO:0007417 central nervous system development 
G 0 :0tJ07399_nervous system development 
G0:0048731 system development 
GO:0006813_p6tassium ion transport 
G 0 :0006811 Jon  transport 
G 0 :0030001 m etal ion transport 
G 0 :00066T 2_cation transport 
G 0 :0050877_neurophysiological process 
G 0 :0007267_cell-cell signaling 
G0:0007268_synaptic transmission 
GO:0019226Jransmission of nerve impulse
Figure 8 .7  GSD analysis  of th e  GNF hum an t is su e  exp ress ion  d ataset.
Heatmap represents log median-centred gene expression values ranging from -2 
(bright green) through 0 (black) to 2 (bright red). Black and blue cells in the 
picketplots indicate the presence of samples and genes within corresponding sample 
classes and gene sets respectively, while white cells indicate their absence. All 
hierarchical clustering was carried out using correlation distance and average 
linkage. For ease of visualization, some GOBP terms that are very sim ilar to others 
have not been displayed, as have GOBP terms represented by less than 5 genes in 
the heatmap.
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As can be observed, the heatmap exhibits expression patterns that are primarily based on 
groups of similar tissues, and the hierarchical clustering of samples has resulted in 
strong discrimination between these groups. The most visually striking patterns are 
exhibited in samples that from the Blood/Immune or Brain/Neuronal groups, which are 
the two largest groups of similar tissues within the dataset.
There appear to be two major clusters of genes: the first of which exhibit up-regulation 
in the Blood/Immune samples and down-regulation in the Brain/Neuronal samples. This 
cluster appears to comprise primarily of genes of a few biological themes: immune 
system processes, mRNA metabolism and cellular biosynthesis. The second cluster 
comprises of genes that exhibit down-regulation in the Blood/Immune samples. Within 
this cluster, there a well-defined sub-cluster of genes that exhibit up-regulation within 
the Brain/Neuronal samples. These appear to be genes that primarily represent biological 
themes such as nervous system development, synaptic transmission and ion transport.
Thus it is found that the GSD methodology allows for mining of relevant information 
from within this dataset and visualization scheme can display this information in an 
integrated format. Consider analysis of the results of implementing the GSD 
methodology on this dataset without prior knowledge regarding the tissues that these 
samples represent. Having extracted a set of informative genes and created a heatmap of 
these, the first discovery would be that there are at least two major groups of samples 
that show very similar expression patterns (and could thus be from similar tissue-types). 
The second discovery would involve insight into the nature of these groups of similar 
samples by inspection of the biological themes represented in their expression patterns: 
the up-regulation of many genes involved in many nervous system processes in one of 
the sample groups hints at the neuronal origin of the samples. Similarly, links can be 
made between the immune system process genes that are up-regulated in the other group 
of similar samples, and the nature of the tissues they represent.
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8.2.3.2 Results o f  GSD analysis o f  the Ross AM L dataset
The 12 GOBP terms selected by GSD analysis of the Ross AML dataset comprised of a 
total of 1333 genes. All possible pair-wise distances between these genes were 
calculated. An SD-GDV value was derived for each gene using the vector of distances of 
that gene to all other genes. Genes were then ranked in decreasing order of their SD- 
GDV values and the first quintile (which consisted of 267 genes) was selected for 
visualization. The visualization of these genes is shown in Figure 8.8.
As can be observed from the heatmap, there are several distinct gene expression 
patterns, and the combined effects of these is a hierarchical clustering of samples that 
correlates well with previously known samples classes, i.e. genetic sub-types of AML. 
The largest of the expression patterns exhibited (in terms of the number of genes 
involved) causes the first major grouping of genes into the two largest clusters. This 
expression pattern appears to be strongly influenced by the subtypes of AML 
represented by the samples, as can be evidenced from the enrichment of samples from 
certain sub-types within the two clusters: the first cluster (in which most of these genes 
exhibit down-regulation) comprises of all samples of t(l 5\\l)[PML-RARa] and FAB-M7 
subtypes, most of l(%\2\)[AMLl-ETO) samples and relatively few inv16[CBFfi-MYHl 1] 
and MLL samples. The second cluster (in which most of these genes exhibit up- 
regulation) consists of the majority of inv16[CBF$-MYH11] and MLL samples, and 
relatively few \(%\2\)[AMLl-ETO] samples.
The other smaller expression patterns also appear to vary in concordance with AML 
subtypes. These then allow for well-differentiated sub-clusters (within the first major 
cluster) of samples representing the t(\5\\l)[PML-RARa\, t(%\2\)[AMLl-ETO\, and 
FAB-M7 subtypes. While no expression patterns were found that could discriminate 
between the invJ6[CBFfi-MYHl 1] and MLL subtypes (in the second major cluster), this 
is likely to be a reflection of the molecular heterogeneity of these subtypes — which was 
suggested by the authors in the original study, where highly supervised techniques could 
not discover adequate differentiation between these two subtypes.
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Figure 8 .8  GSD an a lys is  o f  th e  R oss AML d a ta se t .  Heatmap represents log 
median-centred gene expression values ranging from -2 (bright green) through 0 
(black) to 2 (bright red). Black and blue cells in the picketplots indicate the 
presence of samples and genes w ithin corresponding sample classes and gene sets 
respectively, while white cells indicate the ir absence. All hierarchical clustering was 
carried out using correlation distance and average linkage. For ease of visualization, 
GOBP terms represented by less than 5 genes in the heatmap have not been 
displayed.
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As noted earlier in Chapter 7, the majority of terms selected by GSD analysis of this 
dataset all concern a single biological theme: the immune response. The relatedness of 
these terms is noticeable from the picketplot: many genes are shared between these 
terms. Most of the terms include genes that exhibit several different expression patterns 
-  this could imply the possible existence of undiscovered functionality-based sub-groups 
of genes within these terms. At least one expression pattern can be linked with particular 
GOBP terms: the expression pattern of down-regulation in most t( 15; 1 l)[PML-RARa] 
and FAB-M7 samples, and up-regulation in most of the other subtypes appears to 
comprise the majority of selected genes that are annotated with GOBP terms for antigen 
processing and presentation.
8.2.3.3 Results o f  GSD analysis o f  the Broccoli liposarcoma dataset
The 30 GOBP terms selected by GSD analysis of the Broccoli liposarcoma dataset 
comprised of a total of 5042 genes. All possible pair-wise distances between these genes 
were calculated. An SD-GDV value was derived for each gene using the vector of 
distances of that gene to all other genes. Genes were then ranked in decreasing order of 
their SD-GDV values and the first quintile (which consisted of 1009 genes) was selected 
for visualization. The visualization of these genes based on the scheme described above 
is shown in Figure 8.9.
As can be observed, the heatmap includes expression patterns that cause a hierarchical 
clustering of samples which is agreement with the known sample phenotypes. Two 
major clusters are discernible: one of which includes most of the high-grade samples (all 
four DD samples and 6 out of 7 PLEO samples), while the other includes most of the 
low-grade samples (12 out of 15 WD samples).
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Figure 8 .9  GSD an a lys is  o f  th e  Broccoli liposarcom a d a ta se t .  Heatmap 
represents log median-centred gene expression values ranging from -2 (bright 
green) through 0 (black) to 2 (bright red). Black and blue cells in the picketplots 
indicate the presence of samples and genes w ithin corresponding sample classes 
and gene-sets respectively, while white cells indicate the ir absence. All hierarchical 
clustering was carried out using correlation distance and average linkage. For ease 
of visualization, some GOBP terms that are very sim ilar to others have not been 
displayed, as have GOBP terms represented by less than 5 genes in the heatmap.
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As was previously described in Chapter 7, the GOBP terms selected by GSD analysis of 
this dataset could be divided primarily into three major biological themes: mitosis/cell 
division, metabolism and immunity. The hierarchical clustering of the GOBP terms 
appears to reflect this -  terms comprising these themes fall into three well discriminated 
clusters. Indeed the hierarchical clustering is able to further sub-divide terms specific to 
metabolism of lipids and those specific to metabolism of carbohydrates.
Most of the genes annotated with mitosis/cell division terms exhibited expression 
patterns of up-regulation in the high-grade (DD/PLEO) samples, and down-regulation in 
the low-grade (WD) samples. The opposite expression pattern was observed for most 
genes annotated with metabolism terms. As discussed in Chapter 7, these observations 
are biologically plausible. Genes annotated with immunity terms show a range of 
different expression patterns.
8.2.3.4 Results o f  GSD analysis o f  the Ivshina breast cancer dataset
The 50 GOBP terms selected by GSD analysis of the Ivshina breast cancer dataset 
comprised of a total of 3771 genes. All possible pair-wise distances between these genes 
were calculated. An SD-GDV value was derived for each gene using the vector of 
distances of that gene to all other genes. Genes were then ranked in decreasing order of 
their SD-GDV values and the first quintile (which consisted of 754 genes) was selected 
for visualization. The visualization of these genes based on the scheme described above 
is shown in Figure 8.10.
As can be observed in the heatmap, there are several consistent expression patterns that 
are exhibited by the selected genes. The clustering of samples is influenced in varying 
degrees by each of these patterns, and the resultant grouping of clusters does not 
conform very well to the previously known classes of low and high grade samples.
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Figure 8 .1 0  GSD an a lys is  of th e  Ivsh ina b reast  ca n cer  d a ta se t .  Heatmap 
represents log median-centred gene expression values ranging from -2 (bright 
green) through 0 (black) to 2 (bright red). Black and blue cells in the picketplots 
indicate the presence of samples and genes w ithin corresponding sample classes 
and gene sets respectively, while white cells indicate the ir absence. All hierarchical 
clustering was carried out using correlation distance and average linkage. For ease 
of visualization, some GOBP terms that are very sim ilar to others have not been 
displayed, as have GOBP terms represented by less than 5 genes in the heatmap.
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The heatmap also indicates at least three major groups of genes. One of these clusters 
comprises primarily of genes involved in immune system processes -  they exhibit a 
strong expression pattern, and show little concordance with the cancer grades of the 
samples. The relatedness between these terms is also indicated by the large number of 
genes shared between them.
The second cluster comprises primarily of genes involved in cell division processes. The 
expression pattern exhibited by these genes correlates strongly with cancer grades: the 
majority of these exhibit up-regulation in the high-grade G3 and G2b samples, and 
down-regulation in the low-grade G1 and G2a samples. The importance of this 
biological theme of cell division and mitosis in the discrimination between low and high 
grade breast cancer samples has been evident in both the original study as well as further 
explorations described in Chapter 7.
The final cluster of genes exhibit a variety of relatively weaker expression patterns, and 
are annotated to GOBP terms representing a range of biological themes.
The results from this dataset suggest that exploratory analyses such as GSD can discover 
several biological themes within an experiment, each of which could be affected 
differently by the experimental conditions, or could be affected by different 
experimental conditions (and thus show different expression patterns). In this case, one 
of the biological themes discovered (i.e. cell division and mitosis) appears relevant to the 
intent of the researchers who conducted the experiment (i.e. discriminating between low 
and high grade cancer samples on the basis of their gene expression profiles).
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8 A Discussion
This chapter described two further extensions of the framework of GSD analysis of 
microarray data that could be of use to researchers.
It first described the development of a methodology that attempts to identify the most 
informative genes from amongst gene sets selected by GSD analysis. It was found that 
SD-GDV values of genes could allow ranking of the most informative genes, of which 
an arbitrary number of the highest ranking genes could then be selected. This was 
implemented by calculating SD-GDV values for genes considering all genes from all 
GSD-selected gene sets taken together.
Secondly, the chapter described a scheme for visualization of the results that allowed for 
integration of various types of information. Heatmaps of the selected genes displayed the 
various expression patterns exhibited by the genes. Picketplots were included to indicate 
the various gene sets that each of the selected genes was part of. Relationships between 
the gene sets could also be displayed by hierarchical clustering of the gene sets based on 
the genes shared between them.
The methodology designed to extract informative genes was applied to gene sets 
selected by GSD analysis of each of the four microarray datasets described in Chapter 7. 
While the number and proportion of informative genes varies across datasets, a uniform 
arbitrary cut-off for selection of genes was implemented in all cases to avoid user bias: 
in all cases, the top 20% of genes were selected after being ranked in decreasing order of 
their SD-GDV values. It was observed that this methodology could successfully extract 
the most informative genes.
Visualization of these results using the scheme developed indicated that it could 
successfully integrate gene expression data, phenotype data and functional annotation/
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meta-data in a format that was visually intuitive: expression patterns of the most 
informative genes could be observed in the heatmap (Eisen et al. 1998), along with 
sample class information. Also, genes within the heatmap could be mapped onto the 
GOBP terms selected by the primary GSD analysis step. Furthermore, relationships 
between the terms were also displayed and the hierarchical clustering of these terms 
could indicate larger underlying biological themes.
The methodology for extraction of informative genes is perhaps best suited to analysis of 
gene sets selected by the GSD methodology, as it is based on similar principles i.e. using 
the variability of correlation distances based on expression profiles. However, the 
methodology (as well as the scheme for visualization of results) could be used for 
further analysis of the results of any other gene set analysis method.
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Chapter 9: Sum m ary and G eneral D iscussion
This chapter comprises of summarization and discussion of the work described in the 
preceding chapters of this thesis. These have been divided into two sections representing 
work described in Parts A and B of this thesis.
9.1 Part A - Integration of microarray based experiments using 
lists of differentially expressed genes
This section summarizes and discusses Part A of this thesis, which comprises of 
Chapters 2-5. The primary question explored here was whether large-scale comparisons 
between microarray experiments could be carried out using genelists derived from those 
experiments instead of using the entire experimental datasets. Such a strategy could 
facilitate large-scale comparisons of many different microarray experiments in an 
unsupervised fashion, and in theory allow for the possibility of finding unexpected links 
between experiments. Such links could then be further explored using more 
sophisticated integrative techniques which in turn could lead to novel biological insight.
For this purpose, a database of genelists derived manually from published literature was 
used to compare genelists using statistical techniques. It was intended to estimate the 
utility of this strategy by observing the biological plausibility (if any) of the results 
generated. For example, carrying out unsupervised hierarchical clustering of the 
genelists on the basis of some metric indicating similarity between them (e.g. 
hypergeometric Z-scores), and observing if the resultant clusters reflected any 
underlying biology. Other issues that were desired to be explored included the extent to 
which biologically meaningful links between experiments could be found across species 
(in terms of evolutionary distance).
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9.1.1 Summary of results and explorations
Chapter 2 described explorations that helped build the experimental framework and 
strategies with which to carry out comparisons between microarray experiments using 
their genelists. Firstly, strategies were described regarding how genelists created from 
different experiments, using different Affymetrix platforms and across different species 
could be made comparable. Secondly, three different strategies with which the 
significance of the similarity between any two genelists could be quantified were tested. 
It was found that the hypergeometric statistical test was suitable for this purpose as it 
could control for the systematic effects of genelist length and gene universe size.
Chapter 3 then described the results of carrying out comparisons within a database of 
literature-derived genelists spanning a range of different platforms and species. An 
unexpected finding was that of implausibly high levels of similarity between genelists 
derived from the same array-type: hypergeometric Z-scores distributions derived from 
these comparisons were found to be centred between median values of 2-6. This finding 
is counter-intuitive as it is expected that most microarray experiments (and thus the 
genelists derived from them) are dissimilar to each other, and that this would lead to Z- 
score distributions centred on median values of close to zero, as is observed for 
comparisons between lists of randomly selected genes. A second related observation was 
that of a correlation between the size of a genelist and the levels of significance assigned 
for comparisons of that genelist to all other genelists from the same array-type. This 
again is of concern, because one of the reasons the hypergeometric statistical test was 
deemed suitable for these analyses was its ability to control for the systematic effects of 
genelist length.
Chapter 4 first described speculations regarding the reasons for these unexpected 
observations, and it was hypothesized that these are more likely to have occurred due to 
known transcriptional behaviours of genes that violate assumptions of the 
hypergeometric statistical test, rather than reflecting true biological similarities between
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genelists. It then described a statistical model called the ‘biased urn’ which involves the 
use, in the hypergeometric test, of a gene universe size that is different to that of the 
gene universe used to sample genelists. It was shown that under this model, comparisons 
between lists of randomly selected genes could exhibit both the excess levels of 
similarity and the correlation between genelist size and significance as are observed for 
the comparisons described in Chapter 3. To simulate these comparisons of literature- 
derived genelists, the average gene universe size shared between any two experiments 
was estimated by a re-calculation of the Z-scores with different universe sizes and using 
that gene universe size for which the Z-score distributions were centred on median 
values closest to zero. These estimates ranged from only 35-65% of genes represented 
on an array. It was then found that simulation of comparisons between the literature- 
derived genelists using the biased urn model with the estimated universe sizes yielded 
significance patterns that were very similar to those observed in Chapter 3.
This biased urn model and the use of an estimated average gene universe size thus 
represents a potential solution to control for violations of the assumptions of the 
hypergeometric test when used to assess comparisons between genelists derived from 
microarray experiments. However, this strategy has several caveats: firstly it is ad hoc 
and is heavily dependent on the set of genelists used in each analysis. A second issue of 
greater concern is that this methodology only controls for the observed biases at global 
levels (i.e. overall significance levels for many different comparisons taken together), 
and the use of a single estimated average gene universe size for all comparisons could 
lead to erroneous results if there is wide variability in the true sizes of the gene universes 
shared between any pair of experiments. Explorations of this aspect were described in 
Chapter 5 using a subset of the GNF human Gene Expression Atlas comprising the 
expression profiles of a wide range of normal human tissues carried out in the same 
laboratory using the same microarray platform (Affymetrix hgul33a). By simply using 
the number of genes found to be expressed in each tissue-type, it was shown the number 
of genes expressed in any two tissue-types varies greatly for two reasons. Firstly, 
systematic effects of the variability in the number of genes expressed in each tissue.
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Secondly, for biological reasons (particularly tissues-specific gene expression), similar 
tissue types share greater numbers of expressed genes than dissimilar tissue types. 
Finally it was shown that application of an average gene universe size leads to erroneous 
quantification of significance between lists of genes selected randomly from the 
expression universe of different tissue-types; the extent of this error is dependent on the 
magnitude of the difference between the average shared gene universe size used in the 
statistical test, and the true number of genes expressed in any pair of tissues.
9.1.2 The concept of a ‘gene universe’ in microarray data analysis
The concept of defining gene universes is relevant to analyses of microarray data for 
several related reasons. In this thesis, it was first mentioned in Section 1.3.1.1 with 
respect to multiple hypothesis correction techniques applied to p-values derived from 
gene-by-gene tests for differential expression. Because the stringency of the correction 
applied increases with the number of genes tested, it has become convention to remove 
from the gene universe, for an experiment, those genes that are highly unlikely to be 
flagged as differentially expressed by a statistical method (Huber et al. 2008; Scholtens 
and Heydebreck 2005). Such genes include those that are not expressed (due to technical 
or biological reasons), or those that exhibit low variability in expression levels (for 
example house-keeping genes that may be evolutionarily constrained to exhibit stable 
expression levels).
While decreasing the gene universe size could help increase the power (i.e. decrease the 
number of false negatives) of gene-by-gene testing for differential expression by 
decreasing the stringency of tests for multiple hypothesis correction, decreasing the gene 
universe size could help increase the specificity (i.e. decrease the number of false 
positives) of ORA-based approaches for functional analyses of genelists such as tests for 
enrichment of biological themes, like GO terms, in genelists. As Falcon and Gentleman 
point out, the use of an unfiltered gene universe (for example all genes represented on an
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array) could lead to the erroneous assessments of significance (Falcon and Gentleman 
2008). For this reason they include a ‘non-specific filtering’ step, as part of their GOstats 
tool for ORA, to filter out low-variability genes from further analyses because these are 
unlikely to be flagged as differentially expressed (Falcon and Gentleman 2007). The 
concept is similar to that of the biased urn model described in Chapter 4: statistical tests 
such as the hypergeometric test assess the significance of the overlap between any two 
sets of genes by comparing the observed overlap size with that which might be expected 
from two genelists of similar size comprising of genes selected from the same universe 
as the genelists being assessed. The inclusion, in the statistical gene universe, of genes 
that cannot be selected into genelists would decrease the expected overlap size and this 
would lead to assignment of higher levels of significance to an observed overlap than 
ought to be.
For this reason, in their review of ORA tools to assess enrichment of GO terms within 
genelists, Khatri et al criticize those tools that do not filter gene universe sizes; for 
example some tools even include genes that may not be represented on an array, by 
using all genes present in the entire genome of an organism. The inclusion of genes that 
can never be selected as differentially expressed, they argue, “represents a flagrant 
contradiction of the assumptions of the statistical models used” (Khatri and Draghici 
2005). The findings presented in this thesis then extend this criticism to the ORA-based 
comparisons between genelists derived from microarray experiments. The explorations 
show that, when using an unfiltered gene universe in the statistical model, not only is 
there a marked loss of specificity (reflected in the assignment of implausibly high levels 
of similarity between genelists), but also a loss of control of the systematic effects of 
genelist size (reflected in the correlation between genelist size and significance levels). 
These undesirable effects are observed in both the comparisons of genelists derived from 
real microarray experiments, and in the comparisons of lists of randomly selected genes 
using the biased urn model.
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The possible biological reasons for these effects are speculated on in Chapter 4, but the 
extent to which these effects could confound analyses is relatively understudied. The 
finding, in Chapter 4, that the estimated average gene universe size that is shared 
between any two experiments (which may be used to indicate the net effect of the 
transcriptional behaviours of genes that violate statistical assumptions) ranges from only 
35% to 65% of genes on an array would appear to be cause for concern. It is strongly 
suggests that a universe size of all genes represented on an array should not be used for 
comparisons of genelists derived from microarray based experiments.
These effects are particularly an issue for comparisons between experimentally derived 
genelists as compared to comparisons between an experimentally derived genelist and 
one derived from manual annotation (for example, as carried in ORA analyses for 
enrichment of GO terms within a genelist). This is because selection of genes into 
genelists that are derived from experiments is subject to the biological effects of gene 
expression patterns that violate statistical assumptions; this may not be the case for those 
derived from manual annotation (such as gene sets representing pathways or GO terms). 
Indeed, an experiment was carried out (data not shown) where ORA analysis was carried 
out on a series of genelists: none of the unexpected trends observed for comparisons 
between experimentally derived genelists (that is, excess levels of similarity and 
correlation between genelist length and significance) were observed; there also was very 
little difference in the results when using a filtered gene universe (only genes annotated 
with GO terms) as opposed to an unfiltered one (all genes on the array).
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9.1.3 Can genelists be used to compare microarray-based 
experiments?
9.1,3.1 Assessing the significance o f  the number o f  shared genes
The comparison of microarray-based experiments using genelists derived from them is 
based on the rationale that similarity between genelists implies similarity between the 
experiments. This strategy represents a potentially significant decrease in resource- 
intensiveness as compared to meta-analytical strategies requiring re-analysis and 
integration of entire microarray datasets. This would then allow for the possibility of 
large-scale comparisons between many different microarray experiments in an 
unsupervised fashion, which could lead to possible discovery of unexpected links 
between experiments and possible novel biological insights. However, the use of 
genelists to compare different microarray experiments carried out in different 
laboratories, on different platforms and across different species has been a controversial 
issue: there is generally little agreement even between genelists from similar 
experiments (Cahan et al. 2007; Cheadle et al. 2007; Ein-Dor et al. 2005; Jeffery et al. 
2006; Manoli et al. 2006; Tan et al. 2003), and agreement can found only when using 
very standardized experimental protocols and data analysis strategies (Bammler et al. 
2005; Irizarry et al. 2005; Larkin et al. 2005).
For this purpose, it was desired to explore whether carrying out comparisons between 
genelists derived from a wide range of experiments carried out at different laboratories, 
with different experimental protocols and data analysis methodologies, and across 
different species could still yield biologically plausible and useable results, if any. 
However, as described in Chapters 3 and 4, naive comparison of genelists using 
unfiltered gene universes could result in erroneous results: in these circumstances, 
statistical tests to assess similarity between genelists suffer a considerable loss of 
specificity, as well as loss of control of the systematic effects of genelist size. The biased 
urn model described in Chapter 4 can allow for ad hoc modelling and control for these
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statistical biases on a global scale by estimating the average gene universe size for any 
two microarray experiments. However, as explored in Chapter 5, this model could still 
yield erroneous results because of the use of a single estimated gene universe size when 
this size could vary widely due to both systematic effects and biological reasons (such as 
tissue-specific expression patterns).
A more accurate assessment of the similarity between genelists could be carried out by 
estimating the gene universe size for each experiment separately, and using for each 
comparison only those genes that are present in both universes for a pair of genelists. 
For example, consider two genelists x and y, with gene universes of X  and Y 
respectively. These genelists could be compared by using the intersect of x and y  (xy) 
and as the gene universe, the intersect of X  and Y (XY). This would also be reflected by 
filtering x and y  for any genes that are not present in XY. However, the estimation of the 
gene universe for each experiment (for example by removing un-expressed/low 
expression genes and/or low variability genes) is likely to involve re-analysis of the 
entire microarray dataset. Such a resource-intensive strategy would then defeat the 
purpose of comparing genelists as a computationally efficient alternative to more 
sophisticated meta-analytical strategies.
9.1.3.2 Assessing genelists fo r  shared biological themes
Another strategy that may be used to compare genelists from microarray experiments is 
to assess whether a pair of genelists share any underlying biological theme (such as GO 
terms or pathways) (Cheadle et al. 2007; Manoli et al. 2006; Shen et al. 2008). The 
rationale for this is that if two genelists share a common underlying biology, this may 
represent a true biological link between the experiments as opposed to a set of 
overlapping but functionally unconnected genes. Furthermore, this would do away with 
the requirement for assessing the significance of the size of overlap between genelists 
(which has been shown in this thesis to be highly problematic), and also provide direct 
biological insight of the link between the experiments (on the basis of the shared
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biological themes). There are at least three different methodologies that may be used for 
this purpose (Figure 9.1).
Firstly, ORA could be carried out for each of the genelists separately to detect biological 
themes (such as GO terms) that are enriched in each of the genelists (Figure 9.1a). GO 
terms common to both genelists can then be detected. However, it is possible that the 
enrichment may have been caused by different subsets of genes annotated with a 
particular GO term. An extreme example may be one where both genelists exhibit 
enrichment of a particular GO term, but do not actually share any genes in common.
Secondly, ORA could be carried out on solely the overlapping genes -  this would ensure 
that enrichment is due to the shared genes (Figure 9.1b). However, as would be the case 
in the first methodology, such analyses would still require estimation of the overlap of 
gene universe sizes for both experiments being compared; as discussed in Section 
9.1.3.1, this would require re-analysis of both experimental datasets. Using the example 
described in Section 9.1.3.1, the enrichment of GO terms in xy would require 
comparison with the distribution of GO terms in XY.
Thirdly, a more sophisticated analysis (Figure 9.1c) could be carried out by testing for 
enrichment of GO terms in the overlapping genes as compared to the distribution of GO 
terms in each of the genelists (as opposed to comparison with the distribution of GO 
terms in the gene universe). However, there is still a need for estimation of the gene 
universe that is shared between the two experiments because the genelists require to be 
filtered to reflect this. Using the example in Section 9.1.3.1, x and y  would require a 
filtering step to remove genes that are not present in XY. Furthermore, interpretation of 
results would be complicated. For example, three sets of GO terms would be derived: 
terms enriched with respect to both genelists, and those enriched with respect to only 
one or the other genelist.
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Figure 9.1 S trateg ies for detection  of biological th em es shared betw een  
genelists. Three different strategies are shown, all using the sam e schem e: the 
broken grey oval represents a se t of all gen es represented on an array; red 
circles/ovals represent experim entally derived genelists while the blue circles/ovals 
represent the gene universes for those experim ents. The yellow shaded areas 
indicate those gen es that would be tested  for enrichment of biological them es (such 
as GO term s), while the red and green shaded areas represent different gene  
universes that should be used for those tests.
Other issues of theme-based approaches described above include the inability to rank 
similarities between the genelists: the number of GO terms shared between genelists 
may not be an accurate metric because of the parent-child relationships between the 
terms.
Thus it may be concluded that simply using genelists to compare microarray 
experiments, even if supplemented with further information (such as the estimated 
average gene universe size calculated using the biased urn model, or detection of shared 
underlying biological themes) is problematic and likely to produce erroneous results. 
While it may be possible to improve the accuracy of these methods by incorporating 
knowledge about the gene universes for each these experiments, there are several issues 
regarding such a strategy. Firstly, estimation of the gene universes for each of these 
experiments is likely to be as resource-intensive as more sophisticated meta-analytical 
methodologies; this then makes it difficult to justify this strategy as a computationally 
efficient alternative. Secondly, the definition of a gene universe is problematic in itself.
In ORA-based approaches, the concept of genes in relation to gene universes is 
essentially binary: a gene is either absent or present in a gene universe. It is more likely 
that there exists, for each different experiment, a continuum of probabilities for the 
presence of a gene within the gene universe for that experiment; this is dependent on a 
range of technical and biological factors unique to each gene (such as discussed in 
Chapter 4).
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9.2 Part B -  Gene Set Discovery (GSD): a novel methodology for 
unsupervised threshold-free discovery of biological themes 
within microarray datasets
Part B of this thesis comprised of Chapters 6-8, and described explorations that led to 
the development of the GSD analytical framework for unsupervised theme discovery 
within microarray datasets. GSD comprises of three stages: selection of relevant gene 
sets, selection of informative genes within the selected gene sets, and a scheme for 
integrated visualization of results. Also described are the results of the application of the 
GSD methodology to the analysis of four different microarray datasets derived from 
Affymetrix expression profiling platforms.
9.2.1 Summary of results and explorations
Chapter 6 described explorations that led to the development of the first stage of GSD 
analysis, i.e. the selection of gene sets (that could represent biological themes and 
functional annotation, such as GO terms and pathways) from a microarray dataset, 
which could be of interest to a researcher, in an unsupervised fashion. The underlying 
hypothesis of GSD is that if the gene expression matrix for a particular gene set contains 
information, in terms of shared patterns of expression, then it is likely to be relevant to 
the experiment and therefore of interest to a researcher. It was thus desired to derive a 
metric that could indicate the level of such information within the expression matrix for 
any gene set. For this purpose, research focussed on the distance matrices that are 
commonly used for hierarchical clustering of genes and samples (for example, in 
heatmaps), because these distances represent quantifications of the relationships between 
genes and between samples based on similarities of their expression profiles.
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Simulations using hypothetical gene expression matrices into which known levels of 
information could be artificially introduced in a controlled manner were used to test 
several candidate metrics. Of these, the standard deviation of the sample distance matrix 
(SD-SDM) was selected as a suitable metric for two reasons: firstly, it was sensitive to 
the presence of information within a matrix, and there was a relationship between the 
level of information and SD-SDM values. The second desirable property is that, in the 
presence of more than one type of information (i.e. more than one gene expression 
pattern) within an expression matrix, SD-SDM values rank an expression matrix where 
different expression patterns lead to the same grouping of samples over one where 
different expression patterns each cause different groupings of samples. Thus, it allows 
for prioritization of gene sets which can be linked to a single stratification scheme for 
samples.
However, it was also found that SD-SDM values are subject to systematic effects of 
gene set size and the random presence of informative genes (i.e. genes exhibiting non- 
random expression patterns). Thus, it was desired to develop a methodology to assess 
the significance of the SD-SDM value observed for any gene set. Two possible 
strategies were tested for this purpose using simulation studies: firstly, a re-sampling 
based competitive strategy that involved creating a null distribution of SD-SDM values 
using sets of randomly selected genes. Secondly, a randomization based non-competitive 
strategy which involved creation of a null distribution by randomizing values within the 
expression matrix for the gene set being tested. The competitive strategy was deemed 
suitable as it could successfully control for both confounding factors.
While all explorations described in Chapter 6 were carried out using simulated 
microarray datasets, Chapter 7 then described the results of the application of the GSD 
methodology to four real-world microarray datasets. To assess how successfully GSD 
could select relevant gene sets for each of the datasets, assessment was carried out of the 
results, regarding whether they were biologically plausible and/or they were in 
concordance with the results of prior analyses of these datasets. In all cases, the GSD
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methodology was found to successfully identify relevant gene sets and biological themes 
for each experiment.
Chapter 8 then described the development and implementation of two further extensions 
of the GSD analytical pipeline. Firstly a metric was developed that could help identify 
and extract the most informative genes from within a gene set selected by GSD. This 
metric, the standard deviation of the gene distance vector (SD-GDV), is based on 
concepts similar to those that led to the implementation of SD-SDM values in the 
selection of gene sets, and was found to successfully rank genes on the basis of how well 
their expression patterns were shared. Secondly, a scheme was developed to visualize 
the results of GSD analyses. It was designed to integrate various types of information, 
such as the most informative genes from amongst gene sets selected by GSD, the 
different expression patterns exhibited by these genes, the gene sets that these genes 
belong to as well as the relationships between selected gene sets, and any phenotypic 
data that may be available for the samples.
9.2.2 Principles and utility of the GSD methodology
The GSD analytical framework can be considered to be novel in terms of the statistical 
methodologies underlying its functionality. As far as could be researched, no other 
technique was found to use SD-SDM values as measures of cluster ‘strength’, or SD- 
GDV values as a metric to determine the prevalence of the expression pattern exhibited 
by a single gene. While the primary utility of the GSD methodology (i.e. the ability to 
carry out gene set analysis in an unsupervised fashion), is not novel, there very few other 
options available to researchers for this purpose. Only three other such methodologies 
could be identified, and of these, two share the same underlying strategy. These 
methodologies are further discussed in the next section (Section 9.2.3).
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The GSD methodology brings together two traditionally disparate modes of analyses of 
microarray data, which are discussed in the following sections.
9.2.2.1 Functional analysis o f microarray data using biological themes
Biological interpretation of microarray data has been aided considerably by the 
development of databases containing functional annotation of genes (such as GO, 
KEGG and Biocarta), and of statistical methodologies and tools that allow for analysis 
of microarray data in terms of the biological themes represented in these databases 
(typically as sets of genes that are functionally related, or share some common 
underlying biological theme). The additional biological insight provided by such 
analyses allows for many more opportunities and greater scope for utility of the results 
of a microarray based experiment (Bild and Febbo 2005; Curtis et al. 2005).
For example, a list of genes may be identified through a microarray experiment to be 
predictive of a disease (e.g. cancer). Such results may be sufficient for certain analyses 
such as the identification of biomarkers. For example, the van’t Veer 70-gene breast 
cancer signature (v an ’t Veer et al. 2002) has been used in Mammaprint, a molecular 
diagnostic test to assess the risk of breast cancer metastasis (Slodkowska and Ross 
2009). However the utility of such analyses may be limited to such diagnostic tests.
Knowledge of the biological pathways and mechanisms underlying a disease can allow 
for improved options for diagnosis: for example, if a pathway is found to be 
differentially regulated in a disease, this knowledge allows for the potential use of 
antibody-based histo-pathological tests which can be easily carried out in standard 
clinical laboratories. Such diagnostics tests would represent considerable advantages to 
gene expression profiling based diagnostic tests using a list of disparate genes, in several 
aspects: technical (there would be no need for the extraction of RNA from tumour 
samples, which is problematic [particularly from formalin-fixed samples with degraded 
RNA]); logistical (samples can be processed on-site rather than sent to other
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laboratories); and financial (histo-pathological tests would be considerably less 
expensive than molecular diagnostic tests).
Similarly, knowledge of the higher level biological themes could allow for improved 
possibilities for intervention using drugs. Consider a pathway that is differentially 
regulated in the disease state, and several downstream targets of the pathway are 
selected into a list of differentially expressed genes. Intervention may then be carried out 
by treatment with drugs targeting each of these genes. However, there may be too many 
such targets; furthermore, there may be difficulties in designing drugs for them. On the 
other hand, if the underlying pathway (for example the p38 MAP kinase signalling 
pathway) is known, this creates the possibility of targeting a few regulatory genes (in 
this example, p38) rather than many different downstream targets. Furthermore, it would 
allow for selection of targets for which drugs could be more easily designed.
Some of the earliest techniques to carry out such functional analyses of microarray data 
were ‘threshold-based’ ORA methods (see Section 1.4.2) that detected enrichment of 
functional classes of genes within lists of differentially expressed genes. More recently, 
there has been the development of many ‘threshold-free’ methods for this purpose (see 
Section 1.4.3), such as GSEA, which do not require prior definition of a list of 
interesting genes.
9.2.2.2 Class discovery
A key feature of the vast majority of methodologies with which to carry out functional 
analyses of microarray data (or gene set analyses [GSA]) is that they require supervision 
in terms of sample phenotype classes: the user needs to define the sub-groups of samples 
across which differential patterns of expression are expected or desired to be detected. 
For threshold-based GSA methods, this is carried out by the prior definition of a list of 
genes that are found by some statistical test to be differentially expressed across two or 
more sample sub-groups. Threshold free methods directly detect gene sets that are 
differentially expressed across pre-defined sample sub-groups.
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While such analyses are appropriate for many experimental designs, there are also many 
situations where prior knowledge regarding sample sub-groups may not be known. 
Indeed, the very purpose of many microarray-based ‘class discovery’ studies (see 
Section 1.3.2) is the elucidation of distinct sample sub-groups based on gene expression 
profiles.
This mode of analysis is particularly used in studies of cancers: quite often it is found 
that a set of tumour samples are morphologically homogeneous and cannot be 
differentiated on the basis of histological techniques, but yet show diversity in terms of 
clinical variables such as survival rates and response to therapeutic drugs. For this 
purpose class discovery studies are carried out in order to find sub-groups of tumour 
samples based on their gene expression profiles that may then explain their behaviour 
with respect to these clinical variables. One particular publication regarding the use of 
microarrays concerned this very strategy: Alizadeh et al (Alizadeh et al. 2000) studied a 
set of diffuse large B-cell lymphomas that very morphologically indistinct, but exhibited 
a wide range of survival rates. Using class discovery techniques, they could identify two 
distinct sub-classes of these tumours, and found that these new sub-classes exhibited a 
significant difference in survival rates. The creators of the Ivshina breast cancer dataset 
(Ivshina et al. 2006) analyzed in Chapter 7 also carried out class discovery: using a 
classifier gene set, they identified two sub-classes of Grade 2 breast cancers which also 
showed a significant difference in survival rates (as well as other parameters). Other 
examples have been cited in Section 1.3.2.
9.2.2.3 Unsupervised theme discovery in microarray datasets using GSD
The GSD methodology described in this work brings together the two modes of analysis 
described above, such that it can be described as a methodology with which to carry out 
class discovery using biological themes, or equivalently, unsupervised gene set analysis.
The term ‘supervised’ has been generally used in the fields of machine learning and 
microarray data analysis (including this thesis -  See Section 1.3.1) to describe methods
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that require a priori knowledge of classes of entities; for example, in order to ‘train’ 
methodologies to be able to distinguish between sets of entities where such knowledge 
of classes may not be known (see Section 1.3.1.2). However, the concept of the level of 
‘supervision’ required by any analytical methodology can be thought to have a more 
generic meaning: that of the level of user-defined parameters and user-made decisions 
and input.
In theory, methodologies that require less supervision from users have greater potential 
for knowledge discovery and are thus more suited for exploratory analyses. For 
example, threshold-free GSA methods can be considered to be less supervised than 
threshold-based GSA methods, because they do not require the creation of list of 
differentially expressed genes. In the latter case, the researcher can choose from a range 
of statistical threshold levels to define differential expression, each of which could lead 
to different threshold-based GSA results (Pan et al. 2005). Furthermore, threshold-free 
methods allow for the possibility of discovering differentially regulated biological 
themes that may not be enriched within a list of genes exhibiting the greatest changes in 
gene expression (Ben-Shaul et al. 2005; Breitling et al. 2004; Huang da et al. 2009; Nam 
and Kim 2008; Subramanian et al. 2005).
GSD can thus be considered to be a threshold-free GSA method, because it seeks to 
identify relevant gene sets without requiring a list of genes selected by a researcher to be 
of interest. However, it represents a further decrease in supervision as compared to the 
vast majority of other threshold-free GSA methods: it does not require prior definition of 
samples classes across which differential patterns of gene expression are expected or 
desired to be detected. For example, if the GSD methodology is implemented on a 
dataset where sample classes are known a priori, it has the potential to identify gene sets 
that contain unexpected expression patterns i.e. those that would result in groupings of 
samples that are different from known sample classes. These may be due to unknown 
but biologically relevant factors, further analysis of which may lead to novel biological 
insight. Even if the gene sets detected by GSD exhibit expression patterns that result in
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clusters of samples that are as expected, GSD represents a more objective method to 
identify these gene sets.
However, it is surmised that GSD has greater potential utility in class discovery studies 
in which there may be no a priori knowledge regarding sample classes, which as 
discussed above, is particularly the issue in many studies of cancers. The amalgamation 
of the concepts of class discovery and theme-based analysis can allow a researcher to 
ask the question, “which biological theme can stratify this set of cancers?”.
The potential utility of the GSD methodology can be illustrated using the Ivshina breast 
cancer dataset, the analysis of which was described in Section 7.3.3. In the original 
study, the authors desired to understand the basis for wide range of survival rates of 
breast cancer patients exhibiting Grade 2 (G2) tumours. Firstly, they used a biological 
hypothesis: that G2 samples did not represent a continuum of tumour progression stages; 
rather they comprised of two sub-types. One of these sub-types was similar to the low- 
grade G1 samples that exhibited good prognosis (high survival rates), while the other 
was similar to the high grade G3 samples that exhibited bad prognosis (low survival 
rates). On the basis of this hypothesis, they used highly supervised techniques 
incorporating tumour grade information to develop a classifier gene set that could 
discriminate between G1 and G3 samples. They then applied this classifier to the G2 
samples and identified two sub-groups based on the similarity of their expression 
profiles to those of the G1 and G3 samples: G2a (1-like) and G2b (3-like). The 
subsequent discovery that these newly discovered G2 sub-types exhibited a significant 
difference in survival rates provided further evidence in support of the authors’ original 
hypothesis.
In contrast, GSD analysis was able to arrive at similar results using a shorter analytical 
pipeline, and with considerably less supervision: it did not require the authors’ 
hypothesis or knowledge of sample tumour grades. It identified a biological theme 
(mitosis/cell division) that exhibited a particular gene expression pattern. Simple
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hierarchical clustering of samples using the genes involved in this theme led to the 
discovery of two well differentiated classes of samples. It was then found that one 
cluster contained significant majorities of samples classified in the original study as 
either G1 or G2a, while the other contained significant majorities of G3 and G2b 
samples. Furthermore the samples in these clusters exhibited a difference in survival rate 
that was almost as significant as that achieved in the original study using knowledge of 
tumour grades and highly supervised techniques.
In addition, GSD could provide direct insight into the biological theme underlying the 
difference between good prognosis and bad prognosis samples, i.e. mitosis/cell division. 
As discussed in Section 9.2.2.1, such knowledge regarding biological themes allows for 
possibilities for improved diagnosis and intervention. For example, using the findings 
described above, breast cancer diagnoses may be carried out at standard clinical 
laboratories using simple histo-pathological tests utilizing antibody-based markers for 
mitosis (such as Ki67 or MCM2), as opposed to extracting RNA and sending off 
samples to be processed for gene expression profiling at remote locations based on the 
classifier gene set developed by Ivshina et al or Mammaprint. Furthermore, such 
diagnoses could identify which patients may require chemotherapeutic drugs, and that 
they may be treated with drugs specifically designed to target mitosis/cell division 
pathways.
Most cancer patients show differences in terms of which pathways are deregulated, and 
as Bild et al point out, knowledge of which pathways are deregulated in which patients 
allows for the possibility of administration of customized ‘cocktails’ of drugs to patients 
that target specifically those pathways that are found to be deregulated in those patients 
(Bild et al. 2006). The possibility of simultaneous discovery of patient sub-groups based 
on gene expression profiles along with direct identification of the biological themes 
underlying these patient stratifications allowed by GSD methodology thus makes it a 
very suitable potential option for such studies of cancers.
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9.2.3 Other methods for unsupervised theme discovery
While other methods have been developed that attempt to evaluate the importance of 
biological themes (21s gene sets) in microarray datasets without requiring prior 
knowledge of sample/phenotype class information, these are relatively few in number. 
This section discusses some of these methods, and how they compare to the GSD 
methodology.
9.2.3.1 Using average pair-wise gene correlation values to evaluate the importance o f 
biological themes
Pavlidis et al (Pavlidis et al. 2002) used the average of all pair-wise Pearson correlation 
coefficient values for all genes belonging to a gene set as one of three ‘functional class 
scores’ with which to evaluate the importance of that gene set within microarray data. 
The significance of this metric was assessed by comparison with a null distribution 
created using sets of randomly selected genes of the same length as the gene set being 
tested. This methodology was also used by Kim et al as the first step of their Gene Set 
Expression Coherence (GSECA) algorithm (Kim et al. 2007). This metric is similar to 
the M-GDD metric explored in Section 6.2, because the correlation distance between 
any pair of genes is calculated as 1-correlation coefficient (see Materials and Methods).
The rationale for the use of this metric is that gene sets in which most genes exhibit co­
expression are likely to be of interest to a researcher. However, Pavlidis et al themselves 
remark that such use of this measure of gene expression profile similarity to evaluate the 
functional classes of genes may be “too limiting” because “while it may sometimes be 
true that genes which cluster together have related functions, it is certainly not always 
the case that genes with related functions cluster together” (Pavlidis et al. 2002).
A related issue regarding the use of this metric is that it requires differentially expressed 
genes to change in the same direction. For example, consider a microarray dataset with
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two sample classes, A and B. For any particular gene set, the presence of a sub-group of 
genes that exhibit up-regulation in samples of class A and down-regulation in samples of 
class B would increase the magnitude of the average correlation coefficient between 
genes. However, the presence of another sub-group of genes exhibiting an expression 
pattern in the opposite direction (i.e. down-regulation in class A samples and up- 
regulation in class B samples) would cause a decrease in value of this metric. This 
would then lead to an undesirable decrease in significance assigned to that gene set. 
Indeed, Breitling et al remark that the ability of their iterative Group Analysis (iGA) 
method to not be sensitive to differences in expression pattern directions is “a very 
important feature, because genes that share a functional annotation may include 
activators as well as inhibitors of a certain process” (Breitling et al. 2004). This issue 
could become even more acute in datasets involving more than two classes of samples, 
where there is increased potential for diversity in gene expression patterns. It is for this 
reason that M-GDD values were rejected as potential metrics for the GSD methodology 
in Section 6.2.1.3. On the other hand, the SD-SDM values selected as metrics for the 
GSD methodology were shown to be insensitive to the presence of more than one gene 
expression pattern, as long as these patterns corresponded to the same sample groupings.
9.23.2 Annotation driven clustering o f samples using adSplit
Another method with which unsupervised theme discovery with microarray datasets can 
be carried out is adSplit (Lottaz et al. 2007). The feature that is in common to GSD and 
adSplit (and distinguishes them from other such methods to identify relevant gene sets 
without sample class information) is that both methods attempt to select for gene sets on 
basis of the ‘strength’ of sample clusters produced by a particular gene set. adSplit 
achieves this by using the diagonal linear discriminant (DLD) score introduced by von 
Heydebreck (von Heydebreck et al. 2001) as a measure of cluster strength for samples. 
This is conceptually similar to the SD-SDM values used in GSD. The significance of 
DLD scores is determined, similarly to GSD, by using a background distribution of DLD 
scores calculated for sets of randomly selected genes of the same size as the gene set 
being tested.
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However, there are several differences between adSplit and GSD. The primary 
difference is that adSplit uses to two-step approach to derive sample clusters: first a 
hierarchical clustering step is carried out to derive the first two sample clusters. These 
are then used to calculate cluster centroids for the second step, in which k-means 
clustering is used to identify two clusters of samples. The DLD score is then calculated 
for these two clusters. Thus adSplit is limited to the analysis of only two sample clusters 
at a time. Discovery of more sample clusters can only be achieved by iterative 
application of adSplit to previously discovered sample sub-clusters. On the other hand, 
the GSD methodology does not focus on the number of sample classes. Rather, the SD- 
SDM values utilized by GSD can reflect the strength of sample clusters without actually 
carrying out clustering (since only distances between samples are used).
adSplit also involves the use of several additional user-defined parameters. For example, 
for any gene set, only the top 50 genes (by default), when ranked according to the extent 
to which their expression patterns support the discovered clustering of samples, are used 
for calculation of DLD values. Also adSplit imposes a default minimum cluster size of 5 
samples for clusters derived using a gene set. Interestingly, the authors of adSplit also 
recommend that for any gene set, the top 5 most differentially expressed genes be 
ignored (and this is reflected in the default setting for adSplit), as their expression 
patterns may not be shared by most of the other genes in the gene set. On the other hand, 
GSD requires only two user defined parameters -  the first of which is a p-value cut-off 
for significant gene sets (which is also required by adSplit) and another to define the 
most informative genes (for example the top 20%, as used in all examples in this thesis).
It is difficult to choose between GSD and adSplit on theoretical bases. For example, it 
may be argued that GSD compares favourably because it has fewer user-defined 
parameters; this implies a decreased scope for user-induced bias (because it is possible 
that parameters can be changed to achieve results favoured by a researcher). The 
relatively shorter workflow of the GSD methodology also implies that it may be 
computationally efficient as compared to adSplit, especially in the analysis of datasets
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where there may be more than two classes of samples. However, it may also be argued 
that the additional adjustments made by adSplit (selection of a defined number of genes 
within a gene set prior to metric calculation, imposition of a minimum cluster size, and 
rejection of highly variable genes) could lead to biologically more accurate results.
To compare the results of GSD and adSplit, adSplit was used to analyze the four 
microarray datasets used in Chapter 7 to test the GSD methodology. To ensure that the 
results were comparable, the parameters for analysis were the same as used for GSD 
analysis in terms of data normalization (MAS5) and transformation (log and median 
centring), gene set database (GOBP terms), statistical settings (null distributions created 
using 10,000 sets of randomly selected gene sets, and a significance cut-off of p<0.01 
after FDR correction) (see Materials and Methods). The results of adSplit analyses, as 
compared to GSD analyses are displayed in Table 9.1
As can be observed, the biological themes selected by adSplit show some degree of 
biological plausibility and concordance with the results of GSD analyses: the sole term 
selected for the GNF dataset, G0:0048675_axon extension, could be reflective of the 
fact that brain/neuronal tissues comprise the largest group of similar tissues in the 
dataset; this is also thought to have been reflected by the selection of many nervous 
system-related GOBP terms selected by GSD analysis of the dataset. One of the four 
terms selected by adSplit analysis of the Ross AML dataset was also selected by GSD 
(G0:0019882_antigen presentation), while two of the other selected terms are children 
of it. The only term selected by adSplit analysis of the Broccoli liposarcoma dataset 
(G0:0009596_detection of pest, pathogen or parasite) is a child term of a one selected 
by GSD (GO:0009613_response to pest, pathogen or parasite). Nine and two out of the 
fourteen terms selected by adSplit analysis of the Ivshina breast cancer dataset are 
associated with the biological themes of cell division and immunity respectively; these 
are also the two dominant themes shared by GOBP terms selected by GSD analysis of 
this dataset. However, only one term was selected by both methods (G0:0000819_sister 
chromatid segregation).
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Dataset Number of selected terms GOBP terms selected by adSplit analysis
GNF
adSplit 1
G 0:0048675_axon extension
GSD 55
R oss AML
adSplit 4 GO:0019882_antigen presentation  
G0:0019884_antigen presentation, exogenous antigen 
G0:0019886_antigen processing, exogenous antigen via MHC class II 
G0:0006942_regulation of striated muscle contractionGSD 13
Broccoli
liposarcoma
adSplit 1
G0:0009596_detection of pest, pathogen or parasite
GSD 13
Ivshina
Breast
Cancer
adSplit 14
G0:0051329_interphase of mitotic cell cycle 
G 0:0006334_nucleosom e assembly 
G0:0050867_positive regulation of cell activation 
G 0:0007051_spindle organization and biogenesis 
G0:0000226_microtubule cytoskeleton organization and biogenesis 
G0:0007088_regulation of mitosis 
G0:0009596_detection of pest, pathogen or parasite 
G0:0006120_mitochondrial electron transport, NADH to ubiquinone 
G 0:0000075_cell cycle checkpoint 
G 0:0000819_sister chromatid segregation  
G0:0000070_mitotic sister chromatid segregation 
GO:0042110_T cell activation 
G0:0050863_regulation of T cell activation 
G 0:0050909_sensory perception of taste
GSD 50
Table 9 .1  R esu lts  o f adSplit a n a ly ses . The adSplit methodology was used to 
analyze the four datasets that GSD was tested on (in Chapter 7). Terms highlighted 
in red were also selected by GSD analysis.
Despite the similarities in the biological themes selected by either methodology, 
relatively few GOBP terms are common to both, and there are considerable differences 
between the levels of significance assigned to GOBP terms. Figure 9.2 shows Z-scores 
derived from each method plotted against each other. As can be observed, there is little 
or no correlation between the values; many GOBP terms are assigned high levels of 
significance by GSD but not by adSplit and vice-versa.
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Figure 9 .1  S ign ifican ce le v e ls  a ss ig n ed  by adSplit and GSD. Grey points 
represent Z-scores assigned by adSplit (Y-axes) to GOBP terms, relative to Z-scores 
assigned by GSD (X-axes) for the same datasets. Blue points represent terms 
selected by only adSplit (at FDR-corrected pcO .O l), while red points represent 
terms selected only by GSD. Green circled points represent terms selected by both 
methodologies. Legends show correlation coefficients for both sets of Z-scores.
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Based on the comparative analyses described above, it may be concluded that while 
similar biological themes may be discovered by both methods, GSD exhibits greater 
sensitivity than adSplit (as it selected significantly more terms). This is particularly 
advantageous for exploratory studies where sensitivity may be more important to a 
researcher than specificity.
9.2.4 Development and benchmarking of the GSD methodology
The work described in this thesis regarding the GSD methodology was intended to 
provide proof-of-principle that it could be used to perform unsupervised theme-based 
analyses of microarray datasets, and provide useful and biologically meaningful results.
There is scope for further development and refinement of the GSD methodology: for 
example, other more sophisticated metrics may be used to assess the variability of 
sample distance matrices, as opposed to the SD-SDM metric described in this thesis. 
Similarly a more sophisticated metric could be derived to replace the SD-GDV metric 
used to rank potentially informative genes.
In order to assess any additional utility and advantage provided by the GSD 
methodology for the purpose of unsupervised GSA of microarray datasets, a 
comprehensive benchmarking study could be carried out to compare GSD with other 
methods developed for this purpose (such as the three methods described in the previous 
section). Such a study would need to include many different datasets, tested using a 
range of different data pre-processing and transformation schemes, a range of different 
platforms, and range of different annotation-based sources of gene sets as well (such as 
KEGG pathways, other GO terms, etc.)
Indeed benchmarking could be carried out to assess whether methods for unsupervised 
GSA (such as GSD) could provide any advantage over using conventional threshold-
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based and threshold free GSA methods for datasets where sample phenotype classes are 
already known. Assessment could be carried out to determine whether unsupervised 
GSA methods can select similar themes as detected by supervised methods. If 
unsupervised GSA methods detect additional biological themes, further investigations 
could be carried out if these additional results could be of interest to a researcher, 
particularly if these themes represent different groupings of samples than are known.
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Chapter 10: M aterials and M ethods
10.1 Introduction
This chapter provides additional information to support the explorations and results 
described in all the preceding chapters. Details regarding the all technical methodologies 
used during this project are provided, as is further information regarding the data 
analyzed. These are presented on a chapter-wise basis, such that each of the following 
sections contains supplemental information specific to each of the previous chapters and 
are named as such.
All analyses were performed using the R (version 2.3.1) statistical programming 
interface (Ihaka and Gentleman 1996) utilizing Bioconductor (version 1.8) packages 
(Gentleman et al. 2004).
10.2 Strategies for large-scale integration of microarray data 
(Chapter 2)
Chapter 2 described a review and analysis of methods with which to compare disparate 
microarray experiments using lists of differentially expressed genes.
Much of the work described in the chapter concerns two main issues. The first of these 
was the use of biological annotation to enable comparisons of lists of genes from 
experiments carried out on different arrays and species. The second issue concerned 
reviewing the statistical methodologies that could possibly be used to assess the 
significance of the similarity between any pair of lists.
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10.2.1 Conversion of probeset IDs across array-types and species
All information regarding probeset IDs for each of the arrays analysed, as well as the 
biological annotation available for these, was extracted from Bioconductor libraries for 
each of the array types. The names of these libraries are displayed in Table 2.1 in 
Chapter 2.
For all analyses (for example, to observe the number of probeset IDs shared between 
different chip-types), only the non-control probesets were used. Control probesets were 
filtered out by removing all probeset IDs with the prefix ‘AFFX’.
10.2.1.1 Comparison o f list o f genes from  experiments involving the same species
For reasons described in Chapter 2, comparison of genelists from experiments carried 
out using the same organism required conversion of probeset IDs into species-specific 
biological annotation, regardless of whether the lists were derived from the same array 
or not.
Several different types of annotation are available within Bioconductor libraries for the 
probesets within each of the different types of arrays, and at least five types of 
annotation could be used in place of probeset IDs to compare genelists derived from the 
same species: Entrez Gene IDs (EGIDs), gene names, gene symbols, Unigene IDs and 
RefSeq IDs.
Annotation is not available for all probesets in any of the arrays analyzed. Also, there are 
differences in the number of probesets for which each of the different types of 
annotation is available. The numbers of probesets for which each of the five different 
types of annotation identified above are displayed in Table 10.1.
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Gene
Name
Entrez 
Gene ID Refseq ID
Gene
symbol Unigene ID Total
hgu133a 20056 21803 21139 21435 21284 22215
hgu133plus2 41175 48081 45808 47365 46730 54613
hgu95a 11587 12154 11982 12119 12073 12559
mouse4302 40821 41614 37007 41208 40041 45037
moe430a 22181 22347 21764 22266 22123 22626
mgu74av2 11909 12229 11618 11987 11840 12422
Rat2302 22684 23241 23025 23239 22904 31042
rae230a 13198 13462 13311 13456 13314 15866
rgu34a 7863 7970 7849 7966 7873 8740
zebrafish 11004 12249 8372 12249 11254 15502
drosgenomel 0 13130 13086 13092 12914 13966
drosophila2 0 14232 14175 14181 13973 18769
celegans 0 18480 18473 18473 15099 22548
T able  10.1 N u m b e rs  of a n n o t a t e d  p r o b e s e t s  in A ffym etr ix  m ic ro a r ra y  
p la tfo rm s .  Annotations were derived from Bioconductor meta-data packages. Blue 
cells indicate the highest number of annotated probe-sets for each array-type.
As can be observed, in all cases, more probesets are annotated with EGIDs than with any 
other type of annotation. It was also found that across all chips, any probeset that did not 
have an EGID annotation was also not annotated with anything else.
As the meta-data packages for the Arabidopsis arrays did not include EGID annotation, 
this was derived from the Affymetrix NetAffx Analysis Centre (Liu et al. 2003).
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10,2.1.2 Comparison o f list o f genes from  experiments involving different species
Because EGIDs are species-specific, lists of EGIDs from the same species are 
comparable; however lists of EGIDs from different species are not. In order to facilitate 
comparison of genelists from different species, the Bioconductor ‘homology’ packages 
were utilized. These packages were built using source data from the NCBI Homologene 
database (Wheeler et al. 2008).
In this format, a set of homologous genes across several different species are linked by a 
unique Homologene ID. Thus, a human gene can be linked to a homologous mouse gene 
through the shared Homologene ID. For ease of conversion, a database of homologous 
genes shared between all the array-types analysed was created by extracting these 
relationships from the Bioconductor packages.
Inconsistencies were observed in the data contained within these packages. For example, 
when all EGIDs present on the human hgul33a array were taken, and all their 
homologous genes on the mouse mouse4302 array were identified using the 
hsahomology package, a total of 10673 pairs of homologous genes were found. 
However, when changing the order of species, i.e. taking all EGIDs present on the 
mouse4302 array and identifying all homologous genes present on the hgul33a array 
using the mmuhomology package, a total of 10709 pairs of homologous genes were 
identified. These two sets shared 10642 gene-pairs in common. This phenomenon was 
observed in all pairs of species analyzed. To ensure consistency, only those gene-pairs 
that could be identified using the homology packages for both species were used.
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10.2.2 Statistical methodologies to assess similarity between 
genelists
As described in Chapter 2, the size of overlap between two genelists may not accurately 
quantify the level of similarity between two genelists, because this measure is sensitive 
to systematic effects of genelist size and universe size. Three metrics were tested 
regarding the feasibility of their use in assessment of the significance of observed 
overlap size.
10.2.2.1 Fold Change
Consider two genelists of lengths LI and L2, which have an observed overlap size O.
The expected overlap size E can then be calculated as such:
E _  (T1 * L2)
N
Here N  represents the size of the gene universe. The fold change (FC) can then be 
calculated as the ratio of the observed overlap size to the expected overlap size, i.e. O/E. 
As these values are asymmetrical in nature, they are usually logged. This was carried out 
using the R function lo g  (), using the default base (exponential of 1, i.e. natural log).
10.2.2.2 Binary similarity
The binary or Jaccard similarity index is the size of the overlap divided by the total 
number of unique genes present in at least one of the two genelists. Consider two 
genelists A and B. In set theory terms, binary similarity (BS) can be calculated as:
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10.2.2.3 Hypergeometric distribution
The hypergeometric test and its variants have popularly been used in Over- 
Representation Analysis (ORA) studies, for example, to test for the enrichment of GO 
terms within a genelist.
Consider two genelists, of sizes L \ and L2 that come from a gene universe of size N, and 
have an observed overlap size of O. Using the hypergeometric distribution, at least two 
metrics can be derived that can help assess the significance of similarities between any 
pair of genelists. The first of these is a Z-score (Z) which is an ‘effect size’ that 
represents a standardization of the observed overlap size, taking into account the sizes of 
the genelists and of the gene universe. It is calculated as the difference between the 
observed (O) and expected (E) overlap size, divided by the standard deviation of 
observed size (sdO). Thus,
Z = O - E
O -
L\*L2
N
sdO L ( L2 \ (, f L l - l }JL1 — 1------- 1 -
V y N  j I  N , V N - 1J
The second is a p-value (p) that is represents the cumulative probability of finding that 
two genelists of length LI  and L2 share O or more genes. It is calculated as:
'L \ '
\ l
N - L \
L 2 - i
/ =  o r N  ^
k L 2 j
Note that in both equations shown above, the positions of L\  and L2 are interchangeable 
(i.e. would lead to the same results). The formula for hypergeometric Z-scores was 
manually programmed into an R function. Hypergeometric p-values were derived using 
the R function p h y p e r  ( ) .
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10.3 Comparison of lists of differentially expressed genes using 
the hypergeometric test (Chapter 3)
Chapter 3 described the application of the hypergeometric distribution to assess the 
similarity between genelists derived from microarray-based experiments carried out on a 
range of Affymetrix array-types and species.
10.3.1 A local database of genelists manually extracted from 
published literature
For this purpose, a local database of genelists was created by manual extraction of 
genelists from published literature. Details of the numbers of genelists extracted for each 
Affymetrix array-types are shown in Table 3.1 in Chapter 3.
The genelists that were manually extracted from scientific publications, and any 
supplementary information provided, were those that were created using statistical tests 
and algorithms (for example, a t-test to assess differential expression of genes and 
subsequent multiple-hypothesis correction of p-values), rather than those created using 
manual curation (for example, a list of the top 20 genes exhibiting the highest levels of 
differential expression). The number of genelists derived from each of the publications 
varied widely; when more than one genelist could be derived from a single publication, 
they were collapsed into a single genelist using the R un ion  () function to achieve one 
genelist per publication.
Details of all genelists are provided in Appendix la. All genelists other than those for 
experiments performed on the Affymetrix hgul33a platform were kindly provided by 
Miss Hui-Sun Leong of the Department of Pathology at Cardiff University. All genelists 
are provided in Appendix lb.
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10.3.2 Comparison and statistical assessment of similarity between 
genelists across array-types and species
An overview of the technical methodology used to make genelists comparable and then 
assess their similarity is provided in Section 3.2 in Chapter 3.
The hypergeometric test provides a p-value for each test pair of genelists (see Section 
10.2.2.3), which represents the probability of the level of similarity (i.e. the number of 
shared genes) observed for that pair of genelists occurring by chance alone for genelists 
of that size, when sampled from the universe of that size. Typically a p-value of <0.05 is 
used as a cut-off level for significance i.e. a pair of genelists are only considered to 
exhibit statistically significant levels of similarity if that probability of such levels 
occurring by chance alone is less than 5%.
However, the simultaneous testing of many pairs of genelists creates an issue of multiple 
hypothesis testing. For example, consider that a genelist is compared to a set of 100 
other genelists; under the criterion of selecting those tests that yield p-values of <0.05, it 
is expected that 5 genelists would show significant similarity with the test genelist just 
by chance alone. These constitute Type I errors (false positives), and the number of 
these is expected to increase along with the number of simultaneous tests.
One of the popular methods to deal with this issue is control of the false-discovery rate 
(FDR) using the Benjamini-Hochberg method (Benjamini and Hochberg 1995). This 
methodology has been implemented throughout this thesis whenever there has been a 
need for multiple hypothesis correction, using the R function p . a d ju s t  ().
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10.3.3 Calculation of evolutionary distance between species
To calculate evolutionary distances between the different species from which genelists 
were compared, source data was extracted from the interactive Tree of Life (iTOL) 
project of the European Molecular Biology Laboratory (Letunic and Bork 2007). The 
multiple sequence alignment used to calculate distances within the tree between the 6 
species under investigation was downloaded. Using the Protdist program of the Phylip 
package of programs for phylogenetic analysis (Felsenstein 1993), distances could be 
calculated between each pair of species. This was carried out using the Dayhoff PAM 
matrix which comprises of empirically derived probabilities of the change of one amino 
acid within a protein sequence to another, and the distance computed is in units of the 
expected fraction of amino acids changed.
10.3.4 Extraction of genelists from the L2L database
As explorations of the local database of genelists indicated excess levels of similarity as 
assessed by the hypergeometric distribution, it was then desired to investigate if this 
phenomenon could also be observed amongst genelists collected in external databases. 
One such database is L2L (Newman and Weiner 2005), and this comprises of genelists 
that have been manually extracted from published literature. Genelists (where genes 
were represented as HUGO gene symbols) were downloaded from the L2L databases for 
experiments carried out on two human and two mouse Affymetrix arrays (see Table 3.4 
in Chapter 3) on the 26th of August, 2008. These genelists are provided in Appendix Ic.
While it was difficult to identify which genelists came from the same publication, it was 
possible to combine lists of genes that were found to be up or down-regulated in the 
same statistical test for differential expression within an experiment. This was carried 
out by combining those pairs of genelists whose names had the same prefix (for 
example, genelists with the names ‘XXX up’ and ‘XX dn’ were combined).
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10.3.5 Assessing the correlation between genelist length and 
significance
Section 3.3.3 described explorations indicating a link between gene set size and the 
levels of similarity of that genelist to all others from experiments carried out on the same 
array-type. Statistical assessment of this relationship was carried out using the Pearson’s 
product-moment test of correlation. Two metrics could be derived from this test: firstly 
an ‘effect size’ (called Pearson’s r), which varies between -1 and 1. A value of 0 implies 
no correlation; a positive r value indicates that the dependent variable increases with the 
causative variable, while a negative value indicates the opposite. The second metric is a 
p-value to indicate the significance of an observed r value. This was implemented using 
the R function c o r . t e s t  ().
10.4 Modelling violations of the assumptions of the 
hypergeometric distribution using the ‘biased urn'  model 
(Chapter 4)
Chapter 4 described explorations of the effect of changing the universe size used for the 
computation of Z-scores when using the hypergeometric distribution to assess the 
similarity between a pair of genelists. Also described was the implementation of the 
biased urn model, under which an estimated ‘average’ gene universe size is used to 
compute Z-scores instead of the total number of genes present on an array. This average 
size was estimated as follows: starting from a universe size of all genes on an array, a 
series of Z-scores distributions representing comparisons of all possible pairs of 
literature derived genelists was created by successively reducing the gene universe size. 
The median Z-scores for each of these distributions are plotted in Figure 10.1 against the 
gene universe size used for calculation of that distribution. The estimated average gene 
universe size was considered to be that which yielded a Z-score distribution centred on a 
median value closest to zero (vertical red lines in Figure 10.1).
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Figure 10.1  ad hoc e s t im ation  o f  th e  a v era g e  s ize  of th e  g e n e  universe  
shared b e tw e e n  any tw o  e x p er im en ts  using th e  b iased  urn m odel. Grey lines 
represent medians of a series of hypergeometric Z-score distributions for 
comparisons of all possible pairs of literature-derived genelists, created using a 
range of different gene universe sizes. X-axes represent gene universe sizes as the 
percentage of genes represented on each array; Y-axes represent hypergeometric 
Z-scores. The horizontal black line represents a median Z-score of 0, while the 
vertical red line represents the gene universe size used as an estimate of the 
average gene universe size for comparison between any two experiments.
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10.5 Exploring gene expression patterns with the GNF 
Expression Atlas (Chapter 5)
Chapter 5 described investigations of the variability of the sizes of the expression 
universes for a wide range of human tissue-types using the GNF Expression Atlas.
10.5.1 Data pre-processing and generation of expression universes
Original CEL files representing microarray data for human tissues were downloaded the 
Gene Expression Omnibus (GEO) database (Edgar et al. 2002), where this data was 
stored with the series identifier GSE1133. A total of 158 Affymetrix hgul33a samples 
were downloaded, which represented 79 different human tissues (two samples per 
tissue). Samples representing cancer cells and foetal tissues were removed, leaving 136 
samples representing 68 different normal human tissues.
The probe intensity values that comprise the CEL files were normalized and converted 
into probeset expression values using the Affymetrix Microarray Suite 5.0 (MAS5) 
algorithm (Affymetrix 2002). To avoid possible biases caused by the presence of more 
than one probeset representing the same EGID (as described in Chapter 2), one probeset 
was selected for each EGID represented on the hgul33a array. For this purpose, the 
median MAS5-normalized expression values for all probesets were recorded across all 
158 samples. For EGIDs having more than one probeset the one exhibiting the greatest 
median expression value was selected.
MAS5 Present/Marginal/Absent (PMA) calls were then used to identify genes that were 
expressed in each of the tissues (i.e. their expression universes). A gene was flagged as 
being expressed in a particular tissue if it was called as ‘Present’ by the MAS5 algorithm 
in at least one of the two samples that represented that tissue.
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MAS5 normalization of CEL files, and generation of PMA calls was carried out using 
the justMASO and detect ion. p. value () functions, respectively, both of which 
are available in the Bioconductor package simpleaf fy (Wilson and Miller 2005).
10.5.2 Hierarchical clustering of 68 human tissues using overlap  
sizes of expression universes
Section 5.2.3 described the use of hierarchical clustering for the unsupervised 
classification the 68 tissues. This was carried out to observe if the resultant groupings of 
samples could reflect tissue-specific expression patterns. Figure 10.2 displays the 
scheme used for the creation of a distance matrix for the clustering procedure. The 
simulations were designed to control for the effects of the variability in the sizes of the 
expression universes of different tissues on the size of overlap.
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Figure 10 .2  Deriving overlap s s iz e s  for u se  as  d is ta n ces  in hierarchical 
clustering of t is s u e s .
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10.5.3 Simulating the effects of using an estimated ‘average’ gene 
universe size.
Section 5.2.4 then described simulations to explore the behaviour of hypergeometric Z- 
scores, relative to the gene universe size used for their calculation, of comparisons 
between genelists created by random sampling of genes form universes of various sizes. 
Figure 10.3 displays the design for these simulations, which was formulated to enable 
control of the effects of genelist length on overlap size.
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Figure  10 .3  C alcu la t ion  of t h r e e  s e t s  of Z - s c o re s  u s in g  t h e  s a m e  s e t  of 
o v e r la p  s izes .
285
Chapter 10: Materials and Methods
10.6 Gene Set Discovery (GSD): Unsupervised identification of 
relevant biological themes within microarray datasets (Chapter 
6)
Chapter 6 described explorations using simulated gene expression matrices, and the 
development of GSD methodology as a tool to carry out unsupervised GSA.
10.6.1 Simulating gene expression matrices
The hypothetical gene expression matrices used in this chapter were intended to simulate 
log transformed, median-centred expression data. It is expected for genes that are not 
differentially expressed, expression values would vary around zero. Up-regulation is 
indicated by values >0; for example, when using log of base 2, a value of 1 represented a 
two-fold increase in expression as compared to the median value for that gene across all 
samples. Similarly, a value of -1 represents a two-fold decrease in expression.
Population of the hypothetical gene expression matrices with simulated expression 
values required estimation of the levels of variability of gene expression values expected 
in real-world data. For this purpose, 62 Affymetrix hgul33a microarray datasets 
downloaded by Dr. Peter Giles (Cardiff University) from GEO were used (data not 
shown). All datasets were logged and median-centred. If more than one probe-set was 
found to be annotated with the same EGID, the probe-set exhibiting the greatest 
variability in expression values (measured as IQR) was selected to represent that EGID; 
this process was carried out for each dataset separately. Standard deviations were 
calculated for each gene in every dataset, i.e. 62 standard deviation values were derived 
for each gene represented on the array. The median standard deviations for each gene 
were then derived. The median of these set of values was ~0.3.
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Thus, unchanged gene expression values were simulated by random selection from a 
normal distribution with a mean value of zero and a standard distribution of 0.3. 
Similarly, values representing up-regulation and down-regulation were randomly 
selected from normal distributions with means of 2 and -2 respectively, and a standard 
distribution of 0.3. This was carried out using the rnorm () function in R.
10.6.2 Distances and clustering
One of the most popular distance measures used to quantify the dissimilarity between 
genes and samples in a microarray dataset is the Pearson Correlation distance (see 
Section 1.3.2.1). The correlation distances used in this thesis are a variation of this; they 
differ in the aspect of using the cosine distances of median-centred gene expression data 
(as opposed to mean-centred data used in Pearson Correlation distance). This is because 
median values are more robust than mean values; the latter are more sensitive to outlier 
values. This was carried out by using the R function D i s t  () from the Bioconductor 
library amap. Hierarchical clustering was carried out using the average linkage method 
through the R function h e  l u s t  ( ) .
10.6.3 Significance testing in the GSD methodology
Chapter 6 described explorations that indicated that SD-SDM values may be suitable 
metrics to indicate the strength of sample clusters for a given set of genes. The 
significance of SD-SDM values observed for gene sets could be assessed by comparison 
with mull distributions of SD-SDM values; two strategies for creating null distributions 
were tested. A null distribution of 10,000 SD-SDM values was calculated for each 
separate length of gene set tested. Two metrics to quantify the significance of observed 
SD-SDM values could be derived: Z-scores and p-values. Z-scores provide ‘effect sizes’ 
which are standardized quantifications of the extent of deviation of an observed SD- 
SDM value from those in the null distribution. This was calculated as:
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_ Obs -  mean(Null)
Z ~ s.d.(Null) ’
Here, z  is the Z-score, Obs is the observed SD-SDM value and Null is the null 
distribution for the gene set being tested (based on its length). P-values represent the 
probability that an observed SD-SDM value could have been observed by chance alone. 
This was calculated as the number of SD-SDM values, in the corresponding null 
distribution for an observed SD-SDM value, that are greater than or equal to the 
observed SD-SDM value, divided by the size of the null distribution (10,000).
10.7 Application of the GSD methodology to four microarray 
datasets (Chapter 7)
Chapter 7 described the results of the application of the GSD methodology to four 
microarray datasets.
10.7.1 Data acquisition
The first dataset analyzed using the GSD methodology was a subset of the GNF 
Expression Atlas (Su et al. 2004). This is the same dataset that was used in Chapter 5. 
See section 10.5.1 for further details. The second dataset analyzed was the Ross AML 
dataset (Ross et al. 2004) created using the Affymetrix hgul33a platform. Raw data 
(CEL files) was downloaded from the website of the St. Jude Children’s Research 
Hospital (Tittp://www.stiuderesearch.org/data/AML 1 /rawFiles/). Only that subset of the 
data was used which represented tumour samples that could were categorized in the 
original study into one of five different AML sub-types. Samples that were classified as 
‘other’ were not considered. The third GSD analysis described was that of the Broccoli 
liposarcoma dataset, which was created using the Affymetrix hgul33plus2 platform. 
This was provided by Dr. Dominique Broccoli from the Curtis and Elizabeth Anderson
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Cancer Institute at the Memorial University Medical Centre, USA. The final GSD 
analysis was performed on the Ivshina breast cancer dataset (Ivshina et al. 2006). Both 
raw data (CEL files) and clinical data (used in survival analyses) were downloaded from 
the Gene Expression Omnibus (GEO) database (Edgar et al. 2002), where this data was 
stored with the series identifier GSE4922. Only data from the Uppsala cohort was used. 
This dataset was created using the Affymetrix hgul33 set platform, which includes both 
the hgul33a and hgul33b arrays. Only data from the hgul33a arrays was used.
10.7.2 Data pre-processing and transformation
All datasets were normalized using the MAS5 algorithm. This was carried out using the 
R function j u s t M a s  () which is available in the Bioconductor package s i m p l e a f f y  
(Wilson and Miller 2005). Normalized data was then further processed prior to 
application of the GSD methodology firstly by log transformation and then by median- 
centring. Log transformation was carried out with the R function l o g  ( )  .
10.7.3 Gene Ontology Biological Process terms
The series of gene sets representing biological themes used for GSD analyses of 
microarray datasets were Gene Ontology Biological Process (GOBP terms). Gene sets 
were created for each different Affymetrix platform separately. These were derived from 
the Bioconductor annotation package GO. This was carried out by extracting the GOBP 
term annotation for each EGID represented on any particular array. Gene sets for each 
GOBP term could then be created by selecting all genes which are annotated with. 
Because the Bioconductor annotation package provides for each EGID only the most 
specific GOBP annotation, the gene set for each GOBP term was also made to include 
all genes annotated with any descendant GOBP terms. For all GSD analyses, those 
GOBP terms comprising of less than 5 genes, or more than 10% of genes present on an 
array, were excluded.
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10.7.4 Hypergeometric tests
ORA analysis of the classifier developed by Ivshina et al (Ivshina et al. 2006) was 
carried out using the hypergeometric statistical test (see Section 10.2.2.3). The gene 
universe used for this purpose comprised of all EGIDs represented on the Affymetrix 
hgul33a array for which GOBP term annotation was available. Thus, two genes from 
the classifier (EGIDs 57758 and 83461) were excluded because they were not annotated 
with any GOBP terms. The hypergeometric test was also used to assess the enrichment 
of tumour grades in sample clusters derived from mitosis/cell cycle GOBP terms 
selected by GSD analysis of the Ivshina breast cancer dataset. The universe comprised 
of all samples in the dataset.
10.7.5 Survival analyses
Kaplan-Meier survival curves and assessment of the difference between survival rates 
were carried out using the R functions survfitO and coxph() respectively. Both 
functions are available as part of the R package survival.
10.7.6 Biomarkers
Figure 7.20 shows the expression values for three biomarkers in the Broccoli 
liposarcoma dataset. The first (7.20a) is that for the IGKV gene which is represented on 
the hgul33plus2 array by the probeset 214768_x_at. The second (7.20b) is that for the 
MCM2 which is a biomarker for proliferation, and is represented by the probeset 
202107_s_at. The third (7.20c) is that for the adipocytic biomarker leptin, which is 
represented by the probeset 207175_at. The data represented in the plots is log 
transformed MAS 5 expression data.
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10.8 Extraction of informative genes and visualization of GSD 
results (Chapter 8)
This chapter described two further extensions developed for the GSD framework of 
analysis. The first of these was a methodology to extract informative genes from within 
gene sets selected by the GSD methodology. The second was a scheme for integrated 
visualization of results.
10.8.1 Simulation of expression matrices
To simulate gene expression matrices to test the metric developed to extract informative 
genes, the same principles were used as for the simulations described in Chapter 6 (see 
Section 10.6.1)
10.8.2 Clustering of gene sets
Part of the scheme developed to visualize results of GSD analyses was displaying of 
relationships between GOBP terms. This was carried out by creating a binary matrix 
using genes selected as informative by GSD. In this matrix, the rows represented the 
genes and the columns represented GOBP terms. The presence of GOBP annotation for 
a gene was indicated by a cell value of 1, and absence by 0. Using this correlation 
distance matrix could be created for the GOBP terms, which was in turn used for 
hierarchical clustering using the average linkage method. The dendrogram derived from 
the clustering was used to represent relationships between the GOBP terms in the 
visualization scheme.
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10.9 Summary and General Discussion (Chapter 9)
Chapter 9 comprises primarily of summarization and discussion of the results and 
explorations described in Chapter 2-8.
10.9.1 Analysis of microarray datasets using adSplit
One of the few instances of primary research described in Chapter 9 involves analysis of 
microarray data using the adSplit methodology (Lottaz et al. 2007). This was carried out 
as an initial comparison between GSD and adSplit. For this purpose, the same datasets 
were used as had been used for GSD analyses described in Chapter 7, and the same pre­
processing (MAS5) and transformation (log and median-centring) steps were 
undertaken. The same series of GOBP terms were also used, except without GOBP 
terms that contained only 5 genes, because with the default settings, adSplit removes the 
top 5 most variable genes from analyses. For this purpose, the FDR correction was re­
applied to p-values derived from GSD, without these excluded GOBP terms.
The adSpit methodology was implemented using the diana2m eans () function 
available in the Bioconductor package a d S p lit .
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A ppendices
All appendices are provided in the attached CD-ROM.
Appendix I: Literature-derived genelists
(a) Details of literature-derived genelists
An Excel spreadsheet is provided containing the details of all the genelists that were 
manually extracted from the literature, and used for the comparisons described in 
Chapter 3.
(b) Literature-derived genelists
This comprises of a folder containing all the literature-derived genelists that were 
compared in Chapter 3. These are provided as R objects names after the Affymetrix 
arrays that the genelists were derived from. Each of the R objects contains a binary 
matrix called ‘EGMat’, where the rows represent all genes (as Entrez Gene IDs) on the 
respective array, and the columns represent experiments. A cell value of 1 indicates the 
presence of the gene represented by that row in the genelist derived from the experiment 
represented by that column; a value of 0 indicates its absence.
(c) Genelists from L2L
This comprises of a folder containing genelists that were downloaded from the L2L 
database and compared in Chapter 3. They are provided in a similar format as the 
genelists in Appendix lb, except that genes are represented by HUGO gene symbols 
rather than Entrez Gene IDs.
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Appendix II: R code for GSD analysis
(a) GOBP_lists
R code to derive Gene Ontology Biological Process (GOBP) annotations for all genes 
that are represented on a particular Affymetrix array.
(b) Transformer
R code for log transformation and median centring of MAS5 gene expression data, as 
well as the selection of a single probeset per Entrez Gene ID represented on the array.
(c) Null Distribution
R code to create the null distribution of SD-SDM values for comparison with those 
derived from GOBP terms.
(d) GSD
R code to calculate SD-SDM values for GOBP terms and the comparison of these with 
the null distribution SD-SDM values to derive p-values and Z-scores.
(e) Informative genes
R code to extract informative genes from within GOBP terms selected by GSD.
(f) Visualization
R code to visualize results of GSD analysis using an integrated scheme.
(g) GSD Usage
R code demonstrating how the above functions can be used, starting from MA5 data.
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